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1. INTRODUCTION 
 
 
Every form of medicines representing the vast materia medica available in 
numerous Traditional systems of medicines are based on the modification of  
formulations to the stage which it can be used in wide category of health conditions in 
accordance with the age , body constitution, nature of disease and its influence in 
digestion and metabolism. Siddha medicine, which was developed and propounded by 
ancient supreme spiritual sages called siddhars with a vision of not only establishing a 
medical science for the health wellbeing, also to implement and guide fundamental ethics 
in each one for their spiritual enrichment towards reaching their ultimate goal of wisdom.  
 Siddha medicine considers human body as the direct replica of nature. With much 
praise to the divine, quote “Andathil ullathey pindam, pindathil ullathey andam “stated 
by Siddhar Sattaimuni there are so many Siddhar school of thoughts in high class Tamizh 
which quantifies the theories of human body origin expressed in material anatomy called 
Panchabootha Panjeekaranam, its evolution , Physiology, Transformation and finally 
degeneration. All this phenomenon comes under the eternal basic principles called 96 
Thathwam or constituent principles including Physical, psychological and spiritual 
entities of a human being. The Siddhars School fully recognizes these ninety-six 
thathwam and further added that human body is composed of 72,000 blood vessels, 
13,000 nerves, 10 main arteries, 10 vital airs all together in the network; and it is, owing 
to the derangement of the any of the principles one become liable to 4448 types of 
diseases
(1)
. 
As a fact of substitution any ailments pertaining to human body there is a healing 
part in nature. Siddha systems, which were developed under the principles of nature, use 
vast variety of material resources from plant, animal, and mineral kingdom. Siddhars had 
an in-depth knowledge in every aspect of natural resources and how it can be transformed 
to healing elements of medicine. Understanding the body nature and the sufferings it 
catches is as tough as understanding the elements of nature. For the effective application 
these natural elements has to be directly or indirectly modified, processed into a form 
acceptable or assimilable by the body constituents. Accordingly, they developed lakhs of 
formulations under different categories each suiting for specific conditions of the body 
and the disease
(2)
. 
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Theeneer
(3)
 or Distillery medicines is one such unique form of medications  under the 
category of 34 common medications (Makkal Urai) and as the first choice in Divine 
treatment ie, 12 supreme classes of medications called Deva Maruthvam
(4)
. Vast 
commentations on Theeneer/Dravagam are attributed to Siddhars like Agasthyar, 
Nandidevar, Thirumoolar, Pulasthyar, Bohar, Theraiyyar, Konganavar, Yacobe, 
Ramadevar, Yugimuni etc. 
The sufferers of liver diseases and asthma are day by day increasing and is now very 
common in our clinical practice. Identifying a novel drug of choice in Liver diseases and 
respiratory diseases is a challenge to the Researchers. Apart from drug of choice, the 
factors like the nature of the formulation, its palatability and faster efficacy has to be also 
considered wisely. As Theeneer is an ideal drug which may cover up all the factors 
mentioned above, the researcher has selected a classical distillate formulation named 
“Sanjeevi Theeneer” that are indicated for wide range of diseases including Liver 
diseases, respiratory diseases, skin diseases, Cardiac diseases etc. The drug has not been 
put into clinical practice or undergone validation. As an initial step Sanjeevi Theeneer 
will be prepared as per the Siddha literatures, Formulation has been standardized, 
analytical studies has been performed followed by Toxicity studies and Pharmacological 
studies in Animal models. The safety and efficacy is established which may pave the way 
for Clinical evaluation. 
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II. AIM AND OBJECTIVES 
 
Aim  
To evaluate the Safety and Pharmacological profile of the test drug “Sanjeevi 
Theeneer” in Animal Models. 
 
 Primary objective  
 
1. Preparation of the Trial drug as per the Siddha literature. 
2. To standardize the trial drug as per AYUSH guidelines. 
3. To Study the Acute, Sub acute and Sub Chronic Toxicity studies of the trial drug 
as per the OECD guidelines. 
4. To Evaluate the Hepato protective activity, Broncho dilator and Anti-Histamine 
activity of the trial drug. 
 
 Secondary objective  
 
1. To Assess the Anti-oxidant property of Sanjeevi Theeneer which supports the 
therapeutic potential of the drug. 
2. To Evaluate and assess the Hepato protective activity of the trial drug against 
Paracetamol induced Hepato toxicity in lower vertebrate like Zebra fish (Danio 
rerio) model.  
3. To compare and study the differences of trial drug prepared from both Traditional 
apparatus and Glass still through GC-MS Analysis. 
4. To collect and document all the literature reviews of Theeneer.  
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III. MATERIALS AND METHODS 
 
DRUG PROFILE 
a. Drug selection and Reference 
Sanjeevi Theeneeris a classical Siddha Herbo mineral distillate formulation mentioned 
in Chikitsa ratna deepam and Siddha Formulary of India 
(5) 
 
b. Ingredients of Sanjeevitheeneer (Table no:  1) 
 
 
S. 
NO 
Ingredient 
Botanical/Scientific 
Name 
Parts Used Quantity 
1 Chukku Zingiber officinale Dry Rhizome (Outer 
skin removed) 
60 g 
2 Milagu Piper nigrum Dry fruit 60 g 
3 Thippili Piper longum Dry Berry 10g 
4 Kadukkai thol Terminalia chebula Dry fruit (seed removed) 25g 
5 Nelli vatral Phyllanthus emblica Dry fruit (seed removed) 50g 
6 Tantrikkai thol Terminalia belerica Dry fruit (seed removed) 25g 
7 Omam Trachyspermum ammi Dry fruit 25g 
8 Vaividangam Embelia ribes Dry fruit 25g 
9 Chithramoola Verpattai Plumbago zeylanica Dry Root Bark 30g 
10 Korai kizhangu Cyperus rotundus Dry Tuber 25g 
11 Panam karkandu Borassus flabellifer Palm Candy 20g 
12 Irumbu Podi Purified Ferrum 
powder 
      -- --------- 60 g 
13 Water   6 Litres 
 
 
c. Raw Drug collection and Authentication 
All the ingredients (Fig: 1) were purchased locally from reputed raw drug shops in 
Chennai and Nagercoil. The herbal ingredients were identified and authenticated from 
the Botany division, National Institute of Siddha (Authentication No: 
NISMB2472016), the mineral sample were identified from Department of Geology, 
Anna university (Annexure 2). 
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Fig: 1 INGREDIENTS OF SANJEEVI THEENEER 
 
   Chukku (Zingiber officinale)               Milagu (Piper nigrum) 
  
 
       Thippili (Piper longum)                   Kadukkai (Terminalia chebula) 
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    Nelli vatral (Phyllanthus emblica)            Thantrikkai (Terminalia belerica) 
 
Omam (Trachyspermum ammi)   Vaividangam (Embelia ribes) 
 
     
      
 
 
 
 
 
 
     Kodiveli verpattai (Plumbago zeylanica)    Panam karkandu (palm sugar candy) 
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Method of Preparation 
d. 1 Purification of Raw drugs 
Table: 2 - Purification (Suddhi) Process of Individual Raw Drugs 
(6) 
 
S.No Raw Drug Method of Purification 
1 Ayam Powdered finely soaked in lemon juice for three days. In 
addition, grinded well, washed and dried (Fig: 2) 
2. Chukku Outer skin removed. 
3. Milagu Cleaned, sorted, and dried. 
4. Thippili Cleaned and dried. 
5. Kadukkai Inner seed removed, washed and dried. 
6. Nelli Vatral Inner seed removed, washed and dried. 
7. Thantrikai Inner seed removed, washed and dried. 
8. Omam Cleaned, sorted and dried. 
9. Vaividangam Cleaned, sorted and dried. 
10 Kodiveli Ver 
pattai
 
Washed thoroughly, cut into pieces, and then soaked in chunna 
neer (Limewater) for 1 samam (3 hours) Finally washed and 
dried again. 
11 Korai kizhangu Cleaned and sorted washed and dried. 
12 Panam 
Karkandu 
Cleaned and sorted. 
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          Fig: 2 Raw Iron powder 
 
 
 
 
 
 
 
 
 
 
Ayam (Raw powder before purification)         Ayam powder soaked in Lemon juice 
               
             Ayam completely dried                           Ayam powder after Purification 
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TRIAL DRUG PREPARATION 
 
For the comparative study of distillates prepared from Traditional still (Valai 
iyanthram) and Glass still denoted as ST (t) and ST (g) respectively. The Comparative 
study is aimed to identify which make of distillate meets the quality parameters as 
mentioned in the Siddha literature and its scientific perspective through GC-MS Analysis. 
Apart from the comparative studies, the sample ST (t) will be utilized for all the Drug 
Standardization, Bio chemical and Preliminary Phyto chemical screening. All the 
concerned Toxicological and Pharmacological studies will be carried out by using ST (t) 
sample. Third sample of Sanjeevi theeneer, ST(c) is prepared in further concentration, 
will be subjected to GC-MS studies only for in depth analysis of the Organic compounds. 
 
d.2 Preparation of Distillate sample - ST (t) and ST (C) 
 
 All the dried raw drugs were powdered and mixed with prescribed quantity of 
water and kept for fermentation upto a period of 7 days. This counts the period of 
fermentation.  
 On the 8th day, the whole mixture is thoroughly stirred and charged in Valai 
iyanthram (Traditional mud still) (Fig: 4). 
 Distillation was started in low flame and the Theeneer was collected a separate 
thick glass bottle with tight lid. 
 The sample was preserved in dark and under moisture and damp free condition 
for all the concerned Analytical, Toxicological and Pharmacological studies. 
 ST (C) sample is Prepared in the same procedure as mentioned above, but with 
the difference in the quantity of water added (1.5 litres for the Batch size). 
 
 
d.3 Preparation of Distillate sample- ST (g)  
 
 This mixture (drug with water) were charged in a glass still which consist of a flat 
bottomed round beaker (1 litre Capacity) , Cylindrical condenser with coils (glass 
made) with provision of water inlet, outlet and steam outlet in one side connected 
to the beaker via „U‟ bend and distillate outlet connected to the collecting bottle. 
 The whole apparatus rests in a heating mantle and temperature set in different 
intervals up to the maximum 100 
0
c (Fig: 5) 
 The distillates collected were preserved for studies. 
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Fig: 2 ST – Fermentation             Valai iyanthram                     Glass Still Apparatus 
 
 
Labeling: 
 
Name    : Sanjeevi Theeneer 
Color    : Light Lemon Yellow  
 Dose    : 15 – 30 ml 
Adjuvant   : Diluted with water 
Date of manufacture  :  15.09.2016 
 Date of expiry   :  1 Year 
 
Indication: 
 
 Kamalai (Jaundice) 
 Peruvayiru (Ascites) 
 Gunma katti 
 Moola noikal (Hemorrhoids) 
 Venkushttam (Leucoderma) 
 Sori, sirangu (Scabies and pruritis) 
 Ilaippu Irumal (Pulmonary Tb) 
 Iraippu Irumal (Bronchial Asthma) 
 Marbu noi (Cardiac ailments) 
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4.1 a Review on Theeneer Maruthvam (Distillation Medicines) 
 
Distillation products are far seen as a special dosage form in all these systems of medicine 
of Indian, Chinese and Persian origin. Experts belonging to each medical system had an immense 
knowledge of extracting valuable essences from raw materials primarily using herbal ingredients. 
The science of distilling materials of herbal origin or non-herbal sources has been elaborately 
discussed in Siddha medicine and the knowledge of chemistry mingling with the medicine 
preparation is far more superior than any other Traditional systems. 
 
 Numerous ancient theories of drug selection and manufacture has been mentioned each in 
significance with each method of drug preparation. Siva Sakthi Thathvam
1
 (Core Essence and 
Energy concept) has been much applied with art of distillation followed in Siddha. An ideology 
contributes the facts about the two major energy existences in each material present in nature and 
how it is classified based on the energy predominance. Sivam or Core Essence is the subtle energy 
part of a material and the Sakthi the subtle material energy surrounding it. Equilibrium of both the 
energies maintains the stability of the material. Theeneer / Dravaga murai (Distillation process) is 
rooted on the concept of separating Sivam or the Core extract of a herbal ingredient in case of 
herbal distillates or separating material energy in the case of mineral or salt distillation thus 
making the distillate Siva Veeryam or Sakthi Veeryam or combined Siva Sakthi Veeryam 
distinguished and termed in-respective of their potency. 
 
Theeneer and Dravagam more or less similar in conceptology but differs in their process 
or make (including raw materials used) and its application part. Both are coined as different form 
of distillates in majority of classical works but the terminologies are commonly used for the same 
distillates 
(7, 8)
. 
 
Theeneer  
 
1. Concept and Terminology  
 
 Theeneer
(3, 9)
 is the distilled essence, which contains the volatile constituents or 
water-soluble constituents of the drugs used in the preparation in a medium of water. 
They are colloidal suspensions (hydrosol) of essential oils as well as water-soluble 
components obtained bysteam distillation from plants/herbs. 
Theeneer (Thee = Fire, Neer = Water)  
 Known by various names like Vatru marunthu, vaattu
, (11)
, Aaavi Neer
 (10)
, Valai Neer 
literally denotes distilled water or essence.  
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These are the common distillation products obtained mainly from plant resources 
that may be simple or compound formulations with or without adding minerals. The 
procedures for manufacture are accessible or uncomplicated, and resulting distillates are 
mainly used as medicines or as neutraceuticals. Herbal distillates are the most commonly 
practiced form among traditional siddha practitioners and as a health supplement among 
the dravidian peoples truly blended with their culture. These are milder forms of 
distillates with less concentration, potency and shelf life. The herbal parts after 
purification, soaking or fermentation in suitable media is charged inside a traditional 
distillation apparatus (Vaalai iyanthram) and subjected to distillation. The steam 
generated due to boiling of the contents rises up, condensed and released out as purest 
form of distillates. Essential oils from the herb parts usually escape much faster before the 
boiling and are collected in the container .These may float as a supernatant layer in the 
distillates and are termed as Theeneer ennai, which are separated and used. 
 
 
Theeneer ennai:  (Essential oil obtained from herbal distillation)
(13) 
 
 These are the volatile oils collected during the first phase of distillation of herbs. 
Theeneer ennai is widely used internally, externally and as an aromatic additive for oils, 
topical linaments and lotions.  
 
1. Classification of Theeneer (based on formulations) 
 
Siddha system describes the usage of wide range of raw materials (plant, animal 
or mineral resources) to obtain the distillates and its nature, yield and properties is 
dependent on the ingredient used. Distillation products can be classified in reference with 
the type of formulations into: 
 
a. Thani sarakku Theeneer/Dravagam (Uni compound distillery formulations) 
were only single plant resources or mineral is used. 
Egs: Senkottai Dravagam
 (7)
, Vasambu dravagam
 (8)
, Pudina theeneer
 (5)
, Sombu 
theeneeer, Oma theeneer
 (13)
. 
 
b. Pala sarakku Theeneer/Dravagam (Poly compound distillates) were a 
mixture of several herbs, animal products or minerals are used. Egs: Oma Dravagam
11
, 
Mahaguru Dravagam,Sanjeevi theeneer. 
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1.Method of Preparation
 (1-36)
  
 
a. Apparatus   
The apparatus used for distillation is termed as Valai iyanthram
 (14)
Valai is defined as the 
apparatus with provisions or outlet tube to collect the distillates. 
 
 
b. Types of Distillation apparatus
 (15) 
Different types of distillation apparatus has been mentioned depending on the making or 
material used for the distillation. 
 
1. Munn valai (Traditional valai iyanthram made with clay). 
2. Uloga valai (Apparatus made with metals). 
     a. Irumbu valai (Iron apparatus). 
     b. Thambira valai (Copper apparatus). 
     c. Velli Valai (Silver Apparatus). 
3. Spadika valai or Kannadi Valai(Glass made). 
4. Peenkana Valai (Porcelain made) 
 
The types will be selected based on raw materials used suited for various 
distillation methods. Each made has its own peculiarity and it includes the heat 
tolerability, yield and quality of the distillates. Metallic apparatus are indeed used for 
specific preparations. As the raw materials to be distilled should not react with the metal 
used, it is chosen only for herbal distillate production. 
 
Spadika valai (glass made) fails in heat tolerability. With much safety issues, it is 
not chosen for salt, caustic, concentrated distillates in which the apparatus has to bear 
extreme heat and pressure
(15)
. A sustained heat more or less than the boiling point of 
water can be maintained within a glass made apparatus and is optive for distilling herbal 
parts. High yield of volatile oils and clarity distillates can be obtained by it. The usage of 
porcelain made is uncommon in practice and needs further studies. 
 
Among all the apparatus, the traditionally made apparatus stands unique with its 
high heat tolerability, unreactive to raw drugs, higher alkalies or salts with assured quality 
and purity of the distillates. There will be mild to moderate yield loss depending on the 
quality of the clay apparatus. 
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c. Parts of a Traditional distillation apparatus or stills  
 
The apparatus consist of many components, which are equipped in such a way to 
form a single unit, which are collectively termed as Valai Iyanthram or Dravaga valai. So 
many models of various sizes were used depending on the yield required 
(15)
.Clay made 
apparatus(Munn valai
 9
) that in vertical installations are most commonly used. The 
different components of an apparatus serve each purpose and are specific in its make. 
 
Lower vessel (kalayam) is used to charge the raw materials with the medium for 
distillation. Suitable capacity of lower vessel is selected to accommodate the medicine to 
be distilled. The length of the neck portion should not be less than three finger breadth 
with narrow mouth region that has to be tightly fit with the upper vessel (vaalai). The 
junction between the kalayam and vaalai is sealed with clay paste, and after dying of the 
plaster the entire setup is subjected to heating process.  
 
The upper vessel (vaalai) consists of a condenser part to provide a continuous 
water flow above the vessel. Provisions of water inlet on one side and outleton the other 
side are long enough to release the heated water away from the apparatus. The openings 
of the inlet and outlet within the condenser is at different height levels, and the water 
current is maintained in such a way that the cool water flowing in is proportional to the 
heated water going out. From inside an outlet is connected to collect the condensed 
distillates. The outlet tube (valai iyanthra mookku, keezh kuzhai) that is slightly curved as 
a nose is facing downwards in the opposite side of the water outlet with the tip of the 
outlet called receiver (Thamar vai, Kathir vai) kept inside the collecting bottle. 
 
To collect the distillates tightly stoppered thick glass bottles (eg: Vediyuppu 
dravagam, Porcelain bottles (Peenkan kuppi, Peenkana Kinnam) with tight lid or stone 
cork /wooden cork will be used. 
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Table: 3 Basic comparisons of Traditional and Glass Stills. 
 
 Features Glass Stills Traditional Apparatus 
1 Make of the Apparatus Glass Clay Soil 
2 Parts of the Apparatus 
(full set) 
a. Glass beaker (Borosil flat 
bottomed (1no). 
b.‟U‟Bend (2 nos) 
c. Condenser with Steam 
inlet, Distillate outlet, water 
inlet & outlet. 
d. Collecting Bottle (1no). 
e. Heating Mesh. 
a. Lower Vessel 
b. Upper Vessel with 
condenser part, Water inlet 
and outlets, Distillate outlet. 
c. Collecting Vessel or bottle. 
3 Working on Electricity Conventional Fuels
 
4 Heat Loss Minimal Considerable 
5 Steam Loss Minimal Depends on apparatus quality 
and sealing. 
6 Safety Issues
5 
Susceptible to breakage 
during process or 
inexperienced handling. 
Safety issues are concerned. 
No issues of safety 
7 Purpose & Limitations
 
For distillation of water, 
alcohol, herbs. 
*Not suited for Salt 
distillations or super 
concentrated distillates. 
*Best for commercial 
extraction of Volatile oils. 
For distillation of wide range 
of materials of herbal, herbo-
mineral compounds. 
*Best for salt distillations and 
concentrated distillates. 
*Best for Manufacturing 
Traditional therapeutic 
distillates. 
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d. Pre procedures 
 
Before each distillation, preprocedures are done with the aim to make the drug 
ready for distillation. The extracts of the materials will be easily released into the 
medium, also it maintains an environment needed for the conversion of the raw material 
to the stage easier to distillate, or either it purifies or improve its potency of the material 
used. So many traditional preprocedures that is mentioned before one distillation 
depending on the processes or raw material nature. 
d.1 Raw material purification 
d.2 Pounding, powdering or grinding: 
  
The materials become finer, solubility of the raw drugs in the media will be 
fastened and the essence or compounds will become easily available in the media. 
Grinding in suitable media ensures proper mixing. For herbal distillation, the purified 
herbal parts are pounded well before soaking or fermenting for better extraction of 
essence.  
 
d.3 Soaking in Specific media or to enable Fermentation. 
 
Most of the raw drugs before subjecting to distillation are soaked in suitable 
media for specific periods. Soaking dissolutes the raw material in the the media and its 
period may depend on the hardness of the raw material. The main purpose is to soften the 
material and to enable faster extraction while distillation. 
 
Role of fermentation in distillation 
 
 Fermentation has a notable role in the art of distillation. During the process, it 
induces natural alcohol formation and a pH, which favors good solubility of the 
raw material with Simultaneous extraction of wide range of phyto constituents 
from the herbal parts. 
 Detoxification of contaminants or any toxic components from the herbal part also 
occurs during fermentation.  
 Two methods are adopted for fermentation with respect to distillation in Siddha 
system. one is by inducing basic fermentation by adding natural fermenters 
another by  using  synthetic acidic distillatesprepared from omam (Carum 
copticum), padikaram (Alumen alum) and vediyuppu (Potassium nitrate. For 
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fermentation suitable media like water, plant juices are mixed with coarse or fine 
powdered raw drugs along with addition of natural fermenters or synthetic acidic 
distillates in properly sealed vessels preferably wooden or porcelain vessels to 
maintain a controlled and sterile environment.  
 The process of fermentation is considered to improve the power of the 
mixture(Siddhi) before undergoing distillations.  
 
d.4 The raw drugs exposed directly or indirectly to various environments 
 
 Powdered raw drugs are mixed with suitable media kept in sunlight (Soorya 
pudam) until complete dehydration (eg: kadukkai dravagam)
,
 or upto specific periods (eg: 
Kavattam pul dravagam) and finally distilled. In some preparations, powdered raw drugs 
are kept exposed to night dew or moon light (Pani Pudam, Chandra pudam
)
 prior to 
distillation. 
 
e. Procedures employed after distillation
 
 
After herbal distillations, the mud apparatus (both upper still and lower vessel) are 
carefully dismantled and soaked in water not less than one samam (3 hours) washed 
thoroughly and sundried. This method prevents crack formation in mud vessels due to 
constant heat, cross contamination of medicines and makes its ready for the next 
preparations.  
 
Factors determining quality of Theeneer
(1-36)
  
 
The factors that determine the quality and yield of Theeneer include: 
 
1. Quality of the raw material used : 
 
Raw materials of superior quality, devoid of pest or rodent contamination and 
which followed strict purification (if applicable) has to be selected. Expired herbs yield 
inferior quality distillates. 
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2. Apparatus  used for distillation :  
 
 For traditional mud vessels or apparatus quality of the clay used, thickness of the 
vessel, and its method of making has an impact in the yield obtained directly 
proportional to the wastage of medicines. 
 Good yield denotes collection of more than 70% of the quantity of the batch 
volume used. 
 Mud vessels showing cracks after heating indicates less heat resistance due to 
usage of inferior quality clay.Clay pots that have been fired to a point and gazed 
make them more heat resistant.  
 Mud vessels with high porosity will absorb the liquid medicines when kept for a 
long time this may be due to improper baking in traditional owen or its 
preprocessing as mentioned below.  
 Pretreated mud vessels are used in all distillation process, which include soaking 
the mud vessel for at least 2 hours to a full overnight in water, pouring rice 
washed water into the mud vessel, which is kept for a day or upto 4 days.   
 For other types of apparatus as mentioned, materials that hinder the quality is 
avoided. For Distillation the contents are filled upto half of the vessel. 
 
3. Medium for distillation :  
 
Media acts as an effective solvent for most of the raw drugs and as a carrier for 
the medicine principles of the raw drug, that is undergone distillation, and some were 
used due to its therapeutic value. In majority of distillations, pure water is used as the 
medium for distillation. Apart from this dew water (eg: Pooneerdravagam), rice 
washed water (eg: Pooneerpugai neer ), herbal juices (eg: Injidravagam
)
, honey (eg: 
Then dravagam) cow‟s milk (eg: Moongiluppathi Theeneer ) animal urine (eg: 
kadukkai dravagam ) are also used in special formulations. 
4. Quantity used 
 
As a general rule the quantity of water in which the raw drugs completely soaks or 
two parts of the total raw material weight (eg: oma dravagam) or 12 parts of the raw 
material weight (eg: Sanjeevi theeneer). With experience one can ascertain that quantity 
of the water added which varies with nature of the raw drugs, yield or concentration 
needed. 
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5. Plastering 
 
The junction of the two vessels will be properly plastered and dried. This will prevent 
steam loss and ensure heat retainibilty within the vessel for proper boiling of the contents 
or its condensation. Therefore, for maintaining heat retention and for considerable 
distillate yield, proper plastering is crucial
. 
 
6. Fuels: 
Firewood that does not hinder the quality of Theeneer should be used. Varatti 
(cow dung cakes) are also mentioned in special preparations.  
 
7. Mode of heat application 
 
 
The heating procedures should commence from low flame called deepakni
,
 then mid 
flame (kamalakni).  The control of heat is very crucial in distillation, as it maintains a 
slow, steady and maximum extraction or release of phyto compounds and volatile oils in 
case of herbal distillation The herbs should not come in direct contact with heat. It means 
the distillation should not start with high heat or kadakni, which causes chaaring of the 
herbal parts, rapid dissolution of volatile contents and alkaloids. This not only reduces the 
yield, the distillate becomes unpleasant in taste or odour and is considered as inferior 
quality. 
 
8. Storage of distillates and expiry 
 
Bottles should not be kept open after usage. This will prevent the escape of 
valuable essential oils in case of herbal distillates and reactions due to oxidation in case of 
dravagam.Shelf life period of Theeneer is limited to one year.
 
 
5. Traditional quality parameters of distillates(22) 
 
 With reference to traditional experience and literature review, Theeneer should 
have the peculiar color, taste, odor and medicinal property of that of the raw 
drugs used. Otherwise is considered as inferior quality. 
 It is by experience one can know the time for distillation and the quality of the 
distillates. For herbal distillates occurrence of fine aromatic steam marks the 
initial part of distillation followed by collection of condensed distillates.  
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 The aroma, color is unchanged until the end of the middle stage. The final stage 
of distillation is noticed by reduction of fumes, aroma, color and quantity of the 
distillates. This is the point at which the distillation has to be arrested, heating 
beyond this stage causes charring of the herbal contents or raw materials marked 
by appearance of dark fumes with smoky odor. The distillate collected in this 
stage is least inferior quality and should be discarded. 
 
6. Mode of Usage
(5, 7, 8, 15) 
 
Theeneer /Dravagam are purposed for internal usage. 
 
 Dose : For Theeneer as the concentration is mild  it can be taken in the dosage of 1 
karandi (1 teaspoon) 1/2, 1 ounce, 2 ounces , 1/4
th
 of azhakku (1 azhakku = 
168ml) per servings , before or after food  diluted with prescribed quantity of 
water or taken as such.  
 Adjuvant: Most distillates of internal usage are diluted with prescribed quantity 
of water or Luke warm water. Adjuvents like ghee, flour (eg: pooneer dravagm
17
), 
Thrikadugu choornam, mothers milk, honey, jaggery (eg: Mantha dravagam
(22)
) 
are specially recommended adjuvants. 
 Course: Herbal Distillates can be taken on long-term basis as a rejuvenate 
supplement or as medicine depending on the potency and formulation and is 
considered as the safest medicines on long term basis
(29)
 
 Diet Restrictions: Most of the Theeneer indicates mild restrictions as which 
concerns with the disease. Some salt distillates advices avoidance of sour diet. To 
reduce medicine heat induced by potent distillates, ghee, milk depending on ones 
digestive fire is advised. 
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Fig: 6 PARTS OF A VALAI IYANTHRAM (TRADITIONAL DISTILLATION 
STILL) 
 
           Valai (Upper still – Whole view)  Valai (Upper still – Condenser part 
 
 
Valai iyanthram (Single Unit Installed) Valai iyanthram (Single Unit Installed) with Kalayam) 
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    (Chukku) (27) 
NtWngau; (Synonyms): Arukkan, athakam, aardrakam, upakullam, kadupathiram, 
chundi, sowpannam, sowvarnam, navachuru, naagaram, manoushadam, visabheshajam, 
vidamoodiya amritham, verkombu. 
 
Parts Used: Dried rhizome of Ginger. 
 
    (Taste) :       (Pungent)  
     (Potency) :       (Hot) 
    (Division) :      , (Pungent) 
 
      (ACTIONS) 
 
             (Stimulant) 
          (Stomachic) 
              (Carminative) 
 
 
             (General Properties of Chukku) (11, 27) 
 
“                               
                         
                            
                     " 
    -               (26) 
 
Description: With Chukku (Dry Ginger), Soolai (painfull conditions), Vayitru mantham 
(Dyspepsia), Nenjerivu (Retrosternal burning), Dosham, Choodu (Sensation of heat), 
Azhalai, Moolam (Hemorrhoids), Iraippirumal (Asthmatic affections), Pediatric cough, 
Athisaaram (Diarrhoel diseases), Gunmam will be cured. 
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“                      
                        
                    
                     
                     
                        
                 
                       ” 
         ----           (11) 
 
Description: With Chukku Vatha diseases,Vayiroothal (Bloating of the 
abdomen), Chevi-vai-thalaivali (Pain pertaining to to ear, oral cavity and head region), 
Soolai vali (Painfull conditions)Excess watery discharge from eyes, Seetham (cold 
affections) , Bedhi (Diarrhoea),Kapham (Phlegm), Maarbuvali (chest pain), Theeratha 
suram (Chronic fever) will be relieved. Generally, Chukku can be advised in all diseases. 
 
            
 
"                            
                                
                         
                  " 
    -             (        )  ( 11) 
Description: Chukku is a Thathu (nutrient).It cures Vatha diseases, rhinorrhea, and 
moolarogam (Hemorrhoids). 
 
"                      
                   
                     
                  " 
    -             (        )  ( 11) 
 
Description: Many types of diseases will be benefited with Chukku. Gunmam, 
Pakkavatham (Hemiplegic conditions) and Pitha diseases. 
 
 
] 
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"                                
                                  
                                 
                               "   
    -             (        )  ( 11) 
 
Description: Chronic and uncontrolled Vatha diseases (Rheumatic affections), Athisaram 
(Diarrhoel diseases), Vatha gunmam, Eeelai (Excessive sputum), Irumal (Cough), Swasa 
Kasam (Asthmatic affections), Ajeernam (Dyspepsia). 
  
“                                 " 
 
Description : Chukku is very good for Eye related conditions.   
 
         (Therapeutic uses of Chukku) 
 
          
"                         
                        
                        ” 
    -               (26) 
Description: Chukku powder when taken with sugarcane juice at morning period will 
relieve burning sensation of stomach. Chukku kudineer is very benefical to maintain 
health. 
 Chukku paste locally applied for headache, neck pain and painfull joint affections 
yield good results. 
 Chewing pieces of Chukku will relieve throat congestion, hoarseness of voice. 
 Chukku kudineer is very good for dyspepsia, vomiting, chronic fever etc. 
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    (Milagu) (27) 
Synonyms : Kalinai, Kari, kaayam, kolakam, miriyal, sarumapantham, vallisam, 
maasam, malaiyaali. 
Parts Used  :  Seed, Stem, root. 
    (Taste) :       (Pungent)  
     (Potency) :       (Hot) 
    (Division) :      , (Pungent) 
 
      (ACTIONS) 
            (Acrid) 
              (Anti periodic) 
            ( Rubefacient) 
              (Stimulant) 
             (Resolvant) 
           (Anti Vatha) 
      (Anti dote) 
              (Carminative) 
 
TYPES 
 
Pepper has 5 main varieties according to siddha literature they are: 
1. Nalla Milagu 
2. Vaal Milagu 
3. Kola Milagu 
4. Cheeni Milagu 
5. Kaattu Milagu 
 
            (General Properties of Milagu) (11, 27) 
 
"                                
                          
                            
                    " 
    -             (        )  ( 11) 
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Description: Sokai, Suram, soolai, kapham, Mantham will be cured with black pepper. It 
will induce thirst and is a good antidote for spider poison and other toxicities. 
"                            
                        
                                 
                " 
     -             (        )  ( 11) 
      
Description : Pakka  vali, kuyyarogam, vaatham, sronitha noykal, Kathu noi, Maathar 
gunmam, Kaamalai ,Mantham will be cured by using Milagu. 
 
                               
                         
                       
                 " 
     -             (        )  ( 11) 
Description : Seetham, Suram , Paandu, Slethmam, Gunmam, Vaatham, Arusi, Pitham, 
Moolam, Sanni, Megham, kasamwill be prevented with black pepper usage. 
 
“                                  
                              
                         
               " 
    -            (        )  ( 11) 
Description : Silvisham, udarchoodu will be relieved and will improve the vigor . 
 
"                            
                            
                         
                       " 
 
     -            (        )  ( 11) 
Description : Chronic Diseases, Vishapaandu, Kannnoi will be controlled with milagu 
moreover it protect one from Devil spirit attacks. It is good for giddiness associated with 
uterine diseases. 
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         (Therapeutic uses of Milagu) 
 
 Milagu decoction is effective for indigestion 
 Milagu powder at a dose of 260 – 390 mg is a good appetizer. 
 It is included as one of the main ingredients of tooth powder 
 It is one of the ingredient of mukkadugu. 
 Lehyam prepared with Milagu, Perunjeeragam, and Honey is given in the dose of 
kazharchi alavu for hemorrhoids occurring in old peoples and emaciated ones. 
 A mixture of Milagu, venkayam and uppu is a good external application for 
alopecia areata. 
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      (Thippili) 
Synonyms : Aarkathi, unrasam, ulavai nasi, kaaman, kudari, kolakam, koli, 
kozhaiyarukki, saram, chaadi, thulavi, maakathi, kanai, chowndi, thanduli, kalini, 
paanam,  pippili, vaideki, ambu, aathi marunthu. 
 
Parts Used  :  Berry, root. 
    (Taste)  :       (pungent)  
     (Potency) :       (Hot) 
    (Division) :      (Sweet) 
 
      (ACTIONS) 
             (Stimulant) 
              (Carminative) 
 
TYPES 
Thippili are of 2 types 
1. Arisi thippili 
2. Yanai thippili 
 
                   (General Properties of small variety) 
"                                      
                              
                               
                    "  
     -             (        )  ( 11) 
 
Description: With small variety of Long pepper Vishaneer, pitham, prammaipidithal, 
sanni, gunmam, soolai, vizhinoy, kshyam, athisaram will be cured. 
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                     (General Properties of Large variety)  
 
"                               
                             
                                   
                 " 
-             (        )  ( 11) 
Description: Vatham, pasiyinmai, kapham, kural kammal will be reduced with thippili- 
large variety moreover it cures nasal block also. 
 
                
 
“                       
                         
                           
                    
                      
                       
                   
                         " 
     -             (        )  ( 11) 
 
Description: Irumal, gunmam, iraippu, kayappini, eelai, paandu, sanni, arosikam, 
porumal, siarasu noy , moorchainoy, neerkovai, pleekam, malam pidithal, mahodaram, 
vatham, mukutram, suram, kulir, megham will be relieved with long pepper. 
 
"                                
                          -      
                         
                     -    " 
   -                (26) 
 
Description: Aasana noy, thondai noy, aavarana pitham, nasi-vizhi-kaathu noikal, Vinthu 
ilaki pothal will be relieved with long pepper. 
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          (Therapeutic uses of Thippili) 
 
 Thippili 5 parts, thetran seeds 3 parts are powdered well and given in the dose of 
4g with rice washed water for Leucorrhoea, menorrhagia. 
 Thippili powder with betel juice and honey is effective for phlegmatic disorders, 
cough and fever. 
 Thippili powder (1/4 palam) is boiled with 350 ml milk and given for delirium, 
and syncope. 
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       (Kadukkai) 
 
 Synonyms : Anganam, akkodam, anthan, abaranam, abaiyan, amritham, amalai, 
Ammai, amrutha, arabi, arithaki, aliyan, avvyatha, resaki, emavathi, ayavi, haimavathi, 
kadu, kayastha, siyirutham, sirayahi, sirottam, siva, sethaki, sethanika, seya, divya, devi,  
 
Parts Used: Tender and mature fruits 
 
    (Taste)  :       ,    ,     ,     ,      
(Astringent ,   sweet, sour, pungent, bitter)  
     (Potency)   :       (Hot) 
    (Division)   :      (Sweet) 
 
       -      
      -     
      -      
      -     
      -      
 
Kadukkai possess all the tastes except salt. So that it is a good remedy for all the 
diseases pertaining to thridosham or mukutram. With the sour taste, diseases due to 
vatham, with sweet taste pitha diseases, with the bitter, astringent and pungent tastes 
kapha diseases will be cured. Sweet division is due to its 5 elemental conjoince. 
 
       -        (General Properties of  Kadukkai ) 
 
“"                      
                  -          
                          
                   " 
   -               (26) 
 
Description: The diseases of cheek, neck,tongue, male genitalia will be cured with 
kadukkai. It also cures Silipatham (Elephantiasis), Athithoolam (obesity), Vathasonitham, 
Kamalai(Jaundice) , thavara-sangama visham (plant toxicity and toxic bites). 
 
"                        
             -     
                        
              ..... 
     -           
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Description: The outerskin of kadukkai is taken with honey is a tonic to the body 
moreover its an excellent rejuvinator .one who consumes the same will attain Kayasiddhi. 
 
             2 
 
"                          
                             
                          
              "  
-                (26) 
 
Description : Kadukkai can be compared with ones mother who take care of her child 
nourishes the body by providing perfect balanced diet with  sixtastes. Like wise kadukkai 
prevent the occurance of diseases , as an alterative it preserves the body, improves ones 
appetite and taste. So kadukkai is considered superior. 
 
 
              (Classification) 
 
 "                           
                 -     
                          
              " 
  -                (26) 
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Classification of kadukkai 
 
 
S. 
NO 
Types Description Medicinal Properties 
1. Vijayan 
kadukkai 
Habitat: avanthi land,  
Appearance:  like peichurai. 
 Useful in Vatha diseases. 
2. Arohini 
Kadukkai 
Habitat: Kanyakumari 
Appearance: Globular with 4 streaks 
Fruit smaller but Seed larger. 
 Muppini 
 Kapha diseases 
 Can be used externally as an 
application for ulcers. 
3. Prithvi 
Kadukkai 
Habitat: Sowrashtram 
Appearance: Thin outerskin 
 Controls pitha vitiation 
4. Amritham 
sethaki 
Habitat: Kasi 
Appearance: Fleshy. 
Types : Black and white. 
 Cures Kapha derangement. 
 Purgative 
 Tonic and alterative 
5. Jeevanthi Habitat: Forest regions 
Appearance: Golden colored. 
 Hemorrhoids 
6. Thiruviruthi Habitat: Mountains 
Appearance : 5 colored, 3 streaked. 
 Cures ulcers. 
7. Abhayan Habitat: Pothigai hills 
Appearance: 5 streaked, black 
colored, globular, 2 finger length. 
 Eye diseases 
 Expectorant 
 Laxative 
 
Non advisible conditions for Kadukkai Consumption 
 Those who taken dry foods 
 Dyspepsia 
 After fasting  
 Those who are sufferers of toxicity and pitha diseases 
 Pregnant 
 Those who are having febrile illness. 
 Throat congestion. 
 
Medicinal Uses 
 
            
"                   
                       
                    
                             " 
       -               (26) 
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Description: As a rejuvintor kadukkai can be taken with rock salt for kapha derangement, 
with sugar for pitha derangement, with ghee for vatha derangement an with jaggery for 
vitiation of all the three kutram.  
            
"                       
                        -          " 
 
Description: Kadukkai choornam in the dose of 1 nilakadalai alavu  is taken during 
evenings regularly one will be free from affection of jaundice 
 
 If kadukkai is taken with the below prescribed adjuvants during each 
season, that will prevent the vitiation of any diseases occurring in that 
season. 
S.NO Seasons Adjuvant 
1. Kaarkalam (Early rainy season) Induppu (Rock salt ) 
2. Koothirkaalam (Later rainy season) Sugar 
3. Munpani Kalam (Early winter season) Dry ginger 
4. Pinpani Kalam (Later winter season) Long pepper 
5. Ilavenil Kalam ( Early summer season) Honey 
6. Mudhuvenil Kalam (Later Summer 
season) 
jaggery 
 
MEDICINAL USES 
 
 Kadukkai in the form of decoction or kudineer is useful for polyuria and 
eye diseases, and also externally used as wash for  bleeding hemorrhoids. 
 Kadukkai can be used as a tooth powder for gingivitis, bleeding per gum 
and mouth ulcers; moreover, it will strengthen the root. 
 Equal proportion of powder of kadukkai and kasukatti can be used as a a 
dusting powder for external ulcers. 
  The powder can be used as snuff for bleeding sinus. 
 Kadukkai powder stuffed in a cloth and soaked in castor oil kept in 
sunlight (Soorya pudam), is a useful remedy for Amaram (ophalmia 
neonatorum). 
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         (Nellikkai) 
    ngau;  (Synonyms): Aamalakam, aalakam, aambal, aamarikam, thathri, 
korangam, mrithubala, meethunthu. 
Parts Used: Leaf, flower, bark, root, fruit, and seed. 
 
    (Taste) :     ,      ,    , 
 (Astringent, sweet, sour, pungent, bitter)  
     (Potency) :      (cold) 
    (Division) :      (Sweet) 
 
      (Actions) 
Fruit 
               (Refrigent) 
            (Diuretic) 
         (Laxative) 
 
         -        (General Properties of Nellikkai )(11, 27) 
 
“                           
                       -      
                                
                ” 
 
“                           
                      -         
                     
               "  
   -            (        )  ( 11) 
 
DESCRIPTION : Nellikkai when taken during daytime will cure verinoi 
(Psychiatricdiseases), Kaphanoi, Peenisam (Sinusitis), Vaayneer kasappu (bitter taste in 
tongue),Vanthi (Vomiting), Mayakkam (Giddiness), Thalai suzhalal (Vertigo), 
Malabhandam (Constipation), Pramegham (Diabetis). With the sour and astringency of 
the fruit Kapham will be normalised. 
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 "                          
                    
                                
                            " 
     -             (        )  ( 11) 
 
DESCRIPTION: Nelli mulli improves taste,cures viri pitham. Oil processed with 
Nellimulli is used as a head bath will give cooling effect to the eyes.Strengthens the 
physical constituents.Pitha vanthi (Emesis), Megham will be controlled. 
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         (Tantrikkai) 
 
Synonyms : Aksham, Akkaantham, Amutham, ambalathi, aaramam, erikatphalam, 
kanthakatphalam, koolidrumam, kalathoontri, sakatham, thaabamaari, vaanthiyam, 
vibheetham, thirilingam, bhootha vasakam. 
Parts Used: Leaf, Bark, fruit 
 
    (Taste)  :       (Astringent) 
     (Potency) :       (Hot) 
    (Division) :      (Sweet) 
 
      (ACTIONS) 
 
        (Astringent)  
             (Expectorant) 
         (Laxative) 
         (Tonic) 
 
                  (General Properties of Tantrikkai) 
 
"                         
                             
                            
                    " 
          -               (26) 
 
Description: Silanthi visham (spider bite poison), Aankuri pun (Ulcers in male genitalia), 
Seezhmegham (Chronic purulent discharges (leucorrhoea), Vatha pitham, Veppamuthir 
pitham (Aggravated Pitha conditions due to excessive heat) will be cured with Tantrikkai. 
 
[ 
"                          
                                       
                              
                 -   " 
    -             (        )  ( 11) 
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Description:Tantrikkai will improve one‟s complexion and beauty.Vathapitha diseases 
will be relieved.One who takes regularly will be free from any diseases pertaining to 
megham. Moreover, it has the power to eliminate Vatham. 
 
         (Therapeutic uses of Tantrikkai) 
 
 Pox Diseases (Ammai noikal): Tantrikkai powder with honey is given. 
 Wheezing: Tantrikkai outer skin powder (20 g) added with water (170 ml) boiled 
and reduced to 1/3
rd
 after honey is used as adjuvant. 
 Vision Promoter: Tantrikkai powder with jaggery and required honey is given 
internally. 
 Ulcers: Tantrikkai powder is applied as a dusting powder. 
 Throat ulcers, cough and phlegm: Tantrikkai roasted well with pure ghee, covered 
with wheat flour baked and kept in mouth. 
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    (OMAM) 
 
Synonyms   : Asamotham, thippiyam 
Parts Used  :  Seed. 
 
    (Taste)  :        (Bitter) 
     (Potency):       (Hot) 
    (Division)  :        (Pungent) 
General dose  : ¼ -1/2 Varagan 
 
      (ACTION) 
1.          (Stomachic) 
2.          (Antispasmodic) 
3.               (Carminative) 
4.              (Antiseptic) 
5.          (Tonic) 
6.               (Sialogogue) 
 
              (General properties of Omam) 
 
“                           
                            
                                 
                        " 
            -               (26)   
Description:With Omam Kapha juram (Phlegmatic fever), Irumal (cough), 
Seriyamantham (Dyspepsia), Kazhichal (diarrhoel diseases), Oozhi (cholera), Iraippu 
(wheezing), palnoi (Toothache), Kuyya rogam (Genital diseases) e.t.c will be cured. 
 
"                      
                       
                        
                     " 
   -             (        )  ( 11) 
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Description: With Omam bedhi kazhichil (Diarrhoea & dysentries), vayvu (gaseous 
disorders), mantham, vatham, pitham, Athisaram, porumal, suram (pyrexia), 
Kasam(cough) will be cured. 
 
 From Omam, Oma Theeneer and Oma Thailam can be extracted. 
 
 
1. Oma Theeneer  
 
Method of Preparation 
 
For 1440 g of omam add 8400 ml and distilled. 
Dose: 30 – 60ml 
 
Indication: Seriyakazhichal (dysentries), Oozhi (Cholera), Vayitruvali (abdominal pain), 
Mantham (Indigestion). 
 
            
 
"                       
                     
                       
                      
                    
                       
                         
                      " 
   -             (        )  ( 11) 
 
Description: Distillates prepared from omam(oma theeneer) will cure the following 
diseases Bedhi (Diarrhoel diseases), mantham (Indigestion), seriyakazhichal (dysentries), 
vayu iraichal (gaseous disturbances), Pitham (Bilous disorders), Vayu (Gaseous 
disorders), kazhichal (diarrhoel diseases), Neerkaduppu (Stranguary), Neerdosham, Balar 
mantham, Veppukal (Body Heat), neerthodam, Peenisam (Sinusitis) and other painfull 
conditions. 
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2. Oma Thailam 
 
The oil which is collected from the supernatant layer of the Oma Theeneer is 
called Oma Thailam 
 
Dose  : 1-3 drops 
 
Indication : Seriyakazhichal (dysentries), Oozhi (Cholera), Vayitruvali (abdominal     
       pain), Mantham (Indigestion). 
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         (Vai vidangam) 
 
Synonyms: Vayu vilangam, keralam, vaayvilangam, varnanai, vaividangam. 
Parts Used: fruit,seed. 
    (Taste) :      (Bitter) 
     (Potency) :       (Hot) 
    (Division) :       (Pungent) 
 
         -        (General Properties of Vaividangam) (11, 27) 
"                          
                -      
                           
                  " 
         
    -               (26)  
Description: With vaividangam ,pandu (Anaemia), Gunmam (Gastro intestinal ailments), 
parunthoolanoi (obesity), vayu (gaseous disorders), Poison due to bites (snake bite), 
Nunnkrimi(microbes or minute parasites and worms), eruvaipun (ulcers in the anal 
region) will be relieved. 
 
"                        
                      -    
                      
              " 
--          
(11) 
 
Description : Vaividangam will normalize Vatha kutral(Impaired vatha humour), 
moreover it will aid in chemistry of consolidating Rasam(Mercury) and vangam(lead) 
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        ; (Therapeutic uses of Vaividangam) 
 
 Vaividangam is included in so many vermifuge formulations. 
 Vermifuge: The seed powder in the dose 4-16 g with adjuvant honey is given for 
2-3 times a day followed by castor oil purgation on the next day will evacuate the 
intestinal worms. 
 Digestive disorders: The seed powder , 2-4 g is given along with milk for children 
will control colic due to indigestion and other gaseous disturbances. 
 For headache the seeds are powdered finely, mixed with butter, and applied 
externally. 
 For scorpion stings the seed paste can be applied on the spot. 
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          (Korai kizhangu) 
 
Synonyms :        (muthakasu) 
Two varieties of Korai kizhangu are available,small (siru korai) with tubers and big 
(perunkorai)without tubers. 
 
      (Action) 
        (Astringent) 
             (Stimulant) 
         (Tonic) 
            (Diuretic) 
             (Diaphoretic) 
           (Demulcent) 
           (Emmenagogue) 
         (Vermifuge) 
        
"                             
                    -         
                           
                 !  "  
 
"                         
                   -         
                                  
                 " 
      -               (26)  
 
Description: With korai kizhangu seethasuram, kuruthi azhal noi ( Hypertension), Suram 
(pyrexias), neervedkai (Excessive thirst), muppin i(condition to derrangement of 3 
humours), kazhichal ( diarrhoeal diseases), paithyathodam (psychiatric ailments), pitha 
daham (Excessive thirst monitered in heat disorders), kapha rogam (Phlegm disorders), 
Kuthikaal vatham (Calcaneal spur), vanthi (Emesis) will be cured. 
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"                   
                   " 
 
Description: The powder of korai kizhangu tubers is used a regular suppliment for 
respiratory ailments especially cough. 
 
         ( Medicinal Uses of  Korai Kizhangu) 
 
 The decoction made with korai kizhangu is effective for diarrhoeal diseases, 
Gunmam(Gastro intestinal ailments), and vanthi(emesis). 
 Inji along with koraikihangu is grinded with sufficient honey and rolled into pills 
(Chunda sized)this is best given for seetha kazhichil(bacillary dysentry) 
 The fresh tubers are grinded into paste and externally applied locally over the 
breast stimulates milk secretion.The same paste can be applied over the spot of 
scorpion sting for reducing the symptoms or toxicity.when applied all over the 
body regularly before bathing it will relieve body odour.  
 Decoction made with korai kizhangu,Peipudal,Thriphala, Drakhai, veppu, 
vettupala is effective for febrile conditions. 
 Korai kizhangu is one of the main ingredient for many pedaetric prepartions. 
 Korai kizhangu moozhku neer(For bathing): Korai kizhangu, thriphala, 
marukkarai, pungu, kontrai, valuzhuvai, vargothumai, ezhilam palai, koshttam, 
njaazhal, maramanjal, venkadugu is taken and boiled with water. The water can be 
used for bathing in skin conditions like kushttam (Leprosy), sori, sirangu scabies, 
pruritis), paandu (Hypopigmentation). 
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         (Kodiveli) 
 
 Synonyms:  Aninjil, athika naari, athi pathungi, azhal, uthasanan, eri, ezhuna,  oli,  
karunaagam, kanali,  kaarimai,  agni,  thapanan,  vanni, vanama, chithrakam, 
Chithramoolam, thazhal,  nekizhi, vanjatharam. 
 
Types 
1. Karun Kodiveli (Plumbago capensis) 
2. Chen Kodiveli (Plumbago rosea) 
3. Ven Kodiveli (Plumbago zeylanica) 
All the 3 varieties possess similar medicinal qualities. 
  
Parts Used: Root, Root bark 
 
    (Taste) :       (Pungent)  
     (Potency) :       (Hot) 
    (Division) :       (pungent) 
 
      (ACTIONS) 
 
             (Anti Periodic) 
              (Diaphoretic) 
 
 
        (General Properties of Kodiveli) 
 
“                            
                    -       
                        
               ” 
     -               (26)  
 
Description: With Kodiveli, Katti, pun, kazhalai, Vathanoi, Aryappukatti, kuththal, 
sobhai, moolarogam, uthirakattu, neeretram, and peruvayaru will be cured. 
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“                                
                             
                               
                                  "  
     -   (27)  
Description: Kuripun, meghapun, nanju suram will be cu red with kodiveli. 
 
         (Therapeutic uses of Kodiveli) 
 
 The dried root is made into paste and applied over skin diseases like leprosy. 
 The root paste, kottapaakku alavu is given with cow‟s milk as an antidote to toxic 
materials like pashanam. 
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         (Panam Karkandu) 
 
Parts Used :  Palm sugar candy prepared from fermented sap of Palm tree. 
 
                   (General Properties of Panam Karkandu) 
 
"                      
                -          
                              
               " 
   - -               (26)     
     
Description: With Panam karkandu, Megha suram, Sensation of heat associated with pox 
affections (vasoori), Urinary stranguary, excessive thirst will be relieved. 
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Mineralogical  Review 
 
Introduction
 
Iron is an important trace element of the body, being found in functional form in 
hemoglobin, myoglobin, the Cytochromes, enzymes with iron sulphur complexes and 
other iron-dependent enzymes. Iron has the unique ability to alter its oxidation and redox 
states in response to liganding, which makes it essential for various cellular processes
(39)
 
Iron plays an important role in biology, forming complexes with molecular 
oxygen in hemoglobin and myoglobin; these two compounds are common oxygen 
transport proteins in vertebrates. Iron is also the metal at the active site of many important 
redoxenzymes dealing with cellular respiration and oxidation and reduction in plants and 
animals. Iron forms compounds mainly in the +2 and +3 oxidation states. Traditionally, 
iron (II) compounds are called ferrous, and iron (III) compounds ferric. Iron also occurs 
in higher oxidation states. Iron is a necessary trace element found in nearly all living 
organisms. Iron-containing enzymes and proteins, often containing hemeprosthetic 
groups, participate in many biological oxidations and in transport. Examples of proteins 
found in higher organisms include hemoglobin, cytochrome, and catalase 
(40)
 
The most commonly known and studied "bioinorganic" compounds of iron (i.e., 
iron compounds used in biology) are the heme proteins: examples are hemoglobin, 
myoglobin, and cytochrome P450. These compounds can transport gases, build enzymes, 
and be used in transferring electrons. Metallo proteins are a group of proteins with metal 
ion cofactors. Some examples of iron metallo proteins are ferritin and rubredoxin. Many 
enzymes vital to life contain iron, such as catalase, lipoxygenases, and IRE-BP. The cells 
maintain the free iron concentration to a minimum required level to avoid toxic effects of 
excess iron. Iron preparations are used in all Indigenous as well as western medicine for a 
wide range of medical conditions specially for correcting blood parameters. 
Iron has been one of the most important agents in the indigenous medical system 
from time immemorial. Preparations of iron have been extensively employed in different 
pathological conditions in combination with compounds containing vegetable drugs, 
spices, aromatic substances, as also the compounds of other metals, in the treatment of 
different ailments pertaining to blood, bowels and nerves and debilitating 
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conditions
(37)
.The chemistry and metallurgy of iron were highly developed in south India 
from very ancient times
(2) 
 
Siddha aspect of FERRUM (   )  
( 3) 
Elemental iron or ferrum is one among the most widely used Natural metal used in 
siddha medicine. It is included in the category of Thriloham, panchaloham and Pancha 
bootha ulogam. 
 
Five Elemental category: Vayu (Air element) 
Synonyms
 (35) 
"                         
                      
                       
                   
                                   
                            
                          
                            " 
                  -1200 
 
Description:Sathu, ayasu, karuppi, vaazhboomi naatham, karumbi, loham, pindam, 
thirumbi, chittam, Krishna ayam, are the synonyms. Apart from this aki, ayasu, ayil, idi, 
eesajeyam, karungkol, karumbu, karumanal, karumpon, kaalil nekilam are the other 
names attributed to Ayam. 
 
Each one is of different characters. 
1. Pon manal: Gold placer/ Pyrite ferrous sand. 
2. Karu manal: Black sand of ilmenite, magnetite, garnet, rutile, zircon etc. 
3. Karunthathu: Magnetite, ilmenite. 
4. Karumpon: Titano magnetite, Hematite, marcasite. 
5. Vaazhbhoomi natham: Marcasite, siderate. 
6. Essacheyum: Red ochre, lateritic soil, limonite. 
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    (Taste):     ,      ,     (Astringent, Mild sour + bitter)  
      (Potency):           (Hot potency) 
      (ACTIONS) 
            (Tonic) 
          (Alterative) 
        (Appetiser) 
           (Hemetenic) 
 
        (3) 
"                              
                              
                              
                  " 
 
Description: With Ayam,  pitha pandu (Anemia), Venkuttam (Leucoderma), Athithoola 
noi (Obesity), sobhai (Dropsy), mantham (Indigestion), Kamalai (Jaundice), Gunmam 
(Diseases of gastro intestinal region ), Suklanattam (Seminal loss, Oligospermia), 
Kazhichal (Diarrhoea) will be cured. Improves appetite also. 
 
Usage of Elemental Iron Formulations in Siddha Medicine 
Siddha Medicine uses vast majority of iron and iron compounds to treat numerous 
ailments.  Simpler formulations to complex formulations of iron are in practice. Ayam is 
one of the crucial drug added in so many preparations like Kudineer, Lehyam, 
Rasayanam, Parpam, Chendooram,Theeneer/Dravagam,  As each state of the Ferrum 
starting from raw ore to the final product, the nature and properties of the element is 
modified or transformed with numerous processings, the potentiality and therapeutical 
application with each stage and form various accordingly, and hence such transformed 
states of the element is been effectively utilized for each disease condition.  
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Table: 5 Ayam Preparations
(60) 
S.NO 
Ayam Preparations 
 
DOSE/ 
ADJUVANT 
INDICATION 
1. Aya Chenduram Panavedai (488mg), 
Honey 
Pandu, Pitha vettai, Pitha vayu, 
Arosakam 
2. Aya Chenduram 100 – 200mg, 
honey 
Vinthu nattam, Pandu, 
Peruvayiru 
3. Ayakantha chenduram 100 – 200mg, 
honey 
Pandu 
4. Ayaveera Chenduram 1 Kuntri ( 130 mg) Soolai, Kuttam, Vaatha neer 
5. Aya Mezhugu 2 – 4 g, sombu 
kudineer 
Pandu, sobhai, Kamalai 
6. Aya Bringaraja 
Panitham 
- Pandu, Pitha Kamalai, 
Peruvayiru. 
7. Aya Bringaraja Karpam 100 – 200mg, 
honey 
Pandu, Ilaippu, 
8. Arumugha Chenduram 100 – 200mg, 
honey/Thrikadu 
Pandu, Soolai, Andavatham, 
Vatha noikal 
9. Jalamanjari 200 – 400 mg with 
lime juice 
Pandu, Sobhai, Athithoolam 
10. Karisalai lehyam 5 – 10 g Pandu, Kamalai, Pitham, 
Mayakkam. 
11. Karuppu Vishnu Chakra 
mathirai 
½- 1 pill, honey Sanni, kuttam, Anda vatham, 
dhanur vatham, gunmam, parisa 
vatham, 
 
Usage of Elemental Iron in Sanjeevi Theeneer 
 
Out of hundreds of different Ferrum formulations available in siddha classical 
works, some special Theeneer and Dravagam formulations also uses Iron in various 
forms. Sanjeevi Theeneer is one such medicine. 
 
Distillates cannot yield mineral iron presence directly. The other forms of ionic 
state in which the iron exist in distillates is unknown and has to be studied in depth. Some 
preprocedures before undergoing distillation may convert or modify the elemental 
existence. The most possible mechanism will be the processes of fermentation induced 
naturally with the addition of fermenters like palm candy in the formulation Sanjeevi 
Theeneer, in which a considerable lowering of pH due to alcohol formation may dissolve 
or convert into a from in ionic stage to be easily distilled.  
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Zingiber officinale 
(37-47) 
INTRODUCTION:  
 
Chukku is the dried rhizome of Zingiber officinale belonging to family 
Zingiberacea widely cultivated in India; rhizomes dug in january-february, buds and roots 
removed, soaked overnight in water, decorticated, sometimes treated with lime, and dried. 
Dried ginger is of two kinds, peeled and unpeeled, the latter is the cleaned rhizomes dried 
in the sun. In the case of dry ginger, the outer skin is scrapped off. When the fresh drug is 
used is used for extracting the juice, the supernatant fluid alone should be used and the 
sediment (chunnam) discarded. 
 
SCIENTIFIC CLASSIFICATION 
VERNACULAR NAMES 
Kingdom: Plantae 
Clade: Monocots 
Clade: Angiosperms 
Clade: Commelinids 
Order: Zingiberales 
Family: Zingiberaceae 
Genus:Zingiber 
Species: Z. officinale 
Tamizh: Sukku, Inji 
Malayalam: Chukku, inji 
Sanskrit: Nagara, adraka. 
Hindi: sonth 
Assam: Adasuth 
Beng: Suntha , sunthi 
Guj: sunth, Adu 
Tel: Allamu,  
Kan: Sunthi 
Urdu: sonth, zanjabeel. 
Mar: Sunthi, Ale 
English: Ginger root, Ginger. 
 
HABITAT : Ginger is cultivated in many parts of India on a large scale in the warm, 
moist regions, chiefly in Madras, Cochin and Travancore, and to a somewhat less extent 
in Bengal and the Punjab. 
 
Odor :  Aromatic. 
Taste :  Pungent and spicy. 
Color  : Externally pale buff to brownish in color. 
Odor  :  Aromatic and characteristic. 
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Taste  : Pungent  
Parts Used :  Scraped and dried rhizomes as well as the green ones.  
 
Major Alkaloids 
Phytochemicals of ginger vary depending on its growing place, freshness and 
dryness of it . Pungency of dry ginger is caused by shogaols, which were dehydrated form of 
gingerols formed when ginger is dried or cooked.  The concentrations of shogaols, which are 
the major gingerol dehydration products, are more abundant (Jolad et al. 2005) in dry 
ginger than in fresh ginger. The rhizome contains 1-4% essential oil and an oleoresin (5.3-
8.6%). The composition of the essential oil varies as a function of geographical origin, 
but the chief constituent sesquiterpene hydrocarbons (responsible for the aroma) seem to 
remain constant. These compounds include Alphazingiberene, ar-curcumene, hexa 
hydrocurcumin, Beta sesquiphellandrene, Beta bisabolene camphene, phellandrene, citral, 
citronellol, geranial, linalool, bisabolene, limonene, desmethhexahydrocurcumin, cineole, 
borneolzingiberole, and cineole. Monoterpene aldehydes and alcohols are also present  
The constituents responsible 'for the pungent taste of the drug and possibly part of its anti-
emetic properties have been identified as 1-(3‟- methoxy-4'-hydroxyphenyI)-5-
hydroxyalkan-3-ones, known as gingerols. Apart from this lipid (6.8%), proteins (10%), 
fats, waxes and starch (40-60%) vitamin B6, vitamin C, calcium, linoleic acid, acetic 
acid, lignin are present. 
 
Minor Alkaloids: Numerous monoterpene and sesquiterpene hydrocarbons and their 
corresponding dehydration products (oxygenated derivatives in volatile oil),), paradols, 
gingerdols, gingerdiacetates, gingerdiones, 6-ginger sulfonic acid, gingerenones and a number of 
diarylhepataniods, diterpenes, ginger glycolipids A, B &C 
 
Medicinal Uses of Ginger 
 
o Rhizome is highly esteemed as a spice for its characteristic odor and warm 
pungent taste.  
o The rhizomes is useful as an antiemetic, flavoring agent, digestive aid, rheumatic 
diseases, respiratory disorders, nausea, cardio vascular health and gastrointestinal  
o It is used in sprains, sore throats, cramps, muscular aches, pains, constipation, 
hypertension, dementia, helminthiasias, infectious ailments, bronchitis, stomach 
disorders, and useful for insect bites. 
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Piper nigrum 
(37-40) 
 
Introduction 
Piper nigrum (family Piperaceae) is a valuable medicinal plant. It is one of the 
most commonly used spices and considered as ‟‟The King of spices‟‟ among various 
spices. Drug consists of dried unripe fruits.  
SCIENTIFIC CLASSIFICATION VERNACULAR NAMES 
Order : Piperales 
Kingdom : Plantae  
Class: Equisetopsida 
Subclass: Magnolidae 
Super order: Magnolianae 
Family: Piperaceae 
Genus: Piper 
Species :  nigrum 
Binomial name : Piper nigrum 
Tamizh: Milagu 
Malayalam: Kurumulaku 
Sanskrit: Maricha 
Hindi: Kalimirch, Golmirch 
Arabic: Fil Fila Siah, 
Kannada: Karemensu 
Telungu: Miriyalu 
Marathi: Kalamirch. 
Gujarathi: Kalaomirich 
Bengali: Golmorich, Kalimirch 
English: Black Pepper 
 
HABITAT: This plant is indigenous in India, Western Ghats, and Malabar Coast 
growing in the rich soil in the shade of trees
.
 It grows in Kurinji Thinnai. 
 
Color & Appearance: Blackish brown with raised reticulated wrinkles. 
Odor  : Aromatic 
Taste  : Strongly pungent 
Parts Used : Dried fruit. 
 
 The fruits are picked up when fully ripe dried and used in spices and medicines. 
Roots and leaves are also used in traditional siddha medicines. 
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Chemical Constituents: Berries contain Volatile oil (1-2.5%), alkaloids/amide (5-9%) 
and a resin, beta pinene, alpha pinene and humulene. Fruit contains myrcene, piperine, 
quercetin, kaempferol and eugenol. Many investigators isolated different types of 
compounds viz Phenolics, flavonoids, alkaloids, amides and steroids, lignans, neolignans, 
terpenes, chalcones etc and many other compounds. A pungent alkaloid piperine (2-5%) 
and the resin is responsible for its pungent taste. 
 
Minor Alkaloids: Some of the alkaloids/amides like compounds are Brachyamide 
B, Dihydro-pipericide, (2E,4E)-N-Eicosadienoyl-pereridine, N-trans-Feruloyltryamine, 
N-Formylpiperidine, Guineensine, pentadienoyl as piperidine, (2E,4E)- Nisobuty- 
ldecadienamid, isobutyl-eicosadienamide, Tricholein, Trichostachine,  isobutyl-
eicosatrienamide, Isobutyl-octadienamide pipericine, piperettine, piperanine, piperamides, 
pipericide, sarmentine, Sarmentosine, Retrofractamide, piperolein A &B  are also 
considerable. 
 
Black pepper oil is the essential oil obtained by steam distillation of the dried unripe 
berries of piper nigrum. beta caryophyllene (upto 29%), limonene (upto 17%), The volatile oil 
contains large amounts of terpenes, alpha pinene, phellandrene, dipentene, sesquiterpenes. 
 
MEDICINAL USES
 (48) 
 
 Fruits used as a condiment after drying as black pepper or after processing into 
white pepper. 
 It is used with ginger and Piper longum for viral hepatitis. 
 Effective in hemorrhoidal affections and rectal prolapses
.
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Piper Longum 
 
INTRODUCTION 
Thippili is the dried immature, catkin like fruits with bracts of Piper longum. It is 
a slender aromatic climber with perennial woody roots. 
 
SCIENTIFIC CLASSIFICATION 
 Vernacular Names
 
Kingdom :Plantae 
Division : Magnoliophyta 
Class : Magnoliopsida 
Order : Piperales 
Family: Piperaceae 
Genus : Piper 
Species : P. longum 
 
 
 
 
 
Tamizh: Thippili 
Malayalam : Thippali 
Sanskrit: Pippali 
Hindi :Pipar 
URDU: Filfil Daraz 
Assam: Pippal 
Kannada : Hippali 
Telungu: Pippalu 
Marathi: Pimpali 
Gujarathi: Pipali 
Oriya: Pipali 
Punjab: Magh Pipali 
Bengal: Pipul 
English: Long pepper 
 
HABITAT 
Occurring in hotter parts of india from central himalayas to assam  upto lower 
hills of west Bengal   and evergreen forests of western ghats as wild, and also cultivated 
in North east and many parts of the south. It grows in kurinji Thinnai. 
Parts Used: Immature berries (dried unripe fruits or fruiting spikes) dried in the sun and 
stems (roots) 
TASTE :  Pungent producing numbness on the tongue 
Odor  :  Aromatic 
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CHEMICAL CONSTITUENTS
1 
 
Beta caryophyllene, Piperine, Pipernonaline, Piperundecalidine, Piperlatine, 
Sesamine, Dihydriostifransterol, Piplasterol and Futoamide. Resin, Voltile oil, starch, 
gum, fatty oil, inorganic matter and alkaloids. Several aristolactams, piperolactam and 
dioxoaporphines have been isolated from the fruit. 
 
Long pepper contains the long chain isobutyl amide, longamide besides 
guineesine and lignans, pluviatilol, methyl pluviatilol (fargesin), sesamine and asainine 
(Koul etal, Photochemistry, 1988, 27, 3523) 
 
Major alkaloids:Piperine (1-2%), piper longumine (piplartine), piperlonguminine and 
methyl 1-3, 4, 5-trimethoxy cinnamate. 
 
Minor alkaloids:Sesamin. A lignan, dihydrostigmasterol, essential oil consisting of  n-
hexadecane,n-heptadecane, n-octadecae, n-nonadecane, n-cicosane, n-hencosane, alpha–
thujene, terpinolene, zingiberine, p-cymene, p-methoxyacetophenone, dehydrocarveol, 
and two monocyclic sesquiterpenes. The presence of L-tyrosine, L-cysteine 
hydrochloride, DL-serine and L-Aspartic acid as free amino acids also have been reported 
in the fruits. The seeds contain sylvatine, dieudesmin. In addition to plamitic, 
hexadecanoic, stearic, linoleic, oleic, linolenic, higher saturated acids, arachidic acid and 
behenic acids are also reported 
 
MEDICINAL USES: 
 
 Old long pepper is more efficacious in medicine then fresh one(U. C. Dutt) 
 Powdered long pepper with honey is given for cough, cold, asthma, hoarseness 
and hiccup. 
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Terminalia chebula (41, 44) 
Introduction 
 
Kadukkai is the pericarp of mature fruit of Terminalia chebula belonging to family 
Combretaceae.  
SCIENTIFIC CLASSIFICATION
 VERNACULAR NAMES 
Kingdom :Plantae  
Subkingdom: Tracheobionta  
Super division:  Spermatophyta 
Division: Magnoliophyta 
Class: Magnoliopsida 
Subclass: Rosidae 
Order: Myrtales 
Family: Combretaceae 
Genus :Terminalia L. 
Species:Terminalia chebula 
 
Tamizh: Kadukkai 
Malayalam: kadukka 
Sanskrit: Haritaki 
Hindi: Harad 
Kannada: Alalekai 
Bengal: Harithaki 
Telungu: Karakkaya 
Marathi: Hirda 
Gujarathi: Hirdo 
Oriya: Harida 
Punjab: Halela 
Assam: Shilikha 
English: Myrobalan, chebulic 
myrobalan
 
 
Habitat: This tree is wild I the forests of northern India, central provinces and Bengal, 
common in madras, Mysore and in the southern parts of the Bombay presidency. 
 
Parts Used: Dried fruits, immature fruits, mature fruits, myrobalans and galls, mostly the 
outer skin of the fruits. 
 
Taste: Astringent and slightly bitter  
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Chemical constituents: 
 
Major Alkaloids: Myrobalans contain astringent principles, tannin(tannic acid) 45% and 
a large amount of Gallic acid (1.21%), chebulagic acid (5%), ellagic acid, mucilage, a 
brownish yellow coloring matter, chebulinic acid (12.5%) which when heated in water 
splits up into tannic and Gallic acid. Tannins, which on hydrolysis yield chebulic acid and 
D-galloyl glucose. 
Minor Alkaloids: Fruit possesses corilegin, beta D-Glucogallin, glucose and sorbitol. 
Polyphenolic compounds, triterpene glycosides, terchebulin (ellagi tannin), terchebin, 
syringic acid, punicalagin, terflavin A, Flavanoids,reducing sugars and starch .Terpene 
glycosides, arjungenin and arjunglucoside -1 have been isolated from the fruit. 
 
Medicinal Uses: 
 Indigenous medicines use Terminalia chebula for wide range of diseases like 
asthma, diseases of the heart, ascites, biliousness, spleen diseases, tumors, 
bleeding piles, leucoderma, itching, anemia, skin diseases.
 
 Chebulic myrobalans are used in fevers, cough, asthma, urinary diseases, piles, 
worms and rheumatism and scorpion sting.
 
 A decoction of chebulic myrobalan is a good astringent wash useful in bleeding 
piles and some vaginal discharges.
 
 Coarsely powdered and smoked in pine it affords relief in  asthma. 
 Chebulic myrobalans are extensively used in combination with belleric and 
embelic myrobalans under the medicine name of Thriphala and also as an 
adjuvant for so many medicines.
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Phyllanthus emblica (41, 42) 
Introduction: 
The drug consists of fresh and dried fruits of emblica officinalis belonging to 
family Euphorbiaceae. 
 
SCIENTIFIC CLASSIFICATION 
VERNACULAR NAMES  
Kingdom:Plantae  
Subkingdom : Tracheobionta  
Super division:  Spermatophyta  
Division : Angiospermae  
Class : Dicotyledonae  
Subclass : Rosidae 
Order : Geraniales  
Family:  Euphorbiaceae  
Genus : Phyllanthus  
Species : Phyllanthus emblica
 
 
Tamizh: Nellikkai 
Malayalam : Nellikka 
Sanskrit: Amalaka 
Hindi: Amla 
Urdu: Amla 
Kannada: Amalaka 
Telungu: Usirikai 
Marathi: Avala 
Guajarati: Ambala 
Bengal: Amlaki 
Oriya: Amla 
Punjab: Amla 
Assam: Amlakhi 
ENGLISH: Indian Gooseberry 
 
HABITAT: It is found both in the forest and cultivated state, common found in mixed 
deciduous forests in India, ascending to 1300 m on the hills.  
 
Color  :  Grey to black 
Taste  :  Sour and astringent followed by delicately sweet taste. 
 
Parts Used :  Dried fruit, the nut or seed, leaves, root, bark and flowers. Ripe fruits 
generally fresh, dry also used. 
 
 
 
Page | 62 
 
Chemical Constituents: 
Primarily contains tannins, alkaloids, phenolic compounds, amino acids and 
carbohydrates. Its fruit juice contains the highest vitamin C (478.56 mg/100 mL). 
 
Major Alkaloids: Vitamin C(=L.(+).threo.ascorbic acid -2%);tannins(5%), gallic acid, 
ellagic acid, phyllemblic acid and emblicol, Chebulinic acid, Chebulagic acid, Quercetin, 
Emblicanin-A, Emblicanin-B, Punigluconin , Pedunculagin, Ellagotannin. 
 
Amino Acids: Glutamic acid, proline, aspartic acid, alanine and lysine constitute 29.6, 
14.6, 8.1, 5.4 and 5.3% of the total amino acids present. 
 
Minor Alkaloids:  Alkaloids, phyllantidine and phullantine, pectin and minerals. 
Medicinal Uses
 (49-53) 
 Indigenous medicines uses both fresh and dry fruits in so many ailments like 
biliousness, asthma, bronchitis, cardiac diseases, liver complaints, hemorrhoids. 
 It has its beneficial role in cancer, diabetes, liver treatment, heart trouble, ulcer, 
anemia and various other diseases. 
 Fermented liquor prepared from the root is used in jaundice, dyspepsia, and 
cough. 
 Juice of the fresh fruit and ghee mixed together is a good restorative tonic. 
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Terminalia belerica (44, 45) 
Introduction: 
Tantrikkai is the pericarp of dried ripe fruit devoid of seeds, of Terminalia belerica. 
SCIENTIFIC CLASSIFICATION 
VERNACULAR NAMES 
Kingdom:Plantae 
Subkingdom: Tracheobionta 
Division: Magnoliophyta 
Class: Magnoliopsida 
Subclass: Rosidae 
Order: Myrtales 
Family: Combretaceae 
Genus: Terminalia 
Species: belerica 
Tamil: Tanikkai, Tantrikkai 
Malayalam: Thanikka 
Sanskrit: Bibhitaka  
Hindi :Bahera 
Urdu: Bahera 
Kannada : Tare Kai 
Telungu: Thanikkaya 
Marathi: Baheda 
Guajarati: Bahedan 
Bengal: Bayda 
Oriya: Baheda 
Punjab: Bahera 
Assam: Bhomora 
English: Beleric Myrobalan 
 
HABITAT: 
Commonly found in plains and deciduous forests throughout India upto 900m elevation 
where the climate is not very dry. It is also found in the forests of Burma and srilanka. 
 
Parts Used : Fruit, Bark. 
Taste  : Astringent. 
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Chemical Constituents: 
Major Alkaloids : Fruit contain stannins (20-30%) Gallic acid, ellagic acid (0.3%), ethyl 
gallate, galloyl glucose and chebullagic acid, belleric acid, belerioside, arjungenin and its 
glycoside, arjunglucoside, cannogenol-3-0-beta-D-galactopyranosyl (1-4), alpha –L- 
rhamnopyranoside. 
 
Minor Alkaloids : Bellericanin, phyllemblin, termilignan, thaninilignan, 7-Hyroxy-
3, 4 (Methylenedioxy) flavan and anolignan B, mannitol, glucose, fructose, rhamnose and 
Beta –Sitosterol. 
 
Medicinal Uses: 
 Fruits are useful in coughs, hoarseness of voice, eye diseases, scorpion sting etc 
 Dried ripe fruit is astringent and employed in dropsy, piles, and diarrhoea also 
occasionally in fever. 
 It is a constituent of Thriphala, which is prescribed in liver diseases, gastro 
intestinal diseases. And a large variety of diseases. 
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Carum copticum ( 41, 42) 
Introduction: 
Omam is the dried fruit of the Trachyspermum ammi, belonging to family Umbelliferae. 
SCIENTIFIC CLASSIFICATION 
VERNACULAR NAMES  
Kingdom:Plantae  
Subkingdom : Tracheobionta  
Super division:  Spermatophyta  
Division : Magnoliphyta 
Class : Magnoliopsida 
Subclass : Rosidae 
Order : Apiales 
Family: Umbelliferae 
Genus : Trachyspermum 
Species : Trachyspermum ammi
 
 
Tamizh: Omam 
Malayalam: Ayamodhakam 
Sanskrit: Yavani 
Hindi: Ajwain 
Urdu:  Nankhwah 
Kannada: Yom 
Telungu:  Vamu 
Marathi: Onva 
Guajarati:  Ajmo 
Bengal: yamani  
Oriya: Juani 
Arabic: Kamuemulaki 
Assam:  Jain 
English:  Bishops weed 
 
HABITAT: This plant grows largely in eastern India particularly abundant in and around 
Indore and Nizams dominions. Also in Baluchistan, Afghanistan, Egypt, Europe.  
Odor  : Thymolic. 
Taste  : Pungent. 
Parts used : fruit 
 
Chemical Constituents: 
Major Alkaloids: volatile essential oil (5-6 %%), cumene, terpene, thymene. The seeds 
of carum opticum contain the antiseptic thymol and they yield 2-3% of an essential oil 
(ajowan oil) which contains no less than 40-50% of thymol, Carvacrol, alpha and beta 
pinene, camphene. 
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Minor Alkaloids: Carvone, limonene, dillapiol, quercetin, kaemferol, fatty acids (oleic 
and linolieic acid) 
 
Ajowan oil: colorless when recently distilled then turn to yellow tinge and having the 
odor of the fruit and an acrid burning taste, with a specific gravity 0.896. Oil of ajowan 
contains about 36% thymol, cymene which is a liquid hydrocarbon. 
 
Medicinal Uses (43) 
 The distillates are useful carminatives useful in disguising the taste of 
disagreeable drugs especially castor oil and reducing the tendency to cause nausea 
and gripping. 
 Powder with buttermilk is effective in difficult expectoration and dried up phlegm. 
 In Indigenous medical systems the seed s have been used to cure ascites, 
abdominal tumors, splenomegaly, piles, chest pain and as a hepatic and cardiac 
tonic. 
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Embelia ribes (42, 44) 
 Introduction 
The drug consists of dried mature fruit of Embelia ribes belonging to Myrsinaceae. 
SCIENTIFIC CLASSIFICATION 
VERNACULAR NAMES  
Kingdom:Plantae 
Division : Magnoliophyta 
Class : Magnoliopsida 
Order:  Primulales 
Family:  Myrsinaceae 
Genus:  Embelia 
Species:  E.ribes
 
 
Tamizh: Vai vidangam 
Malayalam: Vizhalari 
Sanskrit: Vidanga 
Urdu: Baobarang 
Telungu: Vayuvidangalu 
Assam: Vidang 
Bengali:  Biranga 
Guajarati: Vavidanga 
Hindi: Vayavidanga 
Kannada: Vayuvidanga 
Marathi: Vavidanga 
Punjabi: Babrung 
Oriya: Bidanga 
 
HABITAT: These are perennial herbs & climbers are found in the hilly parts of India 
from the central and lower Himalayas down to Ceylon and Singapore. 
Odor : Slightly aromatic 
Taste :  Pungent 
 
Chemical Constituents: 
Seeds contain benzoquinone compound Embelin ((2, 5-dihydroxy-3-undecyl-2, 5-
cyclohexadiene-1, 4-benzo-quinone), quercitol, tannin, christembine, embelic acid, 
vilangin was isolated from the ripe fruit berries Embelia ribyl ester, Embeliol, Embelinol,  
Potassium embelate .The plant has also been found to contain quercitol and fatty 
ingredients,  an alkaloid, christembine,  a resinoid, tannins and minute quantities of a 
volatile oil. It has also been studied that the seeds of E.ribes showed the presence of Cr, 
K, Ca, Cu, Zn and Mn along with high carbohydrates. 
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Medicinal Uses: 
 Embelin is a useful and safe remedy against tapeworms. 
 The berries enter into the application for ringworm and other skin diseases. 
 In indigenous practice, embellia ribes is widely used in conditions of tumours, 
ascites, bronchitis, cardiac diseases, jaundice, skin diseases, and to expell worms. 
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Plumbago zeylanica (38) 
Introduction: 
Drug consists of the dried root or root bark of Plumbago zeylanica. 
 
SCIENTIFIC CLASSIFICATION 
 VERNACULAR NAMES 
Kingdom:  Plantae 
Subkingdom: Tracheobionta 
Super division: Spermatophyta 
Division: Magnoliophyta  
Class : Magnoliopsida 
Subclass: Caryophyllidae 
Order :     Plumbaginales 
Family:   Plumbaginaceae 
Genus :   Plumbago L. 
Species : Plumbago zeylanica L. 
 
 
Tamizh: Kodiveli, Chithramoolam 
Malayalam: Vella Kodiveli, 
Thumbakodiveli. 
Sanskrit: Chithraka. 
Arabic: Kamuemulaki 
Assam: Agiyachit 
Bengal: Chita  
Guajarati: Chitrakmula 
Hindi: Chitra 
Kannada: Vahni, Chithramoolam. 
Marathi: Chitraka 
Punjabi: Chitrak 
Oriya: Chita 
Telungu: Chithramulam 
English: Ceylon Leadwort. 
 
Habitat: This garden plant is growing wild in Bengal, up, southern India and ceylon.This 
is an allied species and is considered cultivated variety of plumbago rosea. 
Parts used : Root, root bark 
Taste  : Acrid 
Odor  :  disagreeable. 
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Chemical Constituents: 
 
Major Alkaloids: Plumbagin (0.91%), 3-chloroplumbagin, 3,3,-biplumbagin, 
12(3)-tetrahydro-3,3‟-biplumbagin, plumbagic acid, plumbagic acid glucosidases (3‟-0-
beta-glucopyranosyl plumbagic acid and 3‟-0-beta glucopyranosyl plumbagic acid methyl 
ester, 3,8-dihydoxy-6-methoxy -2-iso propyl-1-4-naphthaquinone, 5,7-dihydroxy -8-
methoxy-2-methyl-1,4-naphthoquinone, zeylinone, isozeylanone, elliptinone, droserone, 
isoshinanolone, maritinone, seselin, 5-methoxy seselin, suberosin, xanthyletin, 
xanthoxyletin. 
 
Minor Alkaloids:  Catecholtannins, beta sitosterol, vanilic acid, glucose, steroidal 
gycoside 
 
Medicinal Uses:  
 
 P. zeylanica is used effectively in traditional practices for liver diseases,  enlarged 
liver and spleen and also in ascites. 
 It relieves the obstructed phlegm in chronic colds and cough. 
 It is a  bitter tonic and recommended as a rejuvenator,relieves constipation and 
alleviates the urticaria- the allergic skin rashes. 
 Root has beneficial effect on piles.  
 For hemorrhoids an earthern pot or jar is lined with a paste of the root is used for 
preparing curds which is given for people suffering from piles. 
 Indigenous practices indicate its effectiveness in Spleen enlargement, piles. 
 Indigenous systems uses root, root bark for leucoderma, piles, itching, ring worm, 
scabies, bronchitis, liver diseases, spleen diseases, consumption, anemia. 
 The root is aid to increase the digestive power and is useful in dyspepsia, piles, 
anasarca, diarrhoea, skin diseases. 
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Cyperus rotundus 
Introduction: 
Drug consists of dried rhizomes of Cyprus rotundus. 
 
SCIENTIFIC CLASSIFICATION 
 VERNACULAR NAMES 
Kingdom:  Plantae 
Subkingdom:Tracheobionta 
Super division: Spermatophyta 
Division: Magnoliophyta  
Class :  Liliopsida 
Subclass: Commelinidae 
Order :   Cyperales 
Family:   Cyperaceae 
Genus :Cyprus L 
Species : Cyperus rotundus 
 
Tamizh: Korai kizhangu 
Malayalam:  Muthanga 
Sanskrit:  Mustaka,musta 
Arabic:  Kamuemulaki 
Assam:  Mutha 
Bengal: Mutha 
Guajarati: Moth,nagarmoth 
Hindi: Mutha  
Kannada: Tungegadde 
Marathi: Motha 
Punjabi: Mutha 
Oriya: Chita 
Telungu: Tungamuste 
English: Nutgrass 
 
Habitat: It is a plentiful species occurring throughout the plains of India especially south 
India up to 100 m elevation. It grows in moist areas, rice fields and along watercourses. 
Parts Used : Tuber or bulbous root. 
Chemical Constituents: 
Major Alkaloids: 4 alpha 5 alpha oxidoeudesm-11-en-3 apha-ol, cyprene-1 (a tricyclic 
sesqueterpene) and cyprene-2 (a bicyclic sesquiterpene hydrocarbon), beta –selinene, 
cyperenone, alpha –cyperone. 
 
Essential oil of Cyprus rotundus : alpha cyperone, cyperene, cyperotundone, cyperol, 
beta selinene, beta cryphyllene, valerenal, sugeonyl acetate, alpha copaene, patchoulene, 
trans-pinocarveol, patchoulenenone, aristrol-9-en-3-one, selina-4,11 dienearistrol -9-en-8-
one, kobustone, sugetriol, isokobusone, iocyperol, sugeonol and sitosterol. 
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Medicinal Uses(44, 54) 
 The rhizomes are used as a cooling, intellect promoting, nervine tonic, diuretic, 
antiperiodic, analgesic, anti-inflammatory, antipyretic and to treat diarrhea, 
dysentery, leprosy, bronchitis, amenorrhea, and blood disorders. 
 The tuber part having anti-obesity properties. 
 As an infusion or as soup in fever, diarrhea, dysentery, vomiting, and cholera. 
 
Page | 73 
 
 Borassus flabellifer (44, 54) 
Introduction 
The drug consists of Palm sugar prepared from sweet sap of Borassus flabellifer. 
 
SCIENTIFIC CLASSIFICATION 
VERNACULAR NAMES  
Kingdom:Plantae 
Clade:Monocots 
Clade:Angiosperms 
Clade:Commelinids 
Order : Arecales 
Family: Arecaceae 
Genus: Borassus 
Species: B.Flebellifer 
 
Tamizh: Karumpanai, panai maram 
Malayalam: Karimpana  
Sanskrit:  Thrinaraja  
Hindi: Tar-ka-jhar 
Urdu: Drakhte teri 
Kannada: Taalimara 
Telungu: Taadi chettu 
Guajarati: Tad 
Bengal: Tal 
Oriya: Talo,trinorajo 
Assam: Tal 
English: Palmyra palm 
 
Panam Karkandu 
VERNACULAR NAMES 
Tamizh: Panam Karkandu Hindi: Tal misri 
Malayalam: Panam Kalkandam English:  Sweet palm candy. 
Telungu: Taati kalakanda  
 
HABITAT: The Distribution of flabellifer is so heavily influenced by man. It occurs 
between sea level and 800 metres though is more abundant at low altitude and is 
particularly common in coastal areas with sandy or alluvial soils and in areas with 
permanent soil moisture such as flood plains and river valleys 
 
Parts used: Root, Flowering stalk, juice, bark, and fruit. 
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Medicinal Uses: 
 It is from the toddy juice jaggery and country sugar is prepared in large quantities 
in south India. 
 
Palm sugar: The sweet sap is boiled down to prepare palm candy. About 80% by weight 
of brown sugar can be recovered from palm sap. In the factories, raw jaggery is heaped on 
platforms for 2 months to drain away most of the molasses, then dissolved in water and 
refined to obtain brown crystalline sugar. 
 
o Palm sugar is a nutrient-rich, low-glycemic crystalline sweetener that 
looks tastes, dissolves and melts almost exactly like sugar, but it's 
completely natural and unrefined. Brown in color and naturally rich in a 
number of key vitamins, minerals and phytonutrients, including potassium, 
zinc, iron, and vitamins B1, B2, B3 and B6. 
o Sugar candy otherwise palm sugar that is produced is widely used in 
medicine. 
o Palm candy has reputed uses in respiratory affections and as a laxative for 
children. 
o Palm sugar is anti-bilious and alterative and is used in hepatic disorders. 
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Drug Standardization  (5, 61- 63)
 
 
INTRODUCTION 
 
Standardization  of the drug complies  with confirmation of entire feature of  a 
drug starting from identity, purity and quality through all phases of cycle either it means 
its shelf life ,storage and use by its various parameters . This is very essential to assess the 
quality of the distillate and for the scientific justification. As a preliminary step in the 
standardization of theeneer formulations, Sanjeevi theeneer, which is a poly herbo 
mineral distillate, mentioned in the classical text Chikitsa ratna deepam and Siddha 
Formulary of India (SFI) has been selected. Methods like Heavy metal and microbial load 
analysis, Physio chemical and Preliminary phyto chemical analysis will be perfomed in 
the distillate sample. Gas chromatography Mass spectrometry studies (GC-MS) has been 
executed to screen the biologically active compounds of the distillate.  
 
As per AYUSH Protocol for Standardization, the following parametres were 
studied. 
 
 
Table: 6    Analytical Specifications of Theeneer 
(63) 
 
S.NO TESTS 
1. Organoleptic characters 
  Color 
 Odor 
 Taste 
2. pH 
3. Volatile matter 
4. Specific gravity at 25
0
C 
5. Clarity Test 
6. Microbial Contamination 
7. Test for Specific Pathogen 
8. Test for Heavy metals 
9. Assays 
  Bio chemical analysis 
 Preliminary Phyto chemical Assays 
10. Identification 
 Gas Chromatography Mass Spectrometry ( GC-MS) 
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1. Organo leptic Characters of Sanjeevi Theeneer 
 
This provides first step information regarding the identity, purity and quality of the 
drug. Traditional quality parameters of a siddha distillate formulation  are mostly 
expressed in terms of organo leptic characters  which include color, consistency and 
nature , odor and  taste of the distillate.  
 
o Color: The Distillate was taken in a watch glass or a test tube and placed against 
white black ground in white tube light. It was observed for its color by naked eye. 
o Odor: The Distillate was smell individually. The time interval among two 
smelling was kept 2 minutes to nullify the effect of previous smelling. 
o Taste: Small quantity of Sanjeevi Theeneer was tasted with the tip of the tongue. 
 
2. Determination of pH 
 
pH of the drug is a crucial factor affecting the stability of the product. Stability 
denotes the product retainibility within the specified limits or throughout its usage and 
storage period (c)pH determination values specifies the acidity or alkalinity of the 
solution particularly distillates as the alterations have a strong influence on health. 
Five ml of Sanjeevi Theeneer was weighed accurately in a clear 100 ml beaker. Then 50 
ml distilled water was added to it and stirred. After 30 min, it was then applied into pH 
meter as standard buffer solution of 4.0, 7.9, and 9.2. Repeated the test four and the 
average were recorded. 
 
3.Volatile oil content  
 
 Volatile oils or essential oils are considered as the „essence‟ of the herb material 
obtained during the first phases of hydro distillation.They are biologically active and are 
characterized by its peculiar odor or aroma, oil nature, volatility and pungency on taste. 
They are termed as Theeneer ennai that floats as a separate supernatant layer in the 
distillate collected. 
 
The procedures recommended for analysis of Clarity test, Volatile oil, pH values 
and Specific gravity are as per the guidelines of WHO . 
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5.Tests for specific microorganisms (Microbial Load Analysis) 
 
Herbal materials are most viable for microbiological contamination due to large number 
of bacteria and fungi oftenly sourced from the soil in which it grows or 
cultivated.Unscientific approaches of harvesting,collection,handling,transportation and 
storage may dispose to further contamination and microbial growth. These contaminants 
can be transferred to the finished goods in its various stages.These should not be present 
in the herbal formulations intended for internal usage. 
 
Distillates are free from most of the impurities and basic contaminants but it is 
mandatory as per WHO to undergo microbial analysis as one of the steps to validate the 
genuines of the drug sample.The screening for biological contaminants (Esp bacteria and 
fungi) in the drug is a very crucial need as it indicates whether the microbial level comply 
with the limits set in regional or international pharmacopoeias and in assessing its purity. 
Thereby the sample-Sanjeevi Theeneer has been screened for microbial loads with 
reference to the standards of WHO. 
 
6. Detection of specific toxic metals(Heavy metal Analysis)
 
 
Toxic materials that are hazardous to human health have been categorized widely 
under chemical contaminants .Out of this, Heavy metals Arsenic,Lead, Cadmium and 
Mercury are the most common contaminant occurring in herbal resources.Contaminated 
herbal materials (due to environment pollution or pesticide usage) and its usage in various 
medications is a serious threat to the authenticity of the classical drugs in terms of its 
safety. Heavy metal analysis of any given drug sample is as important as drug 
standardization and safety assessment. The procedures recommended for analysis of 
Heavy metals are as per the guidelines WHO (1998). 
 
Instrument details:  
 Thermo FisherM Series, 650902 V1.27 model Atomic Absorption Spectrometer 
(AAS) was used for the Heavy metal analysis. The Hallow cathode lamp for Pb, Cd, Hg 
and As analysis were used as light source to provide specific wavelength for the elements 
to be determined. 
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5.4. Biochemical Analysis – Sanjeevi theeneer 
 
 
 
S.No Experiment Observation 
Inference 
1. Physical Appearance of extract Light lemon yellow  
2. Action of Heat : The sample was 
taken in a dry test tube and heated 
gently at first and then strong 
No White fumes 
evolved 
Absence of 
Carbonate 
3. Flame Test : The sample was 
mixed with conc Hcl in a watch 
glass an introduced into non-
luminous part of the Bunsen flame 
No Bluish green flame Absence of Copper 
4. Ash Test : A filter paper was 
soaked into the mixture of drug 
sample and diluted cobalt nitrate 
solution and introduced into the 
Bunsen flame and ignited 
No appearance of 
yellow color flame 
Absence of Sodium 
Test for Acid radicals 
1. Test for sulphate: To 2 ml of the 
drug sample added 2 ml of 4% dil 
ammonium oxalate solution 
No cloudy  appearance 
 
Absence of Sulphates 
2. Test for Chloride : To 2 ml of the 
sample 2 ml dil Hcl was added 
until the effervescence ceases off 
No cloudy appearance 
formed 
Absence of Chlorides 
3. Test For Phosphate: 2 ml of the  
sample was treated with 2 ml of 
dil. Ammonium molubdate 
solution and 2 ml of con.Hno3 
No cloudy yellow 
appearance present 
Absence of 
Phosphate 
4. Test For Carbonate: 2 ml of the  
sample was treated with 2 ml of 
dil.magnesium sulphate solution. 
No cloudy  appearance 
present 
Absence of 
Carbonate 
5. Test For Nitrate: 1 ml of  sample 
was treated with copper turning 
and con.H2So4 and viewed the tube 
vertically down. 
No brown gas evolved Absence of Nitrate 
6. Test For Sulphide: 1 ml of the 
drug sample is treated with 2ml of 
conc Hcl. 
No rotten egg smelling 
gas was evolved. 
Absence of Sulphide. 
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7. Test For Fluoride and Oxalate: 
2ml of the  sample was added with 
2 ml dil.acetic acid and 2ml 
dil.calcium chloride solution and 
heated. 
No cloudy appearance. 
Absence of Fluoride 
and Oxalate. 
8. Test For Nitrite: 3 drops of the  
sample was placed on a filter paper 
,on that 2 drops of dil.acetic acid 
and 2 drops of dil.Benzidine 
solution was placed 
No characteristic 
changes were noted 
Absence of nitrite 
9. Test For Borate: Sample was made 
into paste by using dil.sulphuric 
acid and alcohol (95%) and 
introduced into blue flame. 
No appearance of 
bluish green color. 
Absence of Borate. 
II Test For Basic Radicals 
10. Test For Lead : 2 ml of the  
sample was added with 2ml of 
dil.potassium iodine solution. 
No yellow precipitate 
was obtained. 
Absence of Lead. 
2. Test For Copper: Sample was 
made into paste with conc.HCl in a 
watch glass and introduced into the 
non-luminous part of the flame. 
No blue color appeared Absence of Copper. 
3.. Test For Aluminum: To the 2 ml 
of  sample dil.sodium hydroxide 
was added in 5 drops excess. 
No yellow color 
appearance 
Absence of 
Aluminium 
4. Test For Iron 
a. To 2 ml of sample, added 2 ml 
of dil.ammonium solution. 
b. To 2 ml of  sample 2 ml 
thiocyanate solution and 2ml of 
con.Hno3 were added. 
No red color appeared. Absence of Iron. 
5. Test For Zinc: To 2 ml of  sample 
dil.sodium, hydroxide solution was 
added in 5drops excess and 
dil.ammonium chloride was added. 
No white precipitate 
was formed 
Absence of Zinc 
6. Test For Calcium: 2 ml of  sample 
was added with 2 ml of 4% 
dil.ammonium oxalate solution. 
No cloudy appearance 
with precipitate 
Absence of Calcium. 
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7. Test For Magnesium: To 2 ml of  
sample  dil.sodium hydroxide 
solution was added in 5 drops to 
excess 
No white precipitate 
was obtained 
Absence of 
magnesium. 
8. Test For Ammonium: To 2 ml of  
sample 1 ml of Nesslers reagent 
and excess of dil.sodium hydroxide 
solution were added. 
No brown color 
appeared. 
Absence of 
ammonium. 
9. Test For Potassium: Sample  was 
treated with 2 ml of dil.sodium 
nitrate solution and then treated 
with 2 ml of dil.cobalt nitrate in 
30% dil.glacial acetic acid. 
No yellow precipitate 
was obtained. 
Absence of 
potassium 
10. Test For Sodium:  Sample was 
made into paste by using HCl and 
introduced into the blue flame of 
Bunsen burner 
No yellow color flame 
evolved. 
Absence of Sodium. 
11. Test For Mercury: 2 ml of the  
Sample was treated with 2 ml of 
dil.sodium hydroxide solution. 
No yellow precipitate 
was obtained. 
Absence of mercury. 
12. Test For Arsenic: 2 ml of the  
sample was treated with 2 ml of 
dil.sodium hydroxide solution. 
 
No brownish red 
precipitate was 
obtained. 
Absence of Arsenic. 
III.Miscellaneous 
1. Test For Starch: 2 ml of  sample 
was treated with weak dil.Iodine 
solution. 
Blue color was not 
developed. 
Absence of starch 
2. Test For reducing Sugar : 5 ml of 
Benedict‟s qualitative solution was 
taken in a test tube and allowed to 
boil for 2 minutes and added 8 to 
10 drops of  sample and again boil 
it for 2 minutes. The color changes 
were noted 
No Green color 
developed. 
Absence of reducing 
sugar. 
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4. Test For Tannic Acid: 2 ml of  
sample was treated with 2 ml of 
dil.ferric chloride solution. 
No Blue -black 
precipitate was 
obtained. 
Absence of tannnic 
acid. 
5. Test For Unsaturated 
Compound:  To the 2 ml of  
sample, 2ml of dil.potassium 
permanganate solution was added. 
Potassium 
permanganate was not 
decolourised. 
Absence of 
unsaturated 
compound. 
6. Test For Amino acid: 2 drops of 
the  sample was placed on a filter 
paper and dried well 20 ml of 
Burette reagent was added. 
Violet color appeared 
Presence of Amino 
acid. 
7. Test For Type of Compound: 2 
ml  sample was treated with 2 ml 
of dil.ferric chloride solution. No green and red color 
developed 
 
 
 
No violet color 
developed. 
 
Absence quinol 
epinephrine 
pyrocatecho 
antipyrine. 
 
 
Aliphatic amino acid 
and meconic acid, 
apomorphine 
salicylate and 
resorcinol were 
absent. 
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5.5  Preliminary Phyto chemical screening
(61) 
 
Background: 
Plants are the potent reservoir of high class biological compounds with wide range 
of pharmacological properties  and some of it may include alkaloids,flavanoids ,tannins 
and phenolic compounds.With importance to herbal distillation,Theeneer selectively 
avails the bio active principles of the drug (Volatile and organic). An initial step of 
research will be very fruitful in finding the presence of active chemical components in the 
distillate. Thereby it may define the therapeutic outcome of the formulation in a surface 
level .The Classical poly herbo mineral distillate-Sanjeevi theeneer  has been selected  for 
phyto chemical screening  to support the view. 
 
Phyto chemical Assays 
 
Preliminary phyo chemical studies for all the 12 compounds were carried out on the 
distillate Sanjeevi theeneer as per the standards. 
 
1.Test for the presence of Alkaloid- Mayer's reagent  
 
Principle: Most of the alkaloids are precipitated from neutral or slightly acidic solution 
by Mayer‟s reagent (Potassio mercuric iodide solution(HgI4K2) The presence of Alkaloids 
is indicated by a cream or dull white precipitate.To the test drug, about 2ml of Mayer's 
reagent was added and was observed for the presence of Alkaloids. 
 
2. Test for the presence of flavonoids 
 
 
Principle : First addition of  dilute ammonia to the test sample then followed by the 
addition of Concentrated sulphuric acid (few drops) will indicate an  yellowish coloration 
that disappear on standing confirms  the presence of Flavonoids.To 0.1ml of the test 
sample about 5 ml of dilute ammonia solution were been added followed by addition of 
few drops of conc. Sulfuric acid.  
 
3. Test for the presence of Glycosides -Borntrager’s Test  
Principle: Test drug is hydrolyzed with concentrated hydrochloric acid for 2 hours on a 
water bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of 
filtered hydrolysate, 3 ml of chloroform is added and shaken, chloroform layer is 
separated and 10% ammonia solution is added to it. Pink colour indicates presence of 
Glycosides. 
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4. Test for the presence of Triterepnoids - Salkowski test 
 
Principle: To 2ml of the test solution 2ml chloroform was added with few drops of conc. 
Sulphuric acid (3ml) through the side of the test tube. An interface with a reddish brown 
coloration is formed if Terpenoids constituent is present. 
 
5. Test for the presence of Steroids - Salkowski test 
 
Principle: To the test solution, 2ml of chloroform was added with few drops of conc. 
Sulphuric acid (3ml), and shaken well. The upper layer in the test tube turns into red and 
sulphuric acid layer showed yellow with green fluorescence. It showed the presence of 
Steroids.(Joseph et al., 2013) 
 
6. Test for the presence of Carbohydrates - Benedict’s test  
Principle:The Benedict's test allows us to detect the presence of reducing sugars (sugars 
with a free aldehyde or ketone group). The final color of the solution depends on how 
much of this precipitate was formed, and therefore the color(Green,Orange,Red,and 
Brown) gives an indication of how much reducing sugar was present. To 0.5 ml of test 
drug, about 0.5 ml of Benedict‟s reagent is added. The mixture is heated on a boiling 
water bath for 2 minutes. A characteristic coloured precipitate indicates the presence of 
Sugar. 
 
7. Test the presence of Phenol- Lead acetate test 
 
Principle: The test sample is dissolved in of distilled water and to this 3 ml of 10% lead 
acetate solution is added. A bulky white precipitate indicates the presence of Phenolic 
compounds. 
 
8. Test for the presence of tannins (Ferric Chloride Test)
 
Principle: About 0.5ml of test sample is boiled in 20 ml of distilled water in a test tube 
and then filtered. The filtration method used here is the normal method, which includes a 
conical flask and filter paper.0.1% FeCl3 is added to the filtered samples and observed for 
brownish green or a blue black coloration, which shows the presence of Tannins. 
9. Test for the presence of Saponins (foaming Test)
 
Principle: Demonstration of Frothing: Herbal material containing Saponins can cause 
persistant foam when an aqueous decoction or distillate is shaken.The test drug were 
shaken vigorously for 10 mins, and observed for lather formation. 
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10. Test for the presence of Proteins (Biuret Test)
 
Principle: Equal volume of 5% solution of sodium hydroxide and 1% copper sulphate 
were added. Appearance of pink or purple colour indicates the presence of proteins and 
free amino acids (Boxi et al., 2010). 
 
11.Test the presence of Coumarins
 
Principle: 1 ml of test drug, 1 ml of 10% sodium hydroxide was added. The presence of 
Coumarins is indicated by the formation of yellow color.
 
 
12.Test for the presence of Anthocyanin (Sodium Hydroxide Test) 
Principle: About 0.2 ml of the extract was weighed in separate test tube; 1ml of 2N 
Sodium hydroxide was added, and heated for 5 minutes at 100 ± 2°C. Observed for the 
formation of bluish green color, which indicates the presence of Anthocyanin. 
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5.6 GAS CHROMATOGRAPHY MASS SPECTROMETRY                         
(GC-MS) Analysis
 (67, 68) 
INTRODUCTION 
 
GC-MS Plays a key role in the analysis of unknown components of plant origin. 
GC-MS ionizes compound and measures their mass numbers. Ionization method includes 
EI (Electron Ionization). The EI method produces ions by colliding thermal electrons 
emitted from a filament with sample gas molecules. This method provides high stability 
in ionization and obtained mass spectra show good reproducibility. The EI method 
provides good result for quantitative analysis as well. Quantitative analysis with GC-MS, 
in which only ions specific to the compounds are measured, is highly selective method 
without interfering components. Gas chromatography Technique involves the separation 
of volatile components in a test sample using suitable capillary column coated with polar 
or non-polar or intermediate polar chemicals. Elite-1 column (100% Dimethyl 
polysiloxane) is a non-polar column used for analysis of phyto-components. Elite -5 
column (5% phenyl and 95% methyl polysiloxane) is an intermediate column and also 
used for the estimation of Phytochemical. An inert gas such as hydrogen or nitrogen or 
helium is used as a carrier gas .The compounds of test sample is evaporated in the 
injection port of the GC equipment and segregated in the column by absorption and 
adsorption technique with suitable GC programme.The two samples of Sanjeevi Theeneer 
were individually analysed through  GC-MS 
 
Agilent 7890B GC connected  to  5977A MSD, NIST Ver.2.1 MS data library 
Specification  
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TOXICOLOGICAL EVALUATION OF SANJEEVI THEENEER 
 
Introduction: 
 
Safety is a fundamental principle in the provision of traditional medicines and 
herbal products for health care and a critical component of quality control. OECD 
guidelines provide practical and technical guidance for monitoring the safety of 
traditional medicines within Pharmacovigilance systems. The safety monitoring of 
traditional medicines is compared and contrasted with that of other medicines, currently 
undertaken in the context of the WHO International Drug perspective. 
 
Scope of work: 
 
 Assurance of safety, quality and efficacy of Indian System of Medicines (ISM) is 
the key issue that needs to be addressed while conducting toxicity studies.  
 It is an essential step, which will strengthen the acceptance of Siddha medicines by 
scientific community. 
  Information of toxicity and adverse effects of Siddha formulations are lacking.  
 Some of the formulations are proved effective in various animal studies and many 
more are yet to be tested.  
Hence, the present study was carried out to evaluate the safety of   Sanjeevi 
Theeneer in rodents. 
 
Plan of work: 
The following studies were carried out on Sanjeevi Theeneer 
 Acute Oral toxicity Study - OECD 423 
 Repeated dose 28 Days Oral Toxicity Study - OECD 407 
 Repeated dose 90 Days Oral Toxicity study - OECD 408 
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6.1  ACUTE ORAL TOXICITY STUDY OF SANJEEVI THEENEER 
(OECD GUIDELINE – 423) 
 
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgement on the acute toxicity of the test 
substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
 The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification purposes 
and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test.  
 The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
 
Principle of the Test:  
 
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e. 
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 no further testing is needed 
 dosing of three additional animals, with the same dose  
 dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the 
test substance to one of a series of toxicity classes. 
 
Methodology: 
Selection of Animal Species  
 The preferred rodent species is the Wistar albino rat 
 Healthy young adult animals or commonly used laboratory strains should be 
employed 
 Females should be nulliparous and non-pregnant. 
 Each animal, at the commencement of its dosing, should be between 6 to 8 weeks 
old and the weight (150-200 gm) should fall in an interval within ±20 % of the 
mean weight of any previously dosed animals.  
 
Housing and Feeding Conditions 
 Animals were housed under standard laboratory conditions.  
 They were maintained in a ventilated room. The temperature in the room should 
be 22
0
(±3
0
).  
 The relative humidity should be at least 30% and not exceed 70% (50%-60%). 
 Lighting should be artificial; it is maintained as 12h light/dark cycle.  
 Animals were kept in a clean polypropylene cage. 
 Rats were fed with standard pellet diet (Sai Meera Foods, Bangalore) and water ad 
libitum.  
 Animals may be group-caged by dose, but the number of animals per cage must 
not interfere with clear observations of each animal. 
Preparation of animals:  The animals were randomly selected, marked on its fur to 
permit individual identification, and kept in their cages for at least 7 days prior to dosing 
to allow for acclimatization to the laboratory conditions 
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Test Animals and Test Conditions:  
 Sexually mature Female Wistar albino rats (150-200 gm) were obtained from 
Tanuvas, Madhavaram, Chennai. All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and standard 
pellet diet (Sai meera foods, Bangalore). 
 
Preparation of animals:   
The animals are randomly selected, marked to permit individual identification, and kept 
in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions. 
 
Preparation for Acute Toxicity Studies 
 Rats were deprived of food overnight (but not water 16-18 h) prior to administration of 
the, Sanjeevi Theeneer. 
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
 
IAEC approved Number: IAEC/XLIX/CLBMCP/2016  
Test Substance  : Sanjeevi Theeneer 
Animal Source   : Tanuvas, Madhavaram, Chennai.   
Animals    : Wister Albino Rats (Female-3+3) 
Age     : 6-8 weeks 
Body Weight on Day 0  : 150-200 gm. 
Acclimatization   : Seven days prior to dosing. 
Veterinary examination  : Prior and at the end of the acclimatization period. 
Identification of animals  : By cage number, animal number and individual    
                 marking by using Picric acid. 
Numberofanimals    : 3 Female/group,  
Routeofadministration         : Oral  
Diet     : Pellet feed supplied by Sai meera foods Pvt Ltd, 
Bangalore 
Water       : Aqua guard portable water in polypropylene bottles. 
 
Housing & Environment  : The animals were housed in Polypropylene cages    
                                provided with bedding of husk. 
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Housing temperature : Between 22ºC + 3ºC.   
Relative humidity  : Between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 14 Days 
 
Administration of Doses:  
 Sanjeevi Theeneer was suspended in water and administered to the groups of 
wistar albino rats in a single oral dose by gavage using a feeding needle. The control 
group received an equal volume of the vehicle. Animals were fasted 12 hours prior to 
dosing. Following the period of fasting, the animals were weighed and then the test 
substance was administered. Three Female animals are used for each group. The dose 
level of  5 ml/kg body weight was administered. After the substance has been 
administered, food was withheld for a further 3 - 4 hours. The principle of laboratory 
animal care was followed. Observations were made and recorded systematically and 
continuously as per the guideline after substance administration. The visual observations 
included skin changes, mobility, aggressiveness, sensitivity to sound and pain, as well as 
respiratory movements. Finally, the number of survivors was noted after 24 hrs and these 
animals were then monitered for a further 14 days and observations made daily. The 
toxicological effect was assessed on the basis of mortality. 
 
Limit test 
Number of animals and dose levels 
 
 The limit test is primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having 
toxicity only above regulatory limit doses. 
 Information about the toxicity of the test material can be gained from knowledge 
about similar tested compounds or similar tested mixtures or products, taking into 
consideration the identity and percentage of components known to be of 
toxicological significance. 
 A limit test at one dose level of 2000 mg/kg body weight can be carried out with 
three animals per step. 
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 If the test substance-related mortality was not produced in the experimented 
animals, further testing at the next lower level need not be carried out. 
 Since this test drug is likely to be non-toxic, and the inference from various 
toxicity studies on distillates a limit test at one dose level of 5 ml/kg body weight 
will be carried out with 3 animals for each group. 
 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. It 
should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal. 
 
a. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and 
behavior patterns. Attention should be directed to observations of tremors, convulsions, 
salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria summarized in 
the Human Endpoints Guidance Document is taken into consideration.  
 
b. Behavior: 
 The animals will be observed closely for behavior in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolutions, excitation, head twitches, lacrimation, loss of corneal reflex, loss of 
traction, piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  head 
movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and coma.  
 
c. Food and water Consumption: 
 Food and water consumed per animal was calculated for control and the treated dose 
groups.  
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d. Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
 
e. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 hour 
following drug administration on day 1 of the experiment and daily twice thereafter for 14 
days.   
 
f. Gross necropsy 
All animals (including those which die during the test period are removed from 
the study), will be subjected to gross necropsy. Gross necropsy includes examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and 
uterus of all animals. 
 
g. Mortality: 
Animals were observed for mortality throughout the entire period. 
 
Data and reporting 
 All data were summarized in tabular form, (Table-1-4) showing for each test 
group the number of animals used, the number of animals displaying signs of toxicity, the 
number of animals found dead during the test ,description of toxic symptoms,, weight 
changes, food and water intake. 
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6.2 REPEATED DOSE 28-DAY ORAL TOXICITY STUDY OF 
SANJEEVI THEENEER 
 
Introduction: 
 
 In the assessment and evaluation of the toxic characteristics of a chemical, the 
determination of oral toxicity using repeated doses may be carried out after initial 
information on toxicity has been obtained by acute toxicity testing. This Test guidelines is 
intended to investigate effects on a very broad variety of potential targets of toxicity. It 
provides information on the possible health hazards likely to arise from repeated exposure 
over a relatively limited period. 
 
Principle of the Test: 
 
 The test substance is orally administered daily in graduated doses to several 
groups of experimental animals, one dose level per group for a period of 28 days. 
 During the period of administration, the animals are observed closely, each day 
for signs of toxicity. 
 Animals that die or are euthanized during the test are necropsied and at the 
conclusion of the test, surviving animals are euthanized and necropsied. 
 A 28-day study provides information on the effects of repeated oral exposure and 
can indicate the need for further longer-term studies. 
 It can also provide information on the selection of concentrations for longer-term 
studies. 
 The data derived from using the TG should allow for the characterization of the 
test substance toxicity, for an indication of the dose response relationship and the 
determination of the No-Observed Adverse Effect Level (NOAEL) 
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Test Substance  :  Sanjeevi Theeneer 
Animal Source  :  TANUVAS, Madhavaram, Chennai.   
Animals   :  Wister Albino Rats (Male -15, and Female-15) 
Age    :  6-8 weeks 
Body Weight               :  150-200 gm. 
Acclimatization  :  Seven days prior to dose. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :   By cage number, animal number   and    individual  
   marking by using    Picric acid 
Diet    :  Pellet feed supplied by Sai meera foods Pvt Ltd,       
      Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
      provided with bedding of husk. 
Housing temperature :   between 22ºC + 3ºC.   
Relative humidity  :   between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  28 Days. 
 
Table: 8 Grouping of Animals 
Groups No of Rats 
Group I  Vehicle control (Water) 10(5 male, 5 female) 
Group III ST- Mid dose  5X (2.5ml/ kg) 10(5 male, 5 female) 
Group IV ST- High dose 10X( 5 ml/ kg) 10(5 male, 5 female) 
 ST: Sanjeevi Theenee R 
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I. Methodology 
1. Justification for Dose Selection 
The results of acute toxicity studies in Wistar albino rats indicated thatSanjeevi 
Theeneer was non-toxic and no behavioral changes was observed up to the dose 
level of 5ml /kg body weight. As per OECD, guideline three dose levels usually 
will be  selected for the study. They are low dose (X), mid dose dose (5X), high 
dose (10X). X is calculated by multiplying the therapeutic dose (30 ml) and the 
body surface area of the rat (0.018). i.e X dose is 0.54 ml/kg , (rounded to 0.5ml), 
5X dose is 2.5 ml/ kg, 10X dose is 5 ml/kg. Here as the trial drug has not shown 
acute toxicity, Mid and high doses are selected for the study. 
 
2. Randomization, Numbering and Grouping of Animals: 
30 Wistar Albino Rats (15 M + 15 F) were selected and divided into 4 groups. 
Each group consist of 10 animals (5 male, 5 female). First group treated as a 
control and other two groups were treated with test drug (mid, high) for 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions 
prior to the initiation of treatment. Each animal was marked with picric acid. The 
females were nulliparous and non-pregnant. 
 
3. Preparation and Administration of Dose: 
Sanjeevi Theeneer suspended in with water, it was administered to animals at the 
dose levels of  5X, 10X. The test substance suspensions were freshly prepared 
every two days once for 28 days. The control animals were administered vehicle 
only. The drug was administered orally by using oral gavage once daily for 28 
consecutive days. 
 
4. Observations: 
Experimental animals were kept under observation throughout the course of study 
for the following: 
 
a. Body Weight: 
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the 
data, group mean body weights and percent body weight gain were calculated. 
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b. Food and water Consumption: 
Food and water consumed per animal was calculated for control and the treated 
dose groups.  
 
c. Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
 
d. Mortality: 
All animals were observed twice daily for mortality during entire course of study. 
 
1. Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200 IU /ml) for Biochemistry and potassium EDTA (1.5 mg/ml) for Hematology 
as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. . 
On 28th day of the experiment, 24 h urine samples were collected by placing the 
animals in the metabolic cage with free access to tap water but no feed was given.  
 
 The urine was free from fecal contamination. Toluene is used as a 
preservative while collecting the sample. The sediments present in the urine were 
removed by centrifugation and the collected urine was used for biochemical 
estimations. On 29th day, the animals were fasted for approximately 18 h, then 
slightly anesthetized with ether and blood samples were collected from the retro-
orbital plexus into two tubes: one with EDTA for immediate analysis of 
haematological parameters, the other without any anticoagulant and was 
centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the serum. Serum was 
stored at 20 °C until analyzed for biochemical parameters. 
 
2. Haematological Investigations: 
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count 
and packed cell volume (PCV). 
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3. Biochemical Investigations: 
Serum was used for the estimation of biochemical parameters. Samples of control 
and experimental rats were analyzed for protein, bilirubin, urea, BUN, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. 
Activities of glutamate oxaloacetate transaminase/ Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase 
(GPT/ALT) and alkaline phosphatase were estimated as per the colorimetric 
procedure. 
 
4. Urine analysis:  
Urine samples were collected on end of treatment for estimation of normal 
parameters. The estimations were performed using appropriate methodology. 
 
 
5. Necropsy: 
All the animals were sacrificed on day 29. Necropsy of all animals was carried out 
and the weights of the organs including liver, kidneys, spleen, brain, heart, and 
lungs were recorded. The relative organ weight of each animal was then 
calculated as follows. 
 
                        
                         
                                         
       
 
 
6. Histopathology:  
 
Organs will be collected from all animals, preserved in 10% buffered neutral formalin 
for 24 h, and washed in running water for 24 h.  The organ sliced 5 or 6µm sections 
and were dehydrated in an auto technicon and then cleared in benzene to remove 
absolute alcohol. Embedding was done by passing the cleared samples through three 
cups containing molten paraffin at 50°C and then in a cubical block of paraffin made 
by the “L” moulds. It was followed by microtome and the slides were stained 
withHaematoxylin-eosin red. The organs included Liver, spleen, kidney, Brain and 
Lung. 
 
 
 
Page | 98 
 
 
 
7. Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, water and food 
consumption, hematology and blood chemistry were subjected to One-way 
ANOVA followed by Dunnet‟s multi comparision test using a computer software 
programme GRAPH PAD INSTAT-3 version. All data were summarized in tabular 
form. 
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6.3 REPEATED DOSE 90-DAY ORAL TOXICITY STUDY OF 
SANJEEVI  THEENEER (OECD GUIDELINE - 408) 
 
Introduction: 
 
In the assessment and evaluation of the toxic characteristics of a chemical, the 
determination of sub-chronic oral toxicity using repeated doses may be carried out after 
initial information on toxicity has been obtained from acute or repeated dose 28-day 
toxicity tests. The 90- day study provides information on the possible health hazards 
likely to arise from repeated exposure over a prolonged period. The study will provide 
information on the major toxic effects, indicate target organs and the possibility of 
accumulation, and can provide an estimate of a no-observed-adverse-effect level of 
exposure which can be used in selecting dose levels for chronic studies and for 
establishing safety criteria for human exposure. 
 
Principle of the test: 
 The test substance is orally administered daily in graduated doses to several 
groups of experimental animals, one dose level per group for a period of 90 days. 
 During the period of administration, the animals are observed closely for signs of 
toxicity. 
 Animals which die or are killed during the test are necropsied and, at the 
conclusion of the test, surviving animals are killed and necropsied. 
Test Substance  :  Sanjeevi Theeneer 
Animal Source  :  Tanuvas, Madhavaram, Chennai.   
Animals   :  Wister Albino Rats (Male - 20, and Female-20) 
Age    :  6-8 weeks 
Body Weight               :  150-200 gm. 
Acclimatization  :  Seven days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :   By cage number, animal number   and    individual  
   marking by using picric acid.      
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,       
                        Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
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Housing & Environment :  The animals were housed in Polypropylene cages  
               provided with bedding of husk. 
Housing temperature :   between 22ºC + 3ºC.   
Relative humidity  :   between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  90 Days. 
 
Table: 9 Grouping of Animals 
 
 
 
 
 
 
 
I. Methodology 
 
1.Randomization, Numbering and Grouping of Animals: 
 
60 Wistar Albino Rats (20 M + 20F) were selected and divided into 4 groups. 
Each group consists of 20 animals (Male -10 and Female-10). First group treated as a 
control and other 2 groups were treated with test drug (mid, high) for 90 days. Animals 
were allowed acclimatization period of 7 days to laboratory conditions prior to the 
initiation of treatment. Each animal was marked with picric acid. The females were 
nulliparous and non-pregnant. 
 
2.Justification for Dose Selection: 
 
By following Sub – Acute studies. 
 
3. Preparation and Administration of Dose: 
Sanjeevi Theeneerwas administered to animals at the dose levels of 5X, 10X. The 
control animals were administered vehicle (WATER) only. The drug was administered 
orally by using oral gavage once daily for 90 consecutive days. 
 
 
Groups No of Rats 
Group I  Vehicle control (Water)1ml 20 (10male, 10female) 
Group III STR - Mid dose  5X (2.5Ml/kg) 20 (10male, 10female) 
Group IV STR - High dose 10X( 5ml/kg) 20 (10male, 10female) 
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3.1 Observations: 
Experimental animals were kept under observation throughout the course of Study 
for the following: 
A.  Body Weight: 
Weight of each rat was recorded on day 1,15,30,45,60,75,90, at biweekly 
intervals throughout the course of study. 
B. Food and water Consumption: 
 Food and water consumed per animal was calculated for control and the treated 
dose groups. 
C. Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
D. Mortality: 
All animals were observed twice daily for mortality during entire Course  of  
study.   
E. Necropsy: 
All the animals were sacrificed by excessive anesthesia on day 91. Necropsy of all 
animals was carried out. 
 
3.2 Laboratory Investigations: 
 
Following laboratory investigations were carried out on day 91 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin (200 
IU/ml) for Biochemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
a. Haematological Investigations: 
 Haematological parameters were determined using Haematology analyzer.  
b. Biochemical Investigations:  
              Biochemical parameters were determined using auto-analyzer 
c.   Histopathology:  
 
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Organs will be collected from all 
animals and preserved in 10% buffered neutral formalin for 24 h and washed in running 
water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an auto 
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technicon and then cleared in benzene to remove absolute alcohol. Embedding was done 
by passing the cleared samples through three cups containing molten paraffin at 50°C and 
then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained withHaematoxylin-eosin. 
 
e. Statistical analysis:  
 
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by dunnet test using a statistics software Graph Pad version 7. All data were 
summarized in tabular form Table () 
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7.1 Evaluation of Anti-Oxidant Activity of Sanjeevi Theeneer Using 
Dpph (2, 2-Diphenyl 1-2 picrylhydrazyl) Free radical Scavenging Assay 
 
Procedure:
 
The antioxidant activity of test drug sample ST was determined using the 2,2-
diphenyl 1-2 picrylhydrazyl (DPPH) free radical scavenging assay . Sample ST was 
mixed with 95% methanol to prepare the stock solution in required concentration 
(100μg/ml). From the stock solution 10 μg/ml, 20 μg/ml, 40μg/ml, 60 μg/ml, 80 μg/ml 
and 100 μg/ml of this solution were taken in five test tubes and by serial dilution. 
Ascorbic acid were used as standard was prepared in concentration 10 μg/ml, 20 μg/ml, 
40μg/ml, 60 μg/ml, 80 μg/ml and 100 μg/ml respectively by using methanol as solvent. 
Final reaction mixture containing 1 ml of 0.3 mM DPPH methanol solution was added to 
2.5 ml of sample solution of different concentrations and allowed to react at room 
temperature. Absorbance in the presence of ST at different concentration of (10 μg/ml, 20 
μg/ml, 40μg/ml, 60 μg/ml, 80 μg/ml and 100 μg/ml) was noted after 15 min incubation 
period at 37
0
C. Absorbance was read out at 517 nm using double-beam U.V 
Spectrophotometer by using methanol as blank. 
 
% scavenging = [Absorbance of control - Absorbance of test sample/Absorbance of 
control] X 100 
 
The effective concentration of test sample ST required to scavenge DPPH radical 
by 50% (IC50 value) was obtained by linear regression analysis of dose-response curve 
plotting between %inhibition and concentrations. 
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7.2  Evaluation of Hepatoprotective activity of Sanjeevi Theeneer against 
paracetamol induced Hepato toxicity in zebra fish Danio rerio model
 (77, 78) 
 
Background 
The liver may be considered as the most important organ in drug toxicity because 
it is functionally interposed between the site of absorption and the systemic circulation 
and is a major site of metabolism and elimination of foreign substances; these features 
render it a preferred target for drug toxicity. Drug-induced liver injury (DILI) therefore 
poses a major clinical problem. DILI is initiated by direct hepatotoxic effects of a drug, or 
a reactive metabolite of a drug. 
 
Paracetamol, a widely used analgesic and antipyretic drug, produces acute liver 
damage in high doses in both animals and in humans. Paracetamol administration causes 
necrosis of the centrilobular hepatocytes characterized by nuclear pyknosis and 
eosinophilic cytoplasm followed by large excessive hepatic lesion. The covalent binding 
of Nacetyl- P-benzoquinoneimine, an oxidative product of paracetamol to sulphydryl 
groups of protein, result in lipid peroxidative degradation of glutathione level and 
thereby, produces cell necrosis in the liver. 
 
Zebra Fish Model (Danio rerio) 
 
 Zebra fish is good  translational model to assess drug induced toxicity , Hepato 
protectivity or hepatic regeneration. 
 Can accurately model human physiology. 
 Have similar molecular/ cellular/ drug metabolism/ CYP genes/ Histopathological 
changes. 
  Can reduce and replace higher order animals for Drug studies. 
 
 Materials and Methods 
 
• Purchase : Local Aquarium facility. 
• Acclimatization : four weeks prior to the start of experimentation. 
• Laboratory condition : 28 °C + 1°C , 14:10 h light/dark cycle photo period. 
• Grouping :  four groups of 10 fish each. 
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• Weight  per ml calculation of the drug ST =  0.015 gm (15000 micro gram or 15 
mg)/ ml 
• Drug administration : Dilution of drug  in water . 
• Drug Exposure period : 7 days. 
 
Table: 10 Grouping of Zebra Fishes for Study Trial 
 
Groups Exposure Period 
Group I  Control Untreated 7 Days 
Group II Toxicant 
Paracetamol 5mM (755.8mg) 
per litre concentration 
7 Days 
Group III: Test group (ST 
Low dose) 
Paracetamol 5mM + ST Low 
Dose 150 mg/ litre. 
7 Days 
Group IV: Test group (ST 
High dose) 
Paracetamol 5mM + ST High 
Dose 300 mg/ litre. 
7 Days 
 
Procedure: 
 
Animal belongs to group I left untreated and group II treated with Paracetamol at 
the concentration of 5mM (755.8mg) per liter concentration for the period of seven days. 
Animal belongs to group III received test drug Sanjeevi Theeneer (ST) at the 
concentration of 150 mg/liter and group IV received test drug Sanjeevi Theeneer (ST) at 
the concentration of 300 mg/liter along with paracetamol 5mM for the period of seven 
days. 
 
Histopathology  
 
After a one-week exposure period, the livers of zebrafish were dissected and 
fixed in 10% formalin at 4 °C for 24h. Subsequently, the fixed liver tissues were 
dehydrated in gradient ethanol, hyalinized in xylene, and embedded in paraffin wax at 
56 °C. Then, the paraffin blocks were sectioned at 4-μm thickness. The sections were 
collected on glass slides and stained with hematoxylin and eosin (H&E) using an H&E 
Staining Kit. Histologic lesions were observed using an optical microscope equipped 
with a digital camera. 
 
 
Page | 106 
 
7.3 Evaluation of Hepatoprotective activity of Sanjeevi Theeneer on 
paracetamol induced hepatotoxicity in rat’s model( 76) 
 
AIM:  
  To study the Hepato-Protective study of Sanjeevi Theeneer in Wistar albino rats 
by Paracetamol induced hepatotoxicity method. 
 
Materials and Methods: 
Test Substance                   :   Sanjeevi Theeneer. 
Animal Source  :  TANUVAS, Madhavaram, Chennai.   
Animals   :  Wister Albino Rats (Male -30). 
Age    :  6-8 weeks. 
Body Weight               :  150-200gm. 
Acclimatization  :  14 days prior to dose. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :   By cage number, animal number   and    individual  
   marking by using   Picric acid 
Diet    :  Pellet feed.      
Water                         :  Aqua guard portable water in polypropylene bottles 
Housing & Environment : The animals were housed in Polypropylene cages  
     provided with bedding of husk. 
Housing temperature :   between 22ºC + 3ºC.   
Relative humidity  :   between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
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I. Experimental design: 
 
Paracetamol induced hepatotoxicity in rats model was used for evaluation of hepato- 
protective activity for the Sanjeevi Theeneer. Animals were divided into five groups, each 
group containing six animals (Table: 1) 
 
a. Grouping of Animals 
 
o Group I(normal): received distilled water only for 7 days.  
o Group II(Toxicant): received distilled water for 7 days and Paracetamol 1ml/kg, 
i. p. 1:1 dilution with coconut oil on 7th day.  
o Group III (Test group ST 1): received Sanjeevi Theeneer(0.5ml/kg per day, p.o.) 
for 7 days and paracetamol induction on 7
th
 day.  
o Groups IV (Test group ST 2):  received Sanjeevi Theeneer (1ml/kg per day p.o) 
for 7 days and paracetamol induction on 7th day.  
o Group V (Standard): received standard marketed drug silymarin (25mg/kg per 
day, p.o.) for 7 days and Paracetamol induction on 7
th
 day. (Dr. Sanjay R. Arote 
et. al.) 
 
Table: 11 Grouping of animals 
 
 
 
 
 
 
 
 
 
 
 
 
 b. Blood Sample Collection and Analysis 
 After 14 days of experimental period, blood sample has been collected 
individually for all the animals by retro-orbital puncture method and the blood was 
allowed to clot for 30 min; serum was separated by centrifuging and was used for various 
parameter estimations. Later all the animals were sacrificed by cervical dislocation for 
histopathological study. 
Group Treatment Dose No : of Animals 
A Normal 
control 
Distilled water  6 Rats 
B Toxicant 
Control 
Partacetamol 1ml/kg,  
i. p. 1:1 dilution with 
coconut oil 
6 Rats 
C Test Drug 
ST - 1 
0.5ml/kg, p.o.+ 
paracetamol 
6 Rats 
D Test Drug 
ST - 2 
1ml/kg, p.o.+ 
paracetamol 
6 Rats 
E Standard 
(Silymarin) 
25mg /kg, p.o.+ 
paracetamol 
6 Rats 
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c. Serum Biochemistry 
The whole blood serum was separated by centrifuging for the following analysis. The 
activities of serum glutamate pyruvate transaminase (SGPT), serum glutamate 
oxaloacetate transaminase (SGOT) were estimated using standard methods. Estimation of 
serum ALP, serum bilirubin and electrolytes were also carried out to assess the acute 
hepatic damage caused by paracetamol.  
 
d. Histopathology study 
The animals were sacrificed by decapitation method and the abdomen was cut open to 
remove the liver. , and the individual weights of the livers were estimated. Liver tissue 
was quickly removed after autopsy and fixed in 10% formalin in saline. Initially the 
materials were fixed in 10% buffered neutral formalin and then with Boucins solution 
(mixture of 75 ml of saturated picric acid, 25 ml of 40% formaldehyde and 5 ml of glacial 
acetic acid) for 12 hr, then embedded in paraffin and cut into 5 µm thick section and 
stained using hematoxylin-eosin dye and finally mounted in di-phenyl-xylene were then 
observed under microscope for histopathological changes in liver architecture and their 
photomicrographs were taken for the evaluation of histopathological changes 
 
e. Statistical analysis 
 The experimental results were expressed as the Mean ± SEM for animals in each 
group. The biochemical parameters were analyzed statistically using one-way analysis of 
variance ANOVA, followed by Dunnetts multiple comparison test. P value of < 0.05 was 
considered as statistically significant 
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7.4 Evaluation Of Bronchdilator Activity of Sanjeevi Theeneer- Isolated 
Guinea Pig Tracheal Chain Preparation . 
 
 
Introduction: Histamine plays an important role in the symptomatology of allergic 
reactions. Histamine can provoke bronchoconstriction, it may also be responsible for 
bronchial hypersensitivity which is a common feature of asthma. Targeting histamine, 
either prevention of its release from mast cells or use of histaminergic receptor 
antagonists becomes part of anti histaminic therapy in allergic diseases. Drugs which have 
the capacity to control the histamine release and its further effects can be called as 
antihistaminic or antiallergic drugs
 (80)
. The tracheal muscle has histamine H1, M3.B2 
receptors . The stimulation of histamine H1 receptors cause contraction of bronchiole 
smooth muscles. In present study is to evaluate the effectiveness of Sanjeevi Theeneer in 
inhibition of  histamine induced contraction of Guinea pig tracheal chain preparation, 
indicating histamine H1 receptor antagonist activity 
 
Aim: 
 
 To study the Broncho dilator  of Sanjeevi Theeneer in guinea pig Tracheal chain (79) 
preparation 
 
Materials and methods: 
 
Test Substance : Sanjeevi Theeneer 
Animal Source :  TanuvaS, Madhavaram, Chennai.   
Animal :  Albino Guinea pig (Male -1) 
Body Weight               : 700 gms 
Acclimatization : 14 days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Diet : Pellet feed 
Water :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animal was housed in Polypropylene cage   
   provided with bedding of husk. 
Housing temperature :  25±2°C 
Air changes  : 10 to 15 per hour  
Dark and light cycle  :  12:12 hours. 
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Selection of animals: 
 
           Healthy albino guinea pig weighing 700 gms of male sex was used in this study 
with the approval of the Institutional Animal Ethics Committee and obtained from the 
animal laboratory IAEC approved no: IAEC/XLIX/CLBMCP/2016 
           The animal kept in plastic cage and maintained under controlled environment 
(temperature 25±2
◦
C and 12hrs dark and light cycle) with standard diet, water and lipitum 
during experiment. The animal was allowed an acclimatization period of 14 days before 
actual experiment. The animal experiment was performed with accordance legistation on 
welfare.  
 
Procedure:  
 
The guinea pigs (overnight fasted weighing 300-500g) were sacrificed. The 
trachea was cut at suitable length (approximately 2 cm long) was mounted in an organ 
bath containing Krebs solution of the composition; Nacl 5.9, kcl 0.35, cacl2 O.28, Mgso4 
0.11, Nahco3 2.1, KH2 PO4 O.16 and glucose 2.0gm per liter which will be continuously 
aerated and maintained at 37 ± 0.5.c, one end tracheal chain will be attached to an S 
shaped aerated tube and other attached to an isotonic frontal wrighting lever to smoked 
drum. Histamine was added in different concentrations and contractions were recorded. In 
order to observe the broncho dilator effect of the test substance on induced contractions, 
the test material Sanjeevi Theeneer was added in a cumulative fashion (15 ml and 30 ml) 
to obtain the concentration-dependent inhibitory responses. The relaxation of the tissue 
preparation was expressed as percentage of inhibition in contraction. Percent of maximum 
contractile responses were plotted to record dose response curves of histamine in the 
absence and presence of Sanjeevi Theeneer. 
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7.5 EVALUATION OF ANTI-HISTAMINE (H1 RECEPTOR 
ANTAGONISM)    OF SANJEEVI THEENEER- Isolated Guinea Pig 
Ileum Preparation. 
 
Introduction: 
Guinea pig ileum is used for screening of antihistaminic activity. The stimulation of H1 
receptors produces graded dose related contraction of isolated guinea pig ileum
 (81)
  
 
Aim: 
To study the Anti- Histamine activity of Sanjeevi Theeneer in guinea pig ileal 
preparation.. 
 
Procedure:  
The guinea pigs (overnight fasted weighing 300-500g) were sacrificed. The 
abdomen was cut open a suitable length of the ileum (approximately 2 cm long) was 
mounted in an organ bath containing Tyrode solution. The composition of the tyrode 
solution in Mm was NaCl 137Mm, NaHCO3, 12 Mm, NaH2PO4  0.3mM, KCl 2.7 Mm, 
MgCl 1.0Mm, CaCl2 1.0mM and d-glucose 5.6 Mm.  
 
Experiment were performed in a 30 ml organ bath containing Tyrode solution 
maintained at 37 
0
C under a tension of 0.5 gm which was continuously aerated (air 
mixture – O2 + C02) at 37±0.5°. Isometric Contractions were recorded in a smoked 
kymograph paper with frontal writing lever. After an equilibration period of 30 min 
during which the Tyrode solution was changed intervals of 10 mins, contractile responses 
were recorded for histamine (10 micro gram/ml). The contact time of 30 sec recorded at 5 
min time cycle is kept for proper recoding of the responses. The Sanjeevi Theeneer tissue 
contact time was 5 min (Kulkarni, 2003) before the addition of histamine. Dose response 
curve of histamine in plain Tyrode solution and in Tyrode solution containing 15 ml, 30 
ml of Sanjeevi Theeneer were performed. Percentage maximum contractile response was 
plotted to generate dose response curve of histamine, in the absence and presence of the 
drug Sanjeevi Theeneer. 
 
 
Page | 112 
 
 
8. RESULTS 
 
Table: 12 –Organo leptic Reports of Sanjeevi Theeneer 
S. No Parameters Results &Remarks 
a. Description  
1. Color Light lemon yellow. 
2. Odor Pleasant and highly aromatic. 
3. Taste Pleasant and mild pungent. 
b. Clarity test Confirmed / Complies 
c. Volatile Oil 1.320%, 1.332%, 1.324% 
d. Specific gravity at 
25ºC 
0.1622, 0.1624, 0.1626 
e. pH values 7.6 
 
 
Interpretation: The light lemon yellow color with pleasant odor and taste truly complies 
the Traditional Quality parametres of a distillate and it is directly related with the 
bioactivity of the drug. The presence of Volatile content (1.32%) supports the claim of its 
efficacy. The pH of the drug  Sanjeevi Theeneer is 7.6 which proves the alkaline nature of 
the drug, and it is essential for its bioavailability and effectiveness. 
 
 
 
Table: 13 Heavy Metal Analysis (HMA) - Reports of Sanjeevi Theeneer  
 
S. 
No 
Heavy metal 
Reference Limits 
as per API- Vol.-I 
Results 
1. Lead Not more than 10ppm Not detected 
2. Arsenic Not more than 3.0ppm  3.1408ppb 
3. Cadmium Not more than 0.3ppm 0.0073ppm 
4. Mercury Not more than 1.0ppm 14.2894ppb 
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Table: 14 Microbial Load Analyses - Reports of Sanjeevi Theeneer. 
 
S.No Parameters 
Reference Limits 
as per WHO 
(2007) 
Results Remarks 
1. Total Bacterial Count (TBC) 10
5
CFU/gm Less than 10 cfu/ml 
Within 
permissible 
limits 
2. Total Fungal Count (TFC) 10
3
CFU/gm Absent 
3. Enterobacteriaceae 10
3
 Absent 
4. Escherichia coli 10 Absent 
5. Salmonella Spp  Absent Absent 
6. Staphylococcus aureus Absent Absent 
 
Interpretation:  The heavy metal and microbial load presence were within the 
permissible limits. Both the results indicate the nontoxicity and purity of the distillate- 
Sanjeevi theeneer.  
 
Table: 15: Bio chemical Analysis of Sanjeevi Theeneer 
 
S.NO               Parameters         Results 
1.                  Silicate Absent 
2.                Sulphate Absent 
3.               Chloride Absent 
4.               Phosphate Absent 
5.              Carbonate Absent 
6.                 Nitrate Absent 
7.                 Sulphide Absent 
8.                 Oxalate Absent 
9.                  Nitrite Absent 
10.                  Borate Absent 
11.                  Lead  Absent 
12.                 Copper  Absent 
13.              Aluminium  Absent 
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14.                   Iron Absent 
15.                   Zinc Absent 
16.               Calcium Absent 
17.              Magnesium Absent 
18.              Ammonium Absent 
19.                Potassium  Absent 
20.                  Sodium  Absent 
21.                Mercury Absent 
22.                 Arsenic Absent 
23.                   Starch Absent 
24.           Reducing sugar  Absent 
25.               Alkaloids  Present 
26.             Tannic acid Absent 
      
 
Interpretation:  The Bio chemical analysis reported the presence of Alkaloids which are 
active principles possessing Alkaloids possess antispasmodic, analgesic, bactericidal 
effects. A synergistic effect of all these flavonoids, alkaloids, glycosides, tannins, 
phenols, saponins, increases the potency of the drug against Hepatic damages. 
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Table: 16   Results of Phytochemical Analysis of Sanjeevi Theeneer. 
 
S.NO Variable Test Observation Result 
1 
Alkaloids 
ST+ Mayers Reagent (2 ml) -  No dull white 
precipitate 
Absence of 
alkaloids 
2 
Flavonoids 
ST (0.1 ml) + Dil Ammonia (5 
ml)+ Conc H2SO4 
- NO yellowish 
Discolouration 
Absence of 
Flavonoids. 
3 
Glycosides 
H2SO4 hydrolyzed  ST(2 ml) 
+Chloroform (3 ml)+10% 
Ammonia 
-No Pink color 
Absence of 
Glycosides. 
4 
Steroids 
ST+ Chloroform+ Conc H2SO4 
(few drops) 
-No Reddish or 
yellowish Color 
formation 
Absence of 
Steroids. 
5 
Sugar 
ST(2 ml)+ Benedicts Reagent 
(0.5 ml), Heated for 2 mins in 
boiling water bath. 
-No coloured 
precipitate. 
Absence of 
Sugars 
6 
Triterepnoids 
ST+ Chloroform (2 ml)+ Conc 
H2SO4(few drops) 
-No reddish 
Brown 
discoloration 
Absence of 
Terpenoids 
7 
Coumarins 
ST(1 ml)+ 10% NaOH (1 ml) -No Yellow 
color formation 
Absence of 
Coumarins. 
8 
Phenols 
ST dissolved in distilled 
water+10% lead acetate(3 ml) 
+A bulky white 
Precipitate 
Present 
Presence of 
Phenols 
9 
Tannins 
ST(0.5 ml) is boiled in distilled 
water(20 ml) ,filtered (with filter 
paper) then fecl3 (0.1%) is 
added  
-No Brownish 
green or Blue 
Black coloration 
Absence of 
Tannins 
10 
Saponins 
ST mixed with water and shaken 
vigorously for 10 mins 
-No Lather 
formation 
Absence of 
Saponins 
11 
Proteins 
ST+ NaOH (5%)+ CuSO4 -No Pink or 
Purple color 
Absence of 
Proteins 
12 
Anthocyanin 
ST(0.2 ml)+ NaOH (1 
ml),Heated for 5 mins (100 ± 
2°C) 
-No formation 
of Bluish green 
color 
Absence of 
Anthocyanin 
 
ST = Sanjeevi Theeneer. (+) = Positive, (-) = Absence 
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Interpretation: The preliminary phyto chemical analysis shown the presence of Phenolic 
compounds in the drug. Phenolic compounds are considered as the most active and 
predominant group of metabolites derived from the herbal resources (Singh 2007). 
Natural compounds having Anti-oxidant properties are mainly derived from the plants as 
phenolic compounds, phenolic acids, tocopherols and flavonoids ((Ali et al., 2008). 
Phenols exhibit wide range of pharmacological and biological functions especially 
considering the cardiovascular health. Their role in prevention of atherosclerosis (Anti-
atherosclerotic) and inflammation (Anti-inflammatory) and also in improving endothelial 
function has been well established 
23, 24
 various studies prove it as an Anti-carcinogenic, 
Ant apoptosis and Anti-ageing compound. 
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REPORTS – GC-MS OF Sanjeevi Theeneer (ST(t), ST(g), ST (c ) 
 
Fig: 7 GC-MS chromatogram of ST (t) 
 
 
 
 
Table: 17 - GC-MS chromatogram of ST (t) 
 
 
 
 
 
  
Peak No Retention Time 
(RT) 
% Peak Area Peak Intensity 
Rank 
1 4.026 5.71 2 
2 5.044 4.60 4 
3 5.494 3.17 7 
4 5.607 4.40 5 
5 6.332 72.97 1 
6 7.451 3.74 6 
7 10.672 5.40 3 
 Total 100  
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Fig: 8 GC-MS chromatogram of ST (g) 
 
 
 
 
Table: 18 - GC-MS Chromatogram of ST (g) 
 
 
Peak No 
Retention Time 
(RT) 
% Peak Area 
Peak Intensity 
Rank 
1 4.029 10.87 2 
2 4.605 3.45 8 
3 5.046 9.06 4 
4 5.245 4.18 7 
5 5.274 4.96 6 
6 5.534 8.44 5 
7 6.335 48.30 1 
8 7.452 10.73 3 
 Total 100  
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   Table: 19 - GC-MS screened compounds of ST (t) and ST (g) 
 
ST (t) compound details ST (g) compound details 
1,2-Diethylbenzene 
Mw: 134 
 
6,7-Dimethyl-3,5,8,8atetrahydro-1H-2 
benzopyran 
Mw: 224 
 
Bicyclo [3.3.0] octan-3-one, 7 ethylidene- 
Mw: 150 
 
Z,Z-8,10-Hexadecadien-1-ol 
Mw: 238 
 
 
Beta.-Terpineol 
Mw: 154 
 
Octen-1-yn-3-ol 
Mw: 152 
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Terpineol 
Mw: 154 
 
1,4-Methanophthalazine 
Mw: 178 
 
 
p-toluene sulfonate 
Mw: 282 
 
 
Benzoxazol 
Mw: 260 
 
 
 
Z,Z-3,13-Octadecadien-1-ol 
Mw: 266 
 
5,8-Decadien-2-one 
Mw: 180 
 
Page | 121 
 
Isothymol 
Mw: 150 
 
Isothymol 
Mw: 150 
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Table: 20 - Difference between   ST (t) and ST (g) Distillates 
 
A Traditional 
Parameters 
Traditional Distillate 
(ST(t) 
Glass Still Distillate    (ST(g) 
a Nature & 
Appearance 
Moderate clarity ,good Purity Good Clarity and purity 
 1. Color Light lemon yellow Colorless 
2. Aroma Pleasant Aroma  Mildly aromatic 
3. Taste Pleasant taste, slightly pungent No pleasant Taste, Slightly 
pungent 
b Yield Less than Average  Good (>75%) 
c Effect on Long 
storage 
  
 Nature & 
Appearance 
Clarity +, Sediments + No change in clarity ,no 
sediments 
1. Color Color Fading+ No change in color 
2. Aroma Mildly aromatic  Aroma absent 
3. Taste Slight pleasant taste, very less 
pungent 
No pleasant taste, very less 
pungent 
B GCMS Analysis   
 
 
1 Isothymol (72.97%) Isothymol (48.30%) 
 
2 
1,2-Diethylbenzene 6,7-Dimethyl-3,5,8,8a-
tetrahydro-1H-2-benzopyran 
 
3 
Bicyclo[3.3.0]octan-3-one, 7-
ethylidene- 
Z,Z-8,10-Hexadecadien-1-ol 
4 Beta.-Terpineol 1, 4 Methano phthalazine 
5 Terpineol Octen-1-yn-3-ol 
6 p-toluene sulfonate 5,8-Decadien-2-one 
7 cis-Linoleic acid Benzoxazol 
8 ------------------------ Z,Z-3,13-Octadecadien-1-ol 
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Interpretation: There will be difference in the nature and percentage value of the 
original chemical compounds during the various stages of distillation. The most possible 
known mechanisms will be the loss or alteration during various purification procedures 
that is specific to the raw drug or general (including washing, excess drying or sun 
drying), bio degradation due to pH variation while fermentation, inter drug molecular 
interactions- synergist or antagonist (in compound formulations), heat interaction (due to 
the nature, thickness and quality of the apparatus), heat degradation (during boiling, 
evaporation and   re-distillation).  As the process up to the fermentation is similar to both 
the distillates, the factors of heat interaction and heat degradation can be coined to explain 
the differences in quality of the distillates.   
 
Glass stills offer purity of the compounds, yield and is suited for commercial 
purpose. The quality of the distillate as when considering the traditional quality 
parameters like colour, odour, aroma traditional made distillates have priority over glass 
still .Traditional Stills can be tuned to higher temperatures and are way ahead in obtaining 
maximum extraction of organic compounds. For therapeutic purposes, distillates made 
from traditional stills are better one. 
 
There is much difference in the compounds screened in both samples by GC-MS. 
by comparing the Extend of component extraction (peak %) and most of biologically 
active constituents spotted through GC-MS, distillate prepared from traditional still was 
far superior than distillate made in glass still. 
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 Table: 21 - GC-MS CHROMATOGRAM ST (c) 
 
Peak No Retention Time 
% Peak 
Area 
Peak Intensity 
Rank 
1 2.4 8.44 3 
2 5.7 7.46 4 
3 8.9 1.53 5 
4 11.6 0.91 7 
5 11.8 4.8 8 
6 17.6 34.32 1 
7 33.0 1.9 6 
8 36.5 40.85 2 
 TOTAL 100  
 
 
                  Fig: 9 GC-MS CHROMATOGRAM OF NIS 
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Table: 22 - GC-MS screened compounds of ST (C) 
 
ST (t) compound details ST (g) compound details 
Oleic Acid 
Mw: 282 
 
Thymol 
Mw: 150 
 
Dasycarpidan-1-methanol, acetate 
Mw: 130 
 
 
1,6-Octadien-3-ol, 3,7-dimethyl-
(Linalool) 
Mw: 154 
 
 
Beta.-Terpineol 
Mw: 154 
 
Octen-1-yn-3-ol 
Mw: 152 
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Table: 22 Compounds reported from GCMS Analysis -Sanjeevi Theeneer and its 
pharmacology 
S.N
O 
Compounds Chemical 
formula  
Pharmacological Importance /Uses. 
1. Oleic Acid 
(70) 
 
 
C18H34O2 * Cardio vascular Effects 
1. Prevention of Ischemic heart diseases/ Cardio 
protective 
 
2. Inhibition of  platelet function and aggregation 
 
3. Hypocholestremic.
 
4. High density lipoprotein (HDL) enhancer. 
(
Ruiz-Gutiérrez et al. 1996). 
5. Vaso dilator effects 
 
6. Cardiac Tonic (Lahey et al. 2014). 
7. Protection against cardio vascular insulin 
resistance 
 
8. Anti-atherosclerotic.
 
* Effects on body fat (Lim et al. (2013
) 
1. Increases fat oxidation in muscle cells. 
2. Increases expression of genes responsible for fat 
oxidation. 
* Effects in GIT (de Silva et al. 2014).
 
1. Prevention of Ulcerative colitis
 
* Inhibitor of inflammatory cytokine TNF-
ALPHA
(
Yudkin 2007, Vassilious et al. 2009) 
* Effects in Brain
  
1. Reduce age related changes in brains 
mitochondria (Ochoa et al. 2011). 
* Anti-tumor effects
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Interpretation: The compounds screened from the distillate samples like Thymol, Iso 
thymol, Linalool, Dasycarpidan all are scientifically validated for their Excellent Anti-
oxidant, Hepato protective, Anti-inflammatory and Bronchodilator activities. 
 
2. Thymol 
(71, 72) 
 
C10H14O 1. Anti-inflammatory
  
2. Anti-asthmatic 
 
3.  Anti-microbial
 
 
4. Neuro protective
 
 
5. Anti-fungal
  
6. Anti-bacterial
  
7. Hepato protective  
8. Gastro protective
  
9. Cardio protective  
10. Anti-hyperglycemic 
 
11. Anti-hyperlipidemia  
12. Nephro protective 
 
13. Anti-apoptosis  
14. Anti-oxidant
 
 
3. Dasycarpidan-1-
methanol, acetate 
(ester) 
C20H26N2O2 1. Anti-oxidant
  
2. Anti-microbial  
3. Anti-inflammatory  
4. 1,6-Octadien-3-ol, 
3,7-dimethyl-
(Linalool) 
 
C10H18O 1. Anti-inflammatory
  
2. Anti hyperalgesic
 
3. Anti nocioceptive 
4. Anti bacterial
 
5. Anti-fungal
  
6. Spasmolytic
 
 
7. Anti-oxidant
 
 
8. Hypolipidemic 
 
5. Benzene, 1-methyl-4-
(1-methylethenyl)- 
C10H12 Commercial significance 
6. Benzoic acid, 5-
methyl-2-
trimethylsilyloxy-, 
trimethylsilyl ester. 
C14H24O3Si2 Commercial significance 
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Scientific Reviews 
 
 
 Thymol (73) 
 
 Thymol, are naturally occurring monocyclic phenolic compounds. 
 A study suggested that thymol ameliorated airway inflammation in OVA-
induced mouse asthma, possibly through inhibiting NF-κB activation. These 
finding indicates that thymol may be used as an alternative agent for treating 
allergic asthma. 
 In another study,done by palabiyik thymol and Carvacrol protected against 
Paracetamol induced toxicity in HepG2 cells (Hepato cellular carcinoma cell 
lines) by increasing antioxidant activity and reducing pro-inflammatory 
cytokines, such as tumor necrosis factor α and interleukin 1β (72) 
 One study confirmed that thymol has strong ameliorative effect against 
hydrocortisone-induced oxidative stress injury in hepatic tissues. 
 Carvacrol, thymol and their mixtures were studied for its anti-oxidant property 
to protect cells against the damage induced by the H2O2. 
 A study of Thymol on High Fat Diet (HFD) induced obesity in murine model 
proves it as a good Anti-Oxidant, Hypolipidemic and Anti-obesity compound. 
The Study showed significant reduction in lipid peroxidation and a marked 
elevation of Anti-oxidants ,improved Insulin & Leptin sensitivity in HFD 
induced obese rats 
 Animal studies proves that Thymol has typical effect on Tracheal and ileal 
smooth muscles in which a dose dependent Anti-spasmodic property and 
increased mucosal clearance was noted. 
 
 Iso thymol: 
 
 Iso thymol otherwise termed as Carvacrol with the molecular formula C10H14O 
is an organic compound defined as the structural isomer of Thymol belonging 
to the class of Monoterpenes or can be viewed as a Monoterpenic phenol 
having   vast Therapeutic potential and commercial importance. 
 It naturally occurs in so many aromatic plants mostly as a main component in 
the seed oil of Carum copticum. The peculiar aroma of the ajowan seeds is due 
to the presence of this compound. 
 It is mentioned in British Pharmacopoeia as a strong antiseptic agent. 
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 Carvacrol is a very potent Anti-Microbial agent that exhibits strong activity 
against Salmonella typhimurium. 
 
 Linoleic acid 
 
 (LA) is a polyunsaturated omega-6 fatty acid. 
 Linoleic-acid is proven for its activities like Ant arteriosclerotic, Anticoronary, 
Antifibrinolytic, Antihistaminic, Anti-inflammatory, Hepatoprotective. 
 Terpineol  
 The Monoterpenes are natural products belonging to the chemical group of 
terpenes and the main constituents of essential oils. They are found in many 
bioactive essential oils and medicinal plants. Terpineol is a naturally occurring 
monoterpene alcohol 
 Terpineol is antibacterial and antiviral, an immune system stimulant, a good 
general tonic. 
 Borneol and terpineol are two Monoterpenes extracted from Wu Hu Tang, a 
Chinese formulation which consists of seven crude drugs that has been used 
for the treatment of asthma for hundreds of years. The study of their effect on 
isolated tracheal smooth muscle in guinea pig showed that both compounds 
prevented histamine-induced in vitro bronchoconstriction of guinea pig, thus 
indicating its Broncho dilator property. 
 
 Benzoxazole: 
 
 Benzoxazole is an aromatic organic compound. 
 Benzoxazoles belong to the group of well-known antifungal agents with 
antioxidant, antiallergic, antitumoral and antiparasitic activity. 
 
 6,7-Dimethyl-3,5,8,8a-tetrahydro-1H-2-benzopyran 
Benzopyrans and their derivatives, in particular have shown several biological and 
pharmacological properties, such as spasmolytic, Diuretic, Antisterility, 
Anticancer. 
 
The Pharmacological effect of Sanjeevi theeneer as a Hepato protective, Broncho dilator, 
Anti-Histamine and Anti-Oxidant drug is may be due to the presence of these Organic 
compounds which further be confirmed through Animal studies. 
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Acute oral toxicity study ofSanjeevi Theeneer 
Table: 8 Dose finding experiment and its behavioral Signs of acute oral Toxicity 
S.No Observation Group 
( CONTROL ) 
Group 
( TEST GROUP ) 
1 Body weight Normal Normally increased 
 2 Assessments of posture Normal Normal 
3 Signs of Convulsions Absence of sign (-) Absence of sign (-) 
4 Body tone Normal Normal 
5 Lacrimation Normal Absence 
6 Salivation Normal Normal 
7 Change in skin color No significant color 
change 
No significant color 
change 
8 Piloerection Normal Normal 
9 Defecation Normal 
 
Normal 
 10 Sensitivity response Normal Normal 
11 Locomotion Normal Normal 
12 Muscle gripness Normal Normal 
13 Rearing Mild Mild 
14 Urination Normal Normal 
 
Table: 9 Observational study Results 
 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 Control + - - + - + - - - - - - - - - - - 
2 
Test 
group 
(5ml 
/kg) 
 
+ - - + - + - - - - - - - - - - - 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle 
Spasm 11. Muscle relaxant 12. Hypnosis 13.Lacrimation 14. Diarrhoea 15. 
Writhing 16. Respiration 17. Mortality. 
(+ Present, -  Absent) 
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Interpretation of Acute toxicity Studies 
 
 The acute oral toxicity potentials of ST in Wistar albino rats were studied 
effectively.  
 From the maximum tolerable dose, 5ml/kg of ST .The, treated animals were 
observed for mortality, untoward clinical/toxic signs, and alterations in body 
weight gain and necropsy findings during the study.  
 The treated animals survived throughout the study period and did not reveal any 
treatment related major abnormal clinical signs at the test dose levels. 
 Morphological characters like changes in skin, eyes, fur, nose appeared normal. 
 The rats did not reveal any observable signs of central nervous system.  
 The overall percentage of body weight gain in rats treated with the drug every 
weekly was found to be normal indicating that the test animals were in a healthy 
condition during the days of observation period. The changes in water and food 
intake recorded did not show any distinct deviations. 
 On necropsy, no abnormalities were observed. In conclusion, acute oral toxicity 
testing of screened drug did not produce any treatment-related adverse effects. 
This indicates that the dosages administered were below toxic level and proves the 
safety of the drug. 
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Repeated Dose 28- day oral toxic study ofSanjeevi Theeneer 
Table: 10 Body weight of wistar albino rats group exposed to Sanjeevi Theeneer       
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test)    
 
The above results showed that the body weight did not differ and remained within the 
normal limits. The overall percent body weight gain in rats treated with the drug was 
found to be normal showing a steady increase in weight indicating that the test animals 
were in a healthy condition during the 28 days of observation period. 
 
Chart 1: Sub acute Toxicity – Mean value of Body weight of Wistar albino rats 
group exposed to Sanjeevi Theeneer 
 
 
 
0
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100
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200
250
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DAYS
W
EI
G
H
T 
Body weight of wistar albino rats group exposed to Sanjeevi 
Theeneer        
CONTROL
MID DOSE
HIGH DOSE
DOSE 
 
DAYS 
0 7 14 21 28 
CONTROL 220.6±33.673  221.4 ± 40.114 221.7 ± 39.661 
222.6 ± 
39.73 
222.7 ± 41.311 
MID DOSE 176.6± 10.64 176.3 ± 22.74 176.4 ± 38.12 
178.1 ± 
33.36 
179.7 ± 23.12 
HIGH DOSE 187.4± 36.74 187.6 ± 32.72 187.6 ± 32.46 187 ± 22.78 186.92 ± 26.49 
P value (p)* NS NS NS NS NS 
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Table: 11 Water intake (ml/day) of Wistar albino rats group exposed to Sanjeevi 
Theeneer 
 
DOSE 
 
DAYS 
0 7 14 21 28 
CONTROL 61.5 ± 8.95 61±6.23 58.5±6.23 59±8.196 61.5±3.96 
MID DOSE 55.7±4.33 56.3±2.11 57.1±2.43 58.4±2.11 58.4±2.34 
HIGH DOSE 60.1±1.32 60.2±2.13 60.7±2.13 65.2±1.73 63.4±2.65 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D (One way ANOVA 
followed by Dunnett‟s test) 
 
Chart 2: Sub acute Toxicity - Water intake (ml /day) of Control and treated groups 
exposed to Sanjeevi Theeneer. 
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Table: 12 Food intake (gm/day) of Wistar albino rats group exposed to Sanjeevi 
Theeneer       
 
DOSE 
 
DAYS 
0 7 14 21 28 
CONTROL 37±5.37 38.5±3.22 39.5±3.37 38.5±3.37 37±3.12 
MID DOSE 47.2±3.75 47.2±3.60 47.2±4.25 47.4±2.68 49.2±2.44 
HIGH 
DOSE 
46.2±2.34 46.2±2.64 49.6±2.66 48.2±3.20 48.0±3.62 
P value (p)* NS NS NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett‟s test 
 
Chart 3: Sub acute Toxicity - Food intake (gms /day) of Control and treated groups 
exposed to Sanjeevi Theeneer 
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Table: 13 Hematological parameters of Wistar albino rats group exposed to Sanjeevi 
Theeneer 
 
Category Control Mid dose High dose P value 
(p)* 
Hemoglobin (g/dl) 13.8±0.88 14.14±0.66 13.28±0.96 N.S 
Total WBC (×10
3   
l) 11.91±0.59 11.48±0.91 11.20±1.17 N.S 
Neutrophils (%) 33.65±0.06 35.41±1.36 35.20±2.20 N.S 
Lymphocyte (%) 70.24±1.48 70.20±2.66 70.10±2.16 N.S 
Monocyte (%) 0.86±0.07 0.82±0.03 0.81±0.06 N.S 
Eosinophil (%) 0.54±0.09 0.56±0.06 0.57±0.04 N.S 
Basophil    (%) 0.14±0.04 0.20±0.07 0.19±0.06  
Platelets cells 687.17±8.76 683.18±9.0 687.16±9.74 N.S 
Total RBC 10
6
/µl 7.99±0.12 7.82±0.59 8.05±0.72 N.S 
PCV% 37.79±0.6 43±1.68 45.82±2.54 N.S 
MCHC g/dL 33.6±2.23 36.98±1.22 34.03±1.24 N.S 
MCV fL(µm
3
) 49.07±3.64 51.20±1.24 52.24±1.44 N.S 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
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Chart 4:Sub acute Toxicity – The mean value of HB and T.RBC of Control and 
treated groups. 
 
 
Chart 5:Sub acute Toxicity – The mean value of T.WBC of Control and treated 
groups. 
 
 
0
2
4
6
8
10
12
14
16
Control Mid dose High dose
Haemoglobin (g/dl)
Total RBC 106/ µl
10.85
10.9
10.95
11
11.05
11.1
11.15
11.2
11.25
11.3
11.35
Control Mid dose High dose
Total WBC (×103   l) 
Total WBC (×103   l)
Page | 137 
 
Chart 6:Sub acute Toxicity – The mean value of Neutrophils and Lymphocytes of 
Control and treated groups. 
 
 
 
 
Chart 7:Sub acute Toxicity – The mean value of Monocytes, Eosinophil and 
Basophils of Control and treated groups. 
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Chart 8:Sub acute Toxicity – The mean value of Platelet cells of Control and treated 
groups. 
 
 
 
 
 
Chart 9:Sub acute Toxicity – The mean value of PCV, MCHC, MCV of Control and 
treated groups. 
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Table: 14 Biochemical Parameters of of Wistar albino rats group exposed to 
Sanjeevi Theeneer       
 
BIOCHEMICAL 
PARAMETERS 
CONTROL MID 
DOSE 
HIGH 
DOSE 
P 
Value 
(p)* 
GLUCOSE (R) (mg/dl) 74.45±13.4 75 ±11.20 76.42±11.6 N.S 
T. 
CHOLESTEROL(mg/dl) 
115.26±1.83 116.42±1.7
8 
116.22±1.73 N.S 
TRIGLY(mg/dl) 46.35±1.48 44.58±1.30 45.66±1.33* N.S 
LDL 73.8±2.43 73±2.44 73.64±24.32 NS 
VLDL 15.2±2.44 15.44±6.64 15.64±34.36 NS 
HDL 26.66±6.88 26.68±4.66 26.78±21.22 NS 
Ratio 1(T.CHO/HDL) 4.42±2.44 4.44±8.44 4.46±22.22 NS 
Ratio 2(LDL/HDL) 2.83±24.22 2.86±2.20 2.66±46.02 NS 
Albumin (g/dL) 3.3±0.17 3.34±22.02 3.54±6.86 NS 
  
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett‟s test) 
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Chart 10:Sub acute Toxicity – The mean value of Blood sugar of Control and 
treated groups. 
 
 
 
 
 
Chart 11:Sub acute Toxicity – The mean value of of Sr.TC, Sr.TG and treated 
groups. 
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Chart 12:Sub acute Toxicity – The mean value of LDL, VLDL, HDL and treated 
groups. 
 
 
 
 
 
Chart 13:Sub acute Toxicity – The mean value of Serum Albumin of Control and 
treated groups 
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Table: 15 Sub acute Toxicity –  Renal function test of of Wistar albino 
 rats group exposed to Sanjeevi Theeneer 
 
PARAMETERS CONTROL MID DOSE HIGH DOSE P Value 
(p)* 
UREA (mg/dl) 13.35±0.99 14.06±1.38 14.48±1.42 N.S 
CREATININE(mg/d
l) 
0.58±0.08 0.57±0.04 0.55±0.02 N.S 
BUN(mg/dL) 15.12±0.10 16±0.44 16.10±2.12 NS 
URIC ACID(mg/dl) 5.37±0.35 5.36±1.25* 5.35±0.23 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test 
 
 
Chart 14:Sub acute Toxicity – The mean value of Urea, BUN of Control and treated 
groups 
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Chart 15:Sub acute Toxicity – The mean value of Creatinine of Control and treated 
groups 
 
 
 
Chart 16:Sub acute Toxicity – The mean value of Creatinine of Control and treated 
groups 
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Table: 16  Liver Function Test of of Wistar albino rats group exposed to Sanjeevi 
Theeneer 
 
PARAMETERS CONTROL MID DOSE HIGH DOSE P Value 
(p)*  
T BILIRUBIN 
(mg/dl). 
0.50±0.07 0.59±0.08 0.56±0.05 N.S 
SGOT/AST(U/L) 114.95±1.39 117.01±1.53 116.55±1.03 N.S 
SGPT/ALT(U/L) 71.23±1.28 75.34±1.48 74.32±0.68 N.S 
ALP(U/L) 146.25±8.77 148.16±24.07* 149.33±14.65* N.S 
T.PROTEIN (g/dL) 6.32±0.38 7.016±0.23 6.53±0.46 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
 
Chart: 17Sub acute Toxicity – The mean value of Total Bilirubin of Control and 
treated groups 
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Chart: 18Sub-acute Toxicity – The mean value of SGOT, SGPT, ALP of Control 
and treated groups 
 
 
 
 
Chart: 19Sub-acute Toxicity – The mean value of T. Protein of Control and treated 
groups 
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II.b.  Results of Urine parameters 
 
Table: 17 Effect of Sanjeevi Theeneer on Urine parameters in rats 
 
Parameters Control 2.5ml/kg 5ml/kg 
Colour Yellow Pale yellow colourless 
Transparency Clear Clear Clear 
Specific gravity 1.01 1.02 1.01 
pH 7.2 7.3 7.4 
Protein Nil Nil Nil 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood Absent Absent Absent 
RBCs Nil Nil Nil 
Epithelial cells Nil Nil Occasional 
Casts Nil Nil Nil 
 
 
II.c. Results of organ weight in rats 
 Table: 18 Effect of Sanjeevi Theeneer on organ weight in rats 
 
Organ Control 2.5ml/kg 5ml/kg 
Liver (g) 5.24±0.14 5.79±0.3 6.1±0.3 
Heart (g) 0.70±0.05 0.85±0.1 0.91±0.06 
Lung (g) 1.78±0.25 1.89±0.07 1.92±0.08 
Spleen (g) 0.74±0.07 0.86±0.04 0.94±0.02 
Brain (g) 1.43±0.18 1.65±0.14 1.74±0.06 
Kidney (g) 0.70±0.05 0.83±0.05 0.87±0.02 
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Chart: 20 Sub-acute Toxicity –Mean value of organ weight in ratsof Control and 
treated groups 
 
 
 
Interpretation of 28-day repeated dose oral toxicity study in rats 
 
 The repeated oral toxicity potentials of Sanjeevi Theeneer in Wistar albino rats 
were studied effectively.  
 In the sighting study, the test substance was administered in sequential manner at 
doses of 2.5ml, 5ml/kg to groups  3, 4 and water to control group respectively. 
The treated animals were observed for mortality, untoward clinical/toxic signs, 
and alterations in body weight gain and necropsy findings during the study.  
 The treated animals survived throughout the study period of 28 days and did not 
reveal any treatment related major abnormal clinical signs at the test dose levels. 
 Morphological characters of organs (skin, eyes, fur, and nose) appeared normal at 
the end of the study. 
 Food and water intake of the rats did not differ significantly and remained within 
the normal limits. 
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RESULTS- REPEATED DOSE 90-DAY ORAL TOXICITY STUDY 
OF SANJEEVI  THEENEER 
 
Table: 19 Body weight of wistar albino rats group exposed to  Sanjeevi Theeneer 
 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test 
 
Chart: 21 Sub Chronic Toxicity - Mean value ofBody weight of Wistar albino rats 
group  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table: 20Sub Chronic Toxicity - Water intake (ml/day) of Wistar albino rats group 
exposed to Sanjeevi Theeneer 
DOSE 
 
DAYS 
1 15 30 45 60 75 90 
CONTROL 240.6±33.673  
241.4 ± 
41.134 
241.7 ± 
42.661 
244.6 ± 
36.24 
248.4 ± 
22.211 
250±44.54 256±62.22 
MID DOSE 276.4± 12.34 276.3 ± 21.54 
276.4 ± 
32.32 
278.1 ± 
32.34 
279.7 ± 
22.32 
282±48.24 286±92.26 
HIGH 
DOSE 
287± 36.74 288 ± 32.72 288± 32.46 290 ± 22.78 
291.92 ± 
26.49 
292±36.54 293±66.34 
P value 
(p)* 
NS NS NS NS NS NS NS 
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NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test. 
 
Chart: 22 Sub Chronic Toxicity - Water intake (ml /day) of Control and treated 
groups exposed to Sanjeevi Theeneer. 
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DAYS 
1 15 30 45 60 75 90 
CONTROL 80.5 ± 
8.95 
81±9.23 88.5±7.42 88±9.96 89.5±2.76 89.65±2.66 90±74.82 
MID DOSE 85.7±4.33 86.3±2.11 87.12±3.23 88.4±2.11 89.2±1.24 89±2.21 89±1.12 
HIGH 
DOSE 
86.1±1.32 86.2±2.13 87.7±2.25 88.2±1.54 87.4±4.85 88±3.64 89±2.22 
P value (p)* NS NS NS NS NS NS NS 
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Table: 21 Food intake (gm/day) of Wistar albino rats group exposed to Sanjeevi 
Theeneer       
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test 
 
 
Chart: 23 Sub Chronic Toxicity - Food intake (gms /day) of Control and treated 
groups exposed to Sanjeevi Theeneer 
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1 15 30 45 60 75 90 
CONTROL 180.5 ± 
6.35 
181±7.14 188.5±6.22 182±4.954 189.5±4.16 189.65±1.26 190±44.12 
MID DOSE 182.7±4.33 182.3±3.21 187.12±3.23 188.4±6.12 189.2±2.22 189±2.44 194±4.22 
HIGH 
DOSE 
186.1±1.22 186.2±2.12 187.7±2.22 188.2±1.24 189.4±4.85 190±8.84 196±6.82 
P value (p)* NS NS NS NS NS NS NS 
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Table: 22 Haematological parameters of Wistar albino rats group exposed to  
Sanjeevi     Theeneer 
 
Category Control Mid dose High dose P value 
(p)* 
Haemoglobin(g/dl) 16.4±0.48 16.15±0.26 16.28±0.56 N.S 
Total WBC (×10
3   
l) 
12.91±0.25 12.24±0.31 12.60±2.14 N.S 
Neutrophils(%) 32.45±0.03 34.31±1.26 34.50±4.10 N.S 
lymphocyte (%) 80.14±2.18 82.30±1.46 85.18±6.16 N.S 
Monocyte (%) 0.96±0.02 0.92±0.06 0.91±0.04 N.S 
Eosinohil(%) 0.74±0.04 0.76±0.04 0.87±0.02 N.S 
Basophil (%) 0.2±0.07 0.19±0.06 0.22±0.07 N.s 
Platelets cells10
3
/µl 824.16±4.46 863.12±4.0 867.06±7.64 N.S 
Total RBC 10
6
/µl 8.69±0.11 8.62±0.47 8.04±0.42 N.S 
PCV% 36.79±0.6 53±1.34 55.61±1.14 N.S 
MCHC g/dL 34.4±1.22 39.67±2.12 40.30±2.14 N.S 
MCV fL(µm
3
) 51.04±7.24 52.50±2.14 54.64±2.24 N.S 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
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Chart: 24 Sub Chronic Toxicity - Mean value of HB, T.RBC of Control and treated 
groups exposed to Sanjeevi Theeneer. 
 
 
 
 
 
Chart: 25 Sub Chronic Toxicity - Mean value of  T.WBC of Control and treated 
groups exposed to Sanjeevi Theeneer. 
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Chart: 26 Sub Chronic Toxicity - Mean value of  Neutrophil, Lymphocyte of Control 
and treated groups exposed to Sanjeevi Theeneer. 
 
 
 
Chart: 27 Sub Chronic Toxicity - Mean value of  Monocyte, Eosinophil, Basophil of 
Control and treated groups exposed to Sanjeevi Theeneer. 
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Chart: 28  Sub Chronic Toxicity - Mean value of  PCV, MCHC, MCV of Control 
and treated groups exposed to Sanjeevi Theeneer. 
 
 
 
 
Chart: 29  Sub Chronic Toxicity - Mean value of  Platelets of Control and treated 
groups exposed to Sanjeevi Theeneer. 
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Table: 23 Biochemical Parameters of of Wistar albino rats group exposed to 
Sanjeevi Theeneer       
BIOCHEMICAL 
PARAMETERS 
CONTROL MID 
DOSE 
HIGH 
DOSE 
P 
Value 
(p)* 
GLUCOSE (R) (mg/dl) 73.45±13.4 74.26±11.2
0 
76.42±11.6 N.S 
T. 
CHOLESTEROL(mg/dl) 
110.26±1.83 105.42±1.7
8 
100.22±1.73 N.S 
TRIGLY(mg/dl) 46.35±1.48 43.58±1.30 44.66±1.33* N.S 
LDL 73.8±2.43 72±2.44 73.64±24.32 NS 
VLDL 14.2±2.44 15.40±6.64 15±34.36 NS 
HDL 25.66±6.88 24.68±4.66 24.78±21.22 NS 
Albumin (g/dL) 3.1±0.17 3.30±22.02 3.52±6.86 NS 
  
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett‟s test 
 
Chart: 30  Sub Chronic Toxicity - Mean value of Blood Glucose of Control and 
treated groups exposed to Sanjeevi Theeneer. 
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Chart: 31  Sub Chronic Toxicity - Mean value of T. Cholestrol, Triglycerides of 
Control and treated groups exposed to Sanjeevi Theeneer. 
 
 
 
Chart: 32  Sub Chronic Toxicity - Mean value of LDL, VLDL, HDL of Control and 
treated groups exposed to Sanjeevi Theeneer. 
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Chart: 33  Sub Chronic Toxicity - Mean value of  Serum Albumin of Control and 
treated groups exposed to Sanjeevi Theeneer 
 
 
Table: 25 Liver Function Test of  Wistar albino rats group exposed to Sanjeevi 
Theeneer 
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BILIRUBIN 
(mg/dl). 
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(U/L) 
ALP 
(U/L) 
T.PROTEIN 
(g/dL) 
Control 0.55±0.07 31.24±2.37 115±1.39 150.04±04.28 6.5±0.38 
Mid dose 0.55±0.08 24.22±1.19 117±1.53 140.20±01.48 6.73 ± 0.23 
High dose 0.54±0.05 28.08±2.14 116.55±1.03 130.14±10.64 6.60 ±0.46 
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Chart: 34  Sub Chronic Toxicity - Mean value of T. Bilirubin of Control and treated 
groups exposed to Sanjeevi Theeneer. 
 
 
 
Chart: 35  Sub Chronic Toxicity - Mean value of SGPT, SGOT, ALP of Control and 
treated groups exposed to Sanjeevi Theeneer. 
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Table: 26 Renal function test of of Wistar albino rats group exposed to Sanjeevi 
Theeneer 
PARAMETERS CONTROL MID DOSE HIGH DOSE P Value (p)* 
UREA (mg/dl) 13.35±0.99 14.06±1.38 14.48±1.42 N.S 
CREATININE(mg/d
l) 
0.58±0.08 0.62±0.04 0.66±0.02 N.S 
BUN(mg/dL) 15.12±0.10 16±0.44 16.10±2.12 NS 
URIC ACID(mg/dl) 5.37±0.35 5.7±1.25* 5.48±0.23 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
 
 
Chart: 36  Sub Chronic Toxicity - Mean value of Urea, BUN of Control and treated 
groups exposed to Sanjeevi Theeneer. 
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Chart: 37  Sub Chronic Toxicity - Mean value of Uric acid of Control and treated 
groups exposed to Sanjeevi Theeneer. 
 
 
 
 
Chart: 38  Sub Chronic Toxicity - Mean value of Creatinine of Control and treated 
groups exposed to Sanjeevi Theeneer. 
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Interpretation of 90-day repeated dose oral toxicity study in rats 
 
 The repeated oral toxicity potentials of Sanjeevi Theeneer in Wistar albino rats 
were studied effectively.  
 In the sighting study, the test substance was administered in sequential manner at 
doses of  2.5ml, 5ml/kg to groups 2, 3, 4 and water to control group respectively. 
The treated animals were observed for mortality, untoward clinical/toxic signs, 
alterations in body weight gain and necropsy findings during the study.  
 The treated animals survived throughout the study period of 90 days and did not 
reveal any treatment related major abnormal clinical signs at the test dose levels. 
 Morphological characters of organs (skin, eyes, fur, and nose) appeared normal at 
the end of the study. 
 Food and water intake of the rats did not differ significantly and remained within 
the normal limits. 
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Results - DPPH radical scavenging assay of Sanjeevi Theeneer 
 
Table: 27 Percentage inhibition of test drug Sanjeevi Theeeneer (ST) on 
DPPH radical scavenging assay 
Concentration (μl) % Inhibition of  
Ascorbic Acid 
% Inhibition of 
ST 
10 μg/ml 
23.7 ± 8.34 
6.881 ±  1.79 
20 μg/ml 
35.93 ±  4.57 
15.77 ± 2.42 
40 μg/ml 
45.56 ± 9.71 
24.29 ± 2.49 
60 μg/ml 
57.41 ± 3.32 
33.55 ± 6.20 
80 μg/ml 
68.89 ± 7.74 
45.4 ± 5.04 
100 μg/ml 
85.19 ± 2.37 
55.4 ± 3.58 
Data are given as Mean ± SD (n=3) 
 
 
Chart: 39 - Percentage inhibition of test drug Sanjeevi Theeeneer (ST) on  
DPPH radical scavenging assay 
 
0
10
20
30
40
50
60
70
80
90
10 
μg/ml 
20 
μg/ml 
40 
μg/ml 
60 
μg/ml 
80 
μg/ml 
100 
μg/ml 
% Inhibition of  Ascorbic
Acid
% Inhibition of ST
Page | 163 
 
Table: 28 IC50 Values for DPPH radical scavenging Assay by Sanjeevi Theeneer 
(ST) and Standard. 
Test Drug / Standard IC50 Value  DPPH  Assay ±  SD (μg /ml) 
ASCORBIC ACID 46.91  ±  9.93 
ST 90.19  ±  8.57 
Data are given as Mean ± SD (n=3) 
Interpretation: Sanjeevi Theeneer was studied for its Anti-oxidant potential on DPPH 
radical scavenging assay by comparing with standard Ascorbic acid. Sanjeevi Theeneer 
was able to reduce the stable DPPH radical to 50 % reduction with IC50  of  90.19 ±  
8.57)as compared with Ascorbic acid (46.91± 9.93). 
 
 
Chart: 40 - IC50 Values for DPPH radical scavenging Assay by Sanjeevi Theeneer 
(ST) and Standard. 
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Chart: 41 Percentage inhibition of ST on DPPH radical scavenging assay 
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Chart: 42 Percentage inhibition of Standardon DPPH radical scavenging assay 
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RESULTS - Histo Pathology of liver section of zebra fish Danio rerio 
 
     Control – Group I   Negative Control – Group II 
 
       ST- Low Dose – Group III   ST-High Dose – Group IV 
 
 
 
 
 
 
 
 
 
Interpretation of Histopathology study: 
 Histopathology liver samples belongs to control groups reveals the presence of 
perfect polygonal shape of hepatic parenchyma cells with prominent nucleus 
further sinusoids appears with regular interval. 
 Photomicrograph of liver section belongs to group II (Disease control) reveals the 
presence of frequent cytoplasmic vacuolation and with abnormally dilated 
sinusoids. 
 Sample belongs to group III retains the basic structure polygonal shaped hepatic 
parenchyma with occasional indication of karyorrhexis. 
 Appearance of liver parenchyma was almost normal with prominent large nucleus 
with mild inflammatory changes were observed in sample belongs to Group IV. 
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 The results of the present investigation indicates that paracetamol treated groups 
shows sever liver degeneration whereas treatment with test drug ST at both the 
dose level significantly attenuated the paracetamol induced damage in group III 
and IV. Hence from the study it was concluded that the drug ST has possess 
promising hepato protective activity in dose dependent manners and restores the 
basic liver architecture by means of its rejuvenating potential against paracetamol 
induced toxicity in zebra fish model. 
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RESULTS – HEPATO PROTECTIVE STUDIES OF SANJEEVI 
THEENEER 
 
Table: 29 Haematological parameters of Wistar albino rats group exposed to  
Sanjeevi     Theeneer 
 
Parametres 
 
Control 
Toxicant 
Control 
ST 
0.5ml/kg.+ 
Paracetamol 
ST 1ml/kg+ 
Paracetamol 
Sillymarin 25 
mg/kg, + 
Paracetamol 
Haemoglobin(g/
dl) 
16.2 
±0.48 
9.20±0.26 12.15±0.26 15.28±0.56 14.7±0.56 
Total WBC 
(×10
3   
l) 
7.91±0.2
5 
9.22±0.73 8.9 ±0.31 8.30±2.14 7.50 ± 0.30 
Platelets 
cells10
3
/µl 
160.16±4
.4 
90.42±8.1
6 
110.12±4.0 121.06±7.64 130 ± 4 
Total RBC 
10
6
/µl 
8.69±0.1
1 
6.3 ±0.57 7.2±0.47 7.7±0.42 7.3±0.42 
PCV% 43.79±0.
5 
27.24±1.1
2 
33 ±1.34 37.61±1.14 35±1 
MCHC g/dL 34.4±1.2
2 
45.06±0.6
9 
41.67±2.12 40.30±2.14 36.67±1 
MCV fL(µm
3
) 51.04±7.
24 
37.10±2.2
3 
40.50±2.14 46.64±2.24 44.5±2.24 
 
Chart: 43  Hepato Protectivity - Mean value of HB in Control and treated groups. 
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Chart: 44 Hepato Protectivity - Mean value of WBCin Control and treated groups. 
 
 
 
Chart:45 Hepato Protectivity - Mean value of Plateletin Control and treated groups. 
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Chart: 46 Hepato Protectivity - Mean value of  T. RBCin Control and treated 
groups. 
 
 
 
Chart: 47 Hepato Protectivity - Mean value of PCV%in Control and treated groups 
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Chart: 48 Hepato Protectivity - Mean value of MCHCin Control and treated groups 
 
 
 
Chart: 49 Hepato Protectivity - Mean value of MCVin Control and treated groups 
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Table : 29 Effect of ST on direct bilirubin, total bilirubin levels in 
Paracetamolinduced hepatotoxic rats. 
 
Group Treatment Dose (p.o.) Direct 
bilirubin 
(mg/dl) 
Total bilirubin 
(mg/dl) 
A Normal 
control 
Distilled water 0.168 ± 0.60 0.293±0.029 
B Toxicant 
Control 
Paracetamol-1 
ml/kg, 
1.579 ±0.099 1.6±0.005 
C ST - 1 0.5ml/kg, 
p.o.+paracetamol 
1.22 ±0.032** 1.43±0.059** 
D ST - 2 1ml/kg, p.o.+ 
paracetamol 
0.56 ±0.040** 0.50 ±0.1105** 
E Standard 
(Silymarin) 
25 mg/kg, + 
Paracetamol 
0.286 ±0.012** 0.433±0.049** 
Values are mean ± SEM (n=6) one way ANOVA followed by Dunnet‟s test. 
 
 
 
Chart: 50 Hepato Protectivity - Mean value of Direct and Total Bilirubinin Control 
and treated groups 
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Table: 30 Effect of ST on ALT, AST, ALP levels in Paracetamol induced hepatotoxic 
rats. 
 
Group Treatment Dose (p.o) ALT (U/L) AST (U/L) ALP (mg/dl) 
A Normal 
control 
Distilled water 27.145±0.325 33.05±4.5 32.50±0.50 
B Toxicant 
Control 
Paracetamol-1 
ml/kg,  
102 ±2.0 152.05 ±2.50 130.95±0.550 
 ST - 1 0.5ml/kg, 
p.o.+paracetamol 
86.5±2.0** 110.75±8.750** 81.6±0.30** 
C ST - 2 1ml/kg, p.o.+ 
paracetamol 
53.6±1.30** 77.5±3.0** 60.35±0.250** 
D Standard 
(Silymarin) 
25 mg/kg, + 
Paracetamol 
35.5±1.0** 60.5±1.0** 40.05±0.55** 
 
Values are mean ± SEM (n=6) one way ANOVA followed by Dunnet‟s test. Where, ** 
represents significant at P<0.01. 
 
 
 
Chart: 51 Hepato Protectivity - Mean value of ALT, AST, ALPin Control and 
treated groups 
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Table: 31 Effect of ST on Wet liver weight & Wet liver volumes in Paracetamol 
induced hepatotoxic rats. 
 
Group Treatment Dose Wet Liver 
weight 
(gm/100gm) 
Liver volumes 
(ml/100gm) 
A Normal 
control 
Distilled water 2.60± 0.370 2.50 ±0.10 
B Toxicant 
Control 
Paracetamol-1 
ml/kg, p.o. 
5.25 ± 0.150 4.20 ±0.15 
C ST - 1 0.5ml/kg, 
p.o.+paracetamol 
3.55± 0.10** 3.35 ±0.015** 
D ST - 2 1ml/kg, p.o.+ 
paracetamol 
3.10± 0.125** 2.90 ±0.150** 
E Standard 
(Silymarin) 
25mg/kg, p.o.+ 
paracetamol 
3.40± 0.05** 2.75 ±0.05** 
 
Values are mean ± SEM (n=6) one way ANOVA followed by Dunnet‟s test. Where, ** 
represents significant at P<0.01. 
 
 
Chart: 52 Hepato Protectivity - Mean value of  Wet liver weight and Liver volume in 
Control and treated groups 
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HISTOPATHOLOGY REPORTS OF LIVER 
 
 
      NORMAL CONTROL                             TOXIC CONTROL                                                                                      
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Page | 176 
 
Interpretation : The present studies were performed to assess the hepatoprotective 
activity in rats against Paracetamol as hepatotoxin. 
 
Biochemical Parametres 
 
 The administration of the toxicant PCM showed a distinct rise in the levels of 
serum marker enzymes namely ALT, AST, ALP and Total Bilirubin as shown in 
Table. no 29, 30. 
 The activities of serum SGPT, SGOT and ALP and the concentration of total 
bilirubin in the ST treated groups (Tables. 29, 30 ) and the Silymarin group, were 
significantly decreased when compared to PCM treated group and almost near the 
normal value when compared to the negative control.  
 The drug treatment was carried out at two dose levels 0.5ml and 1ml /kg, both of 
which along with the standard treated group showed a significant reduction in the 
elevated enzyme levels. 
 These data suggests a dose dependent Hepato protective activity of ST. The 
present studies were performed to assess the hepatoprotective activity in rats 
against PCM as hepatotoxin to prove its claims in clinical practice against liver 
disorders. 
 
Histopathological Analysis 
 
 Group A: Photomicrograph of liver tissue of control group showing normal 
hepatic cells with central Vein (CV) and sinusoidal dilation (S). 
 Group B: showed fatty changes and slight increase in liver weights compared to 
the control groups. Photomicrograph of liver tissue of Toxicant group showing 
severe centri lobular necrosis (N) with disappearance of nuclei. 
 Group C: Photomicrograph of liver tissue of ST 1 group treated with Sanjeevi 
Theeneer at 0.5ml/kg showing mild degree of necrosis (N) with mild 
inflammatory cells. 
 Group D: Photomicrograph of liver tissue of ST 2 group treated with Sanjeevi 
Theeneer at 1ml/kg showing normal hepatocytes with regenerating hepatocytes 
and mild inflammation in the portal area (M). 
 Group E: Photomicrograph of liver tissue of Silymarin treated group 25mg/kg 
showing normal hepatocytes, portal vein and portal artery. 
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 Estimating the activities of serum marker enzymes, like ALT, AST, ALP can 
make the assessment of liver function when liver cell plasma membrane is 
damaged, a variety of enzyme normally located in the cytosol are released into the 
blood stream. Their estimation in the serum is a useful quantitative marker of the 
extent and type of hepato cellular damage. 
 Reduction in the levels of ALP, ALT and AST towards the normal value is an 
indication of regeneration process.  
 Reduction in ALP levels with concurrent depletion of raised bilirubin levels 
suggests the stability of the biliary function during injury with PCM.  
 These findings suggested the ST administered has significantly neutralized the 
toxic effects of PCM and helped in regeneration of hepatocytes. The tendency of 
these enzymes to return to near normally in ST administered group is a clear 
manifestation of anti-hepatotoxic effects.  
 The measurement of liver body weight ratio is a more accurate approach to 
determine the changes in liver size compared to the measurement of liver weight 
alone as the liver weight largely depends on the size of the rat.  
 The enlargement of livers in PCM-treated rats suggested hepatic lesions and liver 
injury associated with the toxic effects of PCM. These significant changes in the 
liver weights may be attributed to the accumulation of extracellular matrix protein 
and collagen in liver tissue. 
 From the Table 31 it was evident that ST was able to reduce or normalize the wet 
liver weight and wet liver volumes and all the elevated biochemical parameters  
due to the PCM intoxication.  
 The ST thus has a potential application in the condition of jaundice. A possible 
mechanism of the ST on bilirubin levels may be interference with cytochrome 
P450, resulting in the hindrance of the formation of hepatotoxic free radicals, 
thereby protecting the integrity of the membrane. Hence, it may be possible that 
the mechanism of hepatoprotection by ST is due to its antioxidant effect.  
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RESULTS – BRONCHODILATOR ACTIVITY (isolated tracheal chain 
Preparation) 
 
Figure: 5 Dose response Curve with Trial drug Sanjeevi Theeneer in isolated Guinea 
Pig Tracheal Chain Preparation 
 
 
 
Table: 32 Pharmacological analysis- Broncho dilator activity of Sanjeevi Theeneer 
in Guinea pig Tracheal chain preparation 
 
Treatment Conc.in µg/ml 
Height of response 
in mm 
Percentage 
inhibition 
Histamine 10 
20 
40 
80 
160 
320 
08 
09 
10 
12 
14 
19 
 
 
 
- 
 
 
Sanjeevi Theeneer 15 
ml +Histamine 
10 
160 
12 
9 
14 % 
35 % 
Sanjeevi Theeneer 30 
ml +Histamine 
20 
320 
11 
08 
42% 
57% 
% inhibition = [(normal activity - inhibited activity) / (normal activity)] x 100% 
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Results 
             Histamine causes contraction of the guinea pig tracheal chain. At the test Sanjeevi 
Theeneer showed   a dose dependent inhibition of contractions induced by histamine on 
guinea pig  at 5 ml and 10 ml  which is plotted in the graph above in terms of 
concentration in µg/ml versus height in mm . 10 µg and 160 µg/of histamine  produces 
12, 9 mm height of response in the presence of Sanjeevi Theeneer at 5 ml with inhibitory 
efficacy of 14% and 35 %. 20 µg and 320 µg of histamine  produces 11, 8 mm height of 
response in the presence of Sanjeevi Theeneer at 10 ml with inhibitory efficacy of 42% 
and 57 %. This proves its dose dependent inhibition of Histamine induced contractions.  
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Figure : 6 Dose response Curve with Trial drug Sanjeevi Theeneerin 
isolated Guinea Pig Ileum Preparation 
 
 
Table: 33 Pharmacological analysis- Broncho dilator activity of Sanjeevi Theeneer 
in Guinea pig Ileum preparation 
 
Treatment Conc.in µg/ml 
Height of response 
in mm 
Percentage 
inhibition 
Histamine 10 
20 
40 
80 
160 
320 
06 
07 
9 
12 
14 
19 
 
 
- 
 
 
 
Sanjeevi Theeneer 15 
ml+Histamine 
10 
160 
10 
9 
28% 
35 % 
Sanjeevi Theeneer 30 
ml+Histamine 
20 
320 
12 
08 
37% 
57% 
% inhibition = [(normal activity - inhibited activity) / (normal activity)] x 100% 
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Results 
 
             Histamine causes contraction of the guinea pig ileum, the test Sanjeevi Theeneer 
showed   a dose dependent inhibition of contractions induced by histamine on guinea pig  
at doses of 5 ml and 10 ml  which is plotted in the graph above in terms of concentration 
in µg/ml versus height in mm . 10 µg and 160 µg/of histamine  produces 10, 9 mm height 
of response in the presence of Sanjeevi Theeneer at 5 ml with inhibitory efficacy of 28 % 
and 35 %. 20 µg and 320 µg of histamine  produces 12, 8 mm height of response in the 
presence of Sanjeevi Theeneer at 10 ml with inhibitory efficacy of 37 % and 57 %. This 
proves its dose dependent inhibition of Histamine induced contractions. 
 
In isolated guinea pig ileum preparation, there is a right side shift of dose response 
curve of histamine in the presence of Sanjeevi Theeneer. This proves its Anti- Histamine 
activity.  
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9. DISCUSSIONS 
 
 
The Classical distillate Sanjeevi theeneer had been subjected to various studies 
and it confirms the literature evidences. Literary collections, Physicochemical Studies, , 
Bio-chemical analysis, Preliminary Phyto chemical analysis, Toxicity studies, 
Pharmacological studies were done to prove the  Anti-Oxidant,  Hepato protective, 
Bronchodilator and Anti-Histamine activities of.Sanjeevi Theeneer. Literary review about 
the ingredients of this trial drug from various Siddha texts supports the activity.  
 
 Literary collections: 
Literary collections include drug review, which consist both Botanical aspect and 
Gunapadam aspect, pharmaceutical and scientific reviews in support of the study. 
 
 Drug review: 
 The Trial drug is a rich formulation with Anti- oxidant herbs, most are 
described as kalpa mooligai (Herbal Elixirs). 
 Siddha Literatures are supporting the usage of Ingredients of Sanjeevi 
Theeneer in conditions of Liver diseases and Respiratory ailments like 
Bronchial Asthma. 
 All the Ingredients of the trial drug were used in Traditional Siddha 
practices for diseases pertaining to Liver and Respiratory system. 
 Most of the Ingredients of Sanjeevi Theeneer has been scientifically 
validated for its Anti- oxidant, Hepato protective, Bronchodilator and 
Anti-Histamine activities. 
 
 Drug Analysis: 
 Organo leptic characters: Sanjeevi Theeneer is a clear aqueous distillate, 
light lemon yellow coloured with pleasant aroma and mild pungent taste. 
 The analytical part reports the percentage of volatile content and the pH 
specifying alkaline nature of the distillate .The standards are promising as 
per the traditional quality parameters 
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 Heavy metal and Microbial Load Analysis: The heavy metal and 
microbial load presence were within the permissible limits. Both the 
results indicate the nontoxicity and purity of the distillate- Sanjeevi 
theeneer.  
 
 Biochemical analysis: Shown the presence of Alkaloids which are 
important bio active constituents possessing antispasmodic, analgesic, 
bactericidal effects. A synergistic effect of all these flavonoids, alkaloids, 
glycosides, tannins, phenols, saponins, increases the potency of the drug 
against Hepatic damages. 
 
 Preliminary Phyto Chemical Analysis: Qualitative analysis of 
phytochemical variables in Sanjeevi theeneer reports the presence of 
Phenolic compounds.  Phenols exhibit wide range of pharmacological and 
biological functions especially considering the cardiovascular health. Their 
role in prevention of atherosclerosis (Anti-atherosclerotic) and 
inflammation (Anti-inflammatory) and also in improving endothelial 
function has been well established 
23, 24
 various studies prove it as an Anti-
carcinogenic, Ant apoptosis and Anti-ageing compound. 
 
 GC-MS analysis: Reported the presence of major compound Oleic acid 
(% Peak area: 40.85), Dasycarpidan (% Peak area: 1.98), Thymol (% Peak 
area: 34.32 and other secondary metabolites which may have significant 
biological properties contributing to the Therapeutic potential of Sanjeevi 
Theeneer as an Anti-oxidant, Hepato protective, Broncho dilator and Anti-
histamine. 
 
 Toxicity studies: 
 Acute Toxicity Studies: The treated rats with Sanjeevi Theeneer 5 ml/kg 
in the acute toxicity study did not show any mortality, any untoward 
clinical sign, any behavioral signs, alterations in body weight and necropsy 
findings at the end of the study. This indicates that the dosages 
administered were below toxic level and proves the safety of the drug.The 
acute toxicity helped to fix the doses for pharmacological activities. 
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 The Repeated dose 28 day oral toxicity and Repeated dose 90-day oral 
toxicity study: The trial drug Sanjeevi Theeneer were administered in 
Wistar rats. The treated animals survived throughout the study period of 28 
days and 90 days did not reveal any treatment related major abnormal 
clinical signs at the test dose levels. The overall percentage of body weight 
gain in rats treated with the drug was found to be normal indicating that 
the test animals were in a healthy condition during the 90 days of 
observation period.  
 In histo pathological studies both mid dose and high dose, treated rats 
shown no significant abnormalities. The necropsy studies showed no 
remarkable changes. 
 This strongly stress the fact of the drug having no toxic effect on the body 
metabolism.The necropsy studies showed no remarkable changes.So the 
trial drug Sanjeevi Theeneer may be further established under human 
trials. 
 Pharmacological studies: 
The pharmacological activities of Sanjeevi Theeneer like Anti oxidant, Hepato 
protective, Broncho dilator and Anti Histamine  have shown significant outcome 
and results. 
 
 Anti oxidant Activity (Invitro - DPPH radical scavenging assay of 
Sanjeevi Theeneer) 
Sanjeevi Theeneer was studied for its Anti-oxidant potential on DPPH 
radical scavenging assay by comparing with standard Ascorbic acid. 
Sanjeevi Theeneer was able to reduce the stable DPPH radical to 50 % 
reduction with IC50  of  90.19 ±  8.57)as compared with Ascorbic acid 
(46.91± 9.93). So results confirmative as a resultant Anti-oxidant. 
 
 Hepato protective Activity in Wistar Albino rats:The activities of serum 
SGPT, SGOT and ALP and the concentration of total bilirubin in the ST 
treated groups and the Silymarin group, were significantly decreased when 
compared to PCM treated group and almost near the normal value when 
compared to the negative control.  
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 The drug treatment was carried out at two dose levels 0.5ml and 1ml /kg, 
both of which along with the standard treated group showed a significant 
reduction in the elevated enzyme levels. 
 In histo pathological studies Sanjeevi Theeneer administered has 
significantly neutralized the toxic effects of PCM and  helped  in 
regeneration of hepatocytes.  
 These data suggests a dose dependent Hepato protective activity of ST. 
The tendency of these enzymes to return to near normally in ST 
administered group is a clear manifestation of anti-hepatotoxic effects. 
 The present studies were performed to assess the hepatoprotective activity 
in rats against PCM as hepatotoxic to prove its claims in clinical practice 
against liver disorders. 
 Broncho dilator and Anti-Histamine Activity: In isolated tracheal chain 
and isolated guinea pig ileum preparation, there is a right side shift of dose 
response curve of histamine in the presence of Sanjeevi Theeneer. This 
proves its anti-asthmatic and Anti- Histamine activity.  
 Hepato protective Activity in Zebra fish (Danio rerio) models: The 
results of the Histopathological investigation indicates that paracetamol 
treated groups shows sever liver degeneration whereas treatment with test 
drug ST at both the dose level significantly attenuated the paracetamol 
induced damage in group III and IV. Hence from the study it was 
concluded that the drug Sanjeevi Theeneer  possess promising hepato 
protective activity in dose dependent manners and restores the basic liver 
architecture by means of its rejuvenating potential against paracetamol 
induced toxicity in zebra fish model. 
 
From the discussion, this preclinical study of  Sanjeevi Theeneer proves the safety of the 
drug and its efficacy  as a Hepato protective, Broncho dilator and  Anti-Histamine in 
animal model.  Its Anti-oxidant potential has been validated in In vitro studies. The drug 
may be further assessed  and established for Clinical trial studies. 
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10. SUMMARY 
 
 The test drug Sanjeevi Theeneerwas selected from the Classical literature Siddha 
Formulary of Indiafor its Hepato protective, Broncho dilator and Anti Histamine 
studies. 
 
 Review of literature in various categories was carried out. Siddha aspect, botanical 
aspect, scientific aspects and Pharmaceutical review disclosed about the drug and the 
disease. Pharmacological review was done to establish the methodologies.The drug 
was subjected to analysis such as physicochemical, Preliminary phyto chemical 
analysis, Gas chromatography analysis and Anti-oxidant Assays. 
 
 Toxicological study was made according to OECD guidelines comprising the 
acute, repeated dose 28-days oral toxicity and repeated dose 90-days oral toxicity 
study.It showed the safety of the drug which proved its utility in long time 
administration without any harm to the human being. 
 
 Pharmacological studywas done. It revealed the Hepato protective, Broncho 
dilator and Anti Histamine activities in animal model. This present study suggests 
Sanjeevi theeneer has remarkable medicinal value in the treatment of Liver diseases. 
Thus, the herbal formulation Sanjeevi Theeneer is validated for its safety and efficacy 
for treating liver diseases, Asthma and it would be a great drug of choice and as a 
Health supplement. 
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11. CONCLUSION 
 
 
Sanjeevi Theeneer, the Herbo mineral Classical distillate was prepared as per the 
Siddha literature. The prepared drug meets all the Traditional quality parameters andalso 
fulfills the Standardization parameters of Theeneer mentioned in AYUSH guidelines. 
Based on OECD 423,407, 408 the trail drug Sanjeevi Theeneer is considered as nontoxic 
when studied on Animal Models. The Anti-oxidant Studies, Hepato protective studies, 
Bronchodilator and Anti Histamine activities was scientifically validated. Hence, it can 
be concluded as a safe and therapeutically effective drug in Liver diseases and Bronchial 
Asthma and moreover can be used a rejuvinative Health supplement. 
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